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Summary
Introduction and objectives
Intraoperative Radiation Therapy (IORT) is a special modality for cancer treatment that delivers
a single high dose of radiation directly to the exposed tumor bed during the tumor resection
surgery [Palta et al., 1995, Beddar et al., 2006, Calvo et al., 1993, 2013, Lamanna et al., 2012].
One of the main limitations in IORT lies in the diﬃculties that the planning process entails,
which limits the use of this technique [Lamanna et al., 2012, Pascau et al., 2012], and a treatment
planning has not been available in IORT up to now. Recently, a new tool has been introduced:
radiance R©, the ﬁrst Treatment Planning System (TPS) speciﬁcally designed for IORT [Pascau
et al., 2012, Valdivieso-Casique et al., 2015].
The main goal of this thesis has been the development, implementation and evaluation of a
dosimetric tool capable of providing a realistic dose distribution from any intraoperative electron
radiotherapy (IOERT) dedicated accelerator or Intrabeam R© applicator that can be used for dose
treatment planning in the operating room (OR) during an IORT treatment.
This dosimetric tool has been separated in three phases. First, a database of monoenergetic
phase space (PHSP) ﬁles and depth dose proﬁles (DDPs) in water was computed with penEasy
[Sempau et al., 2011, Badal Soler et al., 2008] from detailed simulations of each IOERT accelerator
and Intrabeam R© applicator. Then, the energy spectrum of these monoenergetic simulations was
tuned for each device using simple experimental DDPs provided by the manufacturer to the user,
obtaining an optimized PHSP ﬁle that reproduces the user's data [Ibáñez et al., 2015, Vidal et al.,
2015]. Finally, dose was calculated from this optimized PHSP ﬁle with an accelerated version
of DPM [Sempau et al., 2000, Guerra et al., 2014] in the case of electrons, or with the Hybrid
Monte Carlo (HMC) code we have developed [Vidal et al., 2014b,a, Udías et al., 2017b], in the
case of the Intrabeam R©.
xi
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Materials and methods
Detailed simulations and database generation
We have simulated the most relevant dedicated accelerators employed in IOERT treatments (ie.
NOVAC R©, LIAC R© and MOBETRON R©) with their corresponding applicators, and Intrabeam R©
needle, spherical, surface and ﬂat applicators. These simulations will represent a reference
accelerator or applicator, and will be used to create a database of monoenergetic PHSP and
DDPs in water that will be employed to generate a PHSP ﬁle tuned to each user machine in a
dose treatment planning procedure.
Phase space optimization process
First, a generic spectrum, whose general features were derived from the realistic MC simulations,
is ﬁne-tuned by means of a genetic algorithm [Fernandez-Ramirez et al., 2008] until it
describes the experimental DDP provided by the user of any given applicator. Afterwards,
the monoenergetic PHSP ﬁles are combined with weights given by the energy spectrum, to build
a PHSP ﬁle optimized to describe the experimental dose distribution [Ibáñez et al., 2015, Vidal
et al., 2015, Udías et al., 2017a].
Hybrid Monte Carlo
Dose with the Intrabeam R© device is calculated from the optimized PHSP ﬁle by means of an
in-house developed code, the Hybrid Monte Carlo (HMC) [Vidal et al., 2014b,a, Udías
et al., 2017b]. This code calculates deposited dose within minutes, fully taking into account the
diﬀerent tissues and structures of the patient. It incorporates all the relevant physical processes
at Intrabeam R© working energies, and the savings in calculation time are possible thanks to taking
to the extreme some variance reduction techniques, such as the use of meta-histories, each one
representing the fate of many particles, or the dose normalization, which allows statistic noise-free
dose distributions with a low number of initial meta-histories.
Results
Detailed simulations and database generation. We could compare dose distributions against
experimental data and a good agreement was reached. The optimization process only ﬁts the
DDPs, which is why it is essential that the rest of the dose distribution behaves correctly. By
simulating in detail the diﬀerent accelerators we guarantee a precise shape of the transverse
proﬁles.
Phase space optimization process. We have done a broad validation of this process against
xii
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experimental data in homogeneous and heterogeneous situations. For the validation of
dose distributions in water with spherical applicators, we found some discrepancies between
simulations and measurements due to the anisotropy of the dose in the backward direction.
However, the area presenting the anisotropy has no clinical interest. Regarding the dose
distributions in water with ﬂat and surface applicators, we found a good agreement for the cases
studied, with more than 95% of the voxels fulﬁlling the gamma criteria at the 2%-2 mm level.
In the dose comparisons inside heterogeneous phantoms, either with Intrabeam R© applicators
or IOERT accelerators, we reached a reasonable agreement at the 2%-2 mm level, specially
considering the uncertainties in the measurements.
Hybrid Monte Carlo. We have validated the HMC against penEasy in homogeneous and
heterogeneous phantoms. We have also compared dose distributions in clinical situations. In
general, good results were obtained with the gamma evaluation with the 2%-1 mm criterion. In
a few cases we had to go to a 5%-1 mm criterion to achieve a good agreement. However, the
gamma criteria for the Intrabeam R© has not been stipulated, and values of previous studies can
go from 2%-1 mm [Nwankwo et al., 2013], 2%-2 mm [Clausen et al., 2012] to even 10%-1 mm
[Chiavassa et al., 2014].
Conclusion
The phase space optimization process works correctly, reproducing dose distributions in clinical
situations for both electrons or X-rays beams. It has proven to be fast, ﬂexible and precise
enough for IORT planning.
The HMC provides soft dose distributions accurately and within minutes. It can be used as
a dose calculation tool in the operating room, as its high speed allows an on-the-ﬂy dose
calculation which includes the realistic eﬀects of the beam in the diﬀerent tissues within the
patient's body.
The phase space optimization process and the HMC have been integrated into radiance R©.
xiii

Resumen en castellano
Introducción y objetivos
La radioterapia intraoperatoria (IORT) es una modalidad de tratamiento que consiste en irradiar
directamente el lecho tumoral expuesto durante la cirugía con una dosis única y localizada [Palta
et al., 1995, Beddar et al., 2006, Calvo et al., 1993, 2013, Lamanna et al., 2012]. A pesar de
las ventajas que ofrece esta técnica, hasta hace poco la IORT carecía de las herramientas de
planiﬁcación y dosimetría que se emplean regularmente en radioterapia externa. Para remediar
esta carencia, se creó radiance R©, el primer planiﬁcador de tratamientos para IORT [Pascau
et al., 2012, Valdivieso-Casique et al., 2015].
El principal objetivo de esta tesis ha sido el desarrollo, implementación y validación de una
herramienta de cálculo de dosis capaz de proporcionar una dosis realista de cualquier acelerador
dedicado de IORT con electrones o con el sistema Intrabeam R© que pueda ser usada para planiﬁcar
el tratamiento dentro del quirófano durante una intervención de IORT.
Esta herramienta dosimétrica se ha separado en tres fases. Primero, se ha generado una base
de datos con penEasy [Sempau et al., 2011, Badal Soler et al., 2008] a partir de simulaciones
detalladas de aceleradores de electrones y aplicadores de Intrabeam R©, compuesta por espacios de
fase (PHSP) monoenergéticos y perﬁles de dosis en profundidad (DDPs) en agua. Después, con
un proceso de ajuste en el que necesitamos únicamente la DDP experimental de cada máquina,
obtenemos un PHSP optimizado que reproduce la dosis experimental. Finalmente, la dosis se
calcula a partir de este PHSP, bien con una versión acelerada de DPM [Sempau et al., 2000]
en el caso de trabajar con electrones, o bien con el Monte Carlo Híbrido (HMC) que hemos
desarrollado [Vidal et al., 2014b,a, Udías et al., 2017b] para el Intrabeam R©.
Materiales y métodos
Simulaciones detalladas y generación de la base de datos
xv
Resumen en castellano
Hemos simulado los aceleradores dedicados para IORT de electrones más relevantes con sus
aplicadores correspondientes, así como los distintos aplicadores del R©. Estas simulaciones
servirán para crear la base de datos de PHSP y DDPs monoenergéticos que alimentarán nuestro
algoritmo de optimización.
Proceso de optimización del espacio de fases
Primero, ajustaremos un espectro de energías genérico, derivado de las simulaciones detalladas
de los aceleradores, mediante un algoritmo genético [Fernandez-Ramirez et al., 2008], hasta
que describa la DDP experimental introducida por el usuario. Después usaremos el espectro
optimizado para pesar los PHSP monoenergéticos y obtener un espacio de fases que reproduzca
la dosis experimental [Ibáñez et al., 2015, Vidal et al., 2015, Udías et al., 2017a].
Monte Carlo Híbrido
Para el cálculo de dosis con la máquina Intrabeam R© hemos desarrollado el Monte Carlo
Híbrido (HMC) [Vidal et al., 2014b,a, Udías et al., 2017b]. Este código calcula la dosis
depositada en minutos, y tiene en cuenta el efecto de los distintos tejidos y estructuras en
el interior del paciente. Incorpora los procesos físicos relevantes a las energías de trabajo del
Intrabeam R© y lleva al extremo técnicas de reducción de varianza para acelerar los cálculos, tales
como el uso de meta-historias, cada una de ellas representando el destino que miles de partículas,
o la normalización de la dosis, que permite la obtención de dosis sin apenas ruido estadístico a
partir de pocas meta-historias iniciales.
Resultados
Simulaciones detalladas y generación de la base de datos. Las distribuciones de dosis obtenidas
se han comparado contra medidas experimentales y se ha observado un buen acuerdo entre ellas.
El proceso de optimización del PHSP sólo ajusta la dosis a las DDP experimentales, por lo que
es esencial que el resto de la dosis tenga la distribución adecuada. Al simular en detalle todos
los aceleradores, garantizamos que la forma de los perﬁles transervales sea la correcta.
Proceso de optimización del espacio de fases. Se ha llevado a cabo una amplia validación
del proceso con medidas experimentales en medios homogéneos y heterogéneos. Al realizar la
comparación de dosis con los aplicadores esféricos del Intrabeam R© en agua encontramos algunas
discrepancias debidas a la anisotropía que presentan las medidas experimentales en la parte de
detrás del aplicador. Sin embargo, la localización de la anisotropía está en una zona sin interés
clínico. En el caso de la comparación de dosis con los aplicadores planos y de superﬁcie del
Intrabeam R© en agua vimos que había buen acuerdo entre medidas y simulaciones, con más del
95% de los vóxeles cumpliendo el criterio gamma con límites 2%-2 mm para todos los casos. Y
lo mismo observamos al comparar las dosis en heterogeneidades tanto en IORT de electrones
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como en Intrabeam R©, donde el acuerdo es razonable, especialmente si tenemos en cuenta las
incertidumbres asociadas a la medida experimental.
Monte Carlo Híbrido. El HMC ha sido validado contra penEasy en maniquíes homogéneos y
heterogéneos. También se han comparado las distribuciones de dosis en CTs de pacientes. En
términos de criterio gamma, al nivel del 2%-1 mm se ha obtenido un buen acuerdo en general
entre ambos códigos, aunque en algunos casos se tuvo que aumentar a 5%-1 mm. Sin embargo,
los límites del criterio gamma para las dosis del Intrabeam R© no se han establecido aún, y los
valores que se han usado en estudios previos pueden ir desde 2%-1 mm [Nwankwo et al., 2013],
2%-2 mm [Clausen et al., 2012] hasta incluso 10%-1 mm [Chiavassa et al., 2014].
Conclusiones
El proceso de optimización de espacios de fase funciona correctamente, obteniendo PHSP
que reproducen distribuciones de dosis experimentales tanto para electrones como para el
Intrabeam R©. Se ha demostrado que es rápido, ﬂexible y suﬁcientemente preciso para planiﬁcación
en IORT.
El HMC proporciona distribuciones de dosis suaves y precisas en minutos. Puede usarse como
herramienta de cálculo de dosis en la sala de operaciones, ya que su alta velocidad permite
realizar un cálculo de dosis en el momento que además incluye los efectos realistas del haz al
atravesar las distintas estructuras del cuerpo.
Tanto el proceso de optimización de espacios de fase como el Monte Carlo Híbrido han sido
incorporados en radiance R©.
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this thesis
Intraoperative radiotherapy (IORT) is a modality of cancer treatment that combines the eﬀort
of two disciplines, surgery and radiotherapy, in order to increment the rate of tumor control.
In this treatment technique a high and localized dose of radiation is administrated directly to
the exposed tumor bed during the surgery performed to extract the tumor [Beddar et al., 2006,
Lamanna et al., 2012, Calvo et al., 1993]. The direct visualization of the tumor allows a more
precise deﬁnition of the volume that has to be irradiated and the protection of the surrounding
healthy tissues, by retraction of the tissue or by placing shields. Furthermore, IORT eliminates
the time between surgery and radiotherapy and oﬀers an alternative to those patients in which
external radiotherapy is not indicated. Finally, IORT is also used as the boost radiation of
multidisciplinary treatment approaches, including external radiotherapy.
The ﬁrst reported IORT clinical treatments date back to the early 1900s, just a few years after
the discovery of the X-rays, but the development of this technique really started in the late
1960s with the incorporation of the high-energy electrons as the optimal radiation beam for
IORT treatments [Calvo et al., 1993]. Since then, the technology involved in IORT has been
optimized and several dedicated linear accelerators and X-rays devices, such as Intrabeam R© (Carl
Zeiss Meditec, Dublin, CA, USA) or Axxent R© (Xoft, San Jose, CA, USA) have been developed,
and the number of institutions carrying out this treatment modality has been increasing in all
countries.
However, IORT is, in spite of the years that it has been around, still considered an experimental
procedure. This is mostly due to the fact that no commercial or certiﬁed/approved solution
existed covering the aspects that one is used to ﬁnd in conventional (external or brachytherapy)
radiotherapy. Although treatment planning is a necessary step in external radiotherapy, the
corresponding procedure has not been available in IORT up to now. There are several reasons
to this: There is usually no image for therapy planning, and a basic planning is sketched based
on preoperatory imaging. There are a few places where intraoperatory image is available, thanks
to magnetic resonance imaging (MRI) [Shah et al., 2012], in-room computed tomography (CT)
imaging [Jones et al., 2014] or ultrasounds [Lindner et al., 2006], but it is not at all commonplace.
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Moreover, the position where the applicator is going to be placed, its size and the possible
protections are decided in situ, after examining the surgical results [Lamanna et al., 2012,
Pascau et al., 2012, Beddar et al., 2006]. This means that there is a short time window to
perform and/or tune the treatment plan. Furthermore, there is no actual record of the position
of the applicator, patient or shields during treatment, other than the memory of the people
present, and pictures or videos of the intervention, from which one could only roughly infer the
treatment setup. This prevents the post study of treatments and complicates the quality control.
In view of these inconveniences, planning has been based on isodose curves in water, measured
for each applicator and energy, and from this information, oncologists and medical physics set
the radiotherapy plan.
The need of a tool that allows the radiation oncologist to plan an IORT treatment and to obtain
an estimation of the dose distribution deposited in the volume of interest led the Unidad de
Medicina y Cirugía Experimental and the Servicio de Oncología Radioterápica from the Hospital
General Universitario Gregorio Marañón (HGUGM) in Madrid into developing a tool capable
of simulating an IORT process with electron beams from patient images. The Laboratorio de
Imagen Médica from the HGUGM developed a prototype of a treatment planning system (TPS)
that allowed the positioning of the IOERT applicators superimposed on the patient's CT or MRI
images, and painted the isodose lines in water for each applicator diameter, bevel and energy
[Desco et al., 1997]. The HGUGM contacted then with GMV company in order to transform
this prototype software into a commercial TPS for IOERT. As a result of this collaboration a
project was approved by the Ministry of Industry (FIT-300100-2007-53) to develop the ﬁrst TPS
for IORT: radiance R©.
radiance R© appeared in 2007. In its ﬁrst implementation, simple isodose curves in water were
still used, but radiance R© allowed to load a CT (or any other modality image) of the patient
(either intra-, pre- or post-operatory). This image could be edited to reﬂect better the surgical
ﬁndings and patient situation, and the applicator and energy of the electrons could be changed
and the resulting water isodose could be seen on the screen, co-registered with the patient image,
so that the doctors could then have a more clear picture of the setup and the radiation of the
tumor bed and organs at risk. radiance R© made also possible a much more precise documentation
of the procedure. However, although water measurements were a good starting point towards
providing a planning tool to IORT, they did not take into account the behavior of electrons in
tissues with densities diﬀerent than water.
Since 2009, a collaboration of several universities, companies and hospitals in Madrid have taken
radiance R© to a new level, building a research consortium composed of private companies (GMV,
Técnicas Radiofísicas), medical institutions (Hospital Universitario Gregorio Marañón, Consorcio
Hospitalario Provincial de Castellón, Clínica La Luz, Hospital Ramón y Cajal) and universities
(Universidad Politécnica de Madrid, Universidad Complutense de Madrid, Universidad Rey Juan
Carlos, Universidad de Valencia, Universidad de Granada) [Valdivieso-Casique et al., 2015]. In
2012 the project was extended to include low-energy X-rays intraoperative radiotherapy (IPT-
2012-0401-300000) and early in 2016, radiance R©, including its MC TPS, obtained EU and
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FDA marking and approval for use as TPS in human radiotherapy. Finally, in October 2016 the
companies Carl Zeiss and GMV signed a commercial collaboration agreement, and now every
Intrabeam R© device is being sold with radiance R©, incorporating the codes described in this
thesis, fully taking into account patient's anatomy.
In the new version of radiance R©, intraoperative images are being obtained and incorporated, as
well as a fully registration of the patient and the radiotherapy applicator thanks to video cameras
and reference marks in the OR, with real time visualization and oﬀering the oncologist a similar
control as the one it is customarily achieved in external radiotherapy (ERT). Estimating dose
from isodose curves in water was not longer suﬃcient in this context. It was called for a TPS
tool of similar accuracy and precision as the ones available for ERT, and this means a full Monte
Carlo (MC) based TPS.
Now this proved to be an extremely challenging goal. A MC TPS requires the two following
tasks to be accomplished:
• Detailed simulation of the accelerator and applicators to obtain a complete description of
the radiation being applied to the patient. If repeatability among diﬀerent units of the
same model is not good enough, the detailed simulations should be performed for each
accelerator deployed on the ﬁeld. Commissioning of the unit must include the comparison
to measurements and the validation of the results. Ideally, commissioning has to be an
approach amenable to any user with little knowledge of MC simulations. And it should
be done in a very short time, hours at most. We have tackled this need employing phase
space (PHSP) ﬁles containing the complete description of the particles emitted by the
accelerator, meaning that the simulation of the accelerator and applicator does not need
to be repeated for each case. With regards to tuning to the machine, the chosen procedure
consisted in the pre-computing of a number of virtual monochromatic accelerators, being
described in Chapter 4 [Ibáñez et al., 2015, 2016, Vidal et al., 2015, Udías et al., 2017a].
• A fast calculation of the dose on the patient, taking into account the diﬀerent tissues seen
in the planning or intraoperative CT, once the PHSP ﬁle is given. Dose calculation must be
very fast because it should be possible to repeat the calculations once the patient situation
after surgery is known, and it should be even possible to compute the dose under diﬀerent
scenarios (energy, applicator size or angle, diﬀerent shielding) so that the oncologist and the
medical physicist can tune the setup within minutes, in order to not delay the procedure
and allow an as fast as possible end of the surgical intervention. For the electron case,
a modiﬁcation of the DPM code [Sempau et al., 2000] was incorporated [Herranz et al.,
2014, Guerra et al., 2014, Guerra Gutiérrez et al., 2012] in radiance R©. For Intrabeam R©'s
kilo-voltage X-rays, we have developed [Vidal et al., 2014b,a, Udías et al., 2017b] a new
algorithm for dose calculation aiming to preserve the accuracy of MC approaches, but
avoiding as much statistical noise as possible. This is going to be described in Chapter 6.
This Ph.D. thesis has been carried out inside the Grupo de Física Nuclear from the Universidad
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Complutense de Madrid, which is a component of the radiance R© collaboration. The main
goal of this thesis has been the development, implementation and evaluation of a dosimetric
tool capable of providing a realistic dose distribution from any IOERT dedicated accelerator or
Intrabeam R© applicator that can be used for dose treatment planning in the OR during an IORT
treatment. To do this we have done two mayor contributions to the dose calculation algorithms
implemented in radiance R©. First, we have developed a fast tuning tool to generate PHSP ﬁles
optimized to any user's device providing as input only an experimental DDP in water. Second,
we have developed a dose calculation code suitable for the Intrabeam R© working energies that
includes the accuracy of a MC method and calculates dose distributions in a fraction of time.
The combination of both contributions allows the user to obtain a dose distribution from a PHSP
ﬁle tuned to reproduce his device within minutes.
The objectives of this thesis can be summarized as follows:
• Development of a complete database of detailed IOERT accelerators and Intrabeam R©
applicators by simulating in detail the diﬀerent geometries of the devices and comparing
dose distributions with experimental measurements to assure a correct behavior of every
simulation.
• Development of a phase space tuning procedure to generate a PHSP ﬁle that reproduces
experimental dose distributions from any given DDP in water.
• Validation of the previous procedure against experimental measurements for Intrabeam R©
applicators and IOERT accelerators.
• Development and validation of a dose computation tool, called Hybrid Monte Carlo, for
the Intrabeam R© applicators that calculates accurate dose distributions within minutes.
Therefore, in this thesis we describe the tools developed for the incorporation of realistic dose
calculations into radiance R©, taking into account the heterogeneous composition of the treatment
volume. Such a complex project is the result of a collaboration between several researchers.
However, the speciﬁc contributions of this PhD student to the radiance R© project are listed
below:
• Elaboration of the detailed MC models with penEasy of the diﬀerent IOERT accelerators,
Intrabeam R© X-ray source and spherical, needle, ﬂat and surface applicators.
• Generation of the PHSP and DDP database for all IOERT and XIORT devices.
• Signiﬁcant contribution in the development of the HMC algorithm and the phase space
optimization tools.
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• Measurements with radiochromic ﬁlms for the spherical, ﬂat and surface Intrabeam
applicators in Mannheim and Toulouse.
• Complete validation of the phase space optimization process against reference simulations
and experimental measurements.
• Complete validation of the HMC against reference simulations.
This thesis is organized in six chapters:
In Chapter 1 we present the fundamentals of radiotherapy. First, we introduce the role of the
radiotherapy in the treatment of cancer and the main modalities of administration. Then, we
make a brief introduction of the interaction of photons and electrons with matter, and afterwards,
we focus on the intraoperative radiation therapy and its two modalities: Intraoperative electron
radiotherapy (IOERT) and low energy X-rays intraoperative radiotherapy (XIORT). We describe
the dedicated accelerators used in IOERT and the Intrabeam R© device, we introduce the
dosimetric tools used in an IORT treatment, such as ionization chambers and radiochromic
ﬁlms and we ﬁnally present the dosimetric characteristics of electrons and kilo-voltage photon
beams. We ﬁnally describe the main characteristics of radiance R©.
In Chapter 2 we summarize the main concepts of the Monte Carlo methods, as well as some of
their mathematical and probabilistic bases. We present the main MC codes used in radiotherapy
and we focus on the characteristics of the codes used in this thesis: penEasy, DPM, and the
main MC code in which these two codes are based, PENELOPE.
In Chapter 3 we present the detailed simulations we have done to generate the database that
will be used in Chapter 4. We describe the characteristics of each simulation and geometry,
as well as the resulting dose distributions compared to experimental measurements. We start
with the Intrabeam R© device. We characterize the X-ray source and its energy spectrum, and we
use it to simulate all spherical, ﬂat and surface applicators. In the case of IOERT accelerators,
we describe the geometries and source models for the LIAC R©, NOVAC R© and MOBETRON R©
dedicated accelerators. Finally we present the diﬀerent parameterizations performed to the phase
space ﬁles of the simulations in order to make them easy to handle.
In Chapter 4 we describe the optimization method used to tune a PHSP ﬁle so it reproduces any
given experimental dose. We explain the diﬀerent parts of the optimization tool, starting with
the generation of the database with monochromatic PHSP ﬁles and DDPs from the detailed
simulations of the previous chapter, the optimization of the energy spectrum by means of a
genetic algorithm and the ﬁnal PHSP weighting algorithm that generates the optimized PHSP
ﬁle. We also include some of the results of the genetic algorithm, the comparison of the ﬁtted
DDPs against experimental data and the optimized energy spectra.
In Chapter 5 we perform a complete validation of the ﬁtting procedure described in the previous
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chapter against experimental measurements. For the Intrabeam R© spherical applicators, we
compare against radiochromic ﬁlms that we measured in the Universitätsklinikum of Mannheim
and for the Intrabeam R© ﬂat and surface applicators we compare against measurements we did in
the Institut Universitaire du Cancer in Toulouse. We describe the diﬀerent experimental setups
and the calibration procedure, and we compare dose distributions in water and in heterogeneous
phantoms. For the IOERT accelerators, we use experimental transverse proﬁles measured with a
NOVAC R© at the Universitätsklinikum in Düsseldorf, and we extend the validation to the LIAC R©
and MOBETRON R© against detailed simulations.
In Chapter 6 we present the Hybrid Monte Carlo (HMC) developed to calculate dose for the
diﬀerent Intrabeam R© applicators in a short period of time. We describe the physics incorporated
to the code and the accelerating approaches. We incorporate also a dose normalization to avoid
artifacts and to generate statistical noise-free distributions with a low number of initial particles.
We ﬁnally validate the HMC against penEasy simulations for all applicators, in homogeneous
and heterogeneous media and in two clinical cases.
At the end we present the general conclusions of this thesis and the publications and conference
proceedings derived from this work.
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Chapter 1
Fundamentals of radiotherapy
1.1 The role of radiotherapy in oncology
Nowadays, cancer is one of the leading causes of death worldwide, accounting for 8.2 million
deaths in 2012 [World Health Organization, 2014]. Its high mortality, increasing incidence and
aﬀection to all humankind turn cancer into one of the diseases with higher social impact. World
Cancer Report 2014 [World Health Organization, 2014] highlighted the increasing incidence of
cancer from 12.7 million in 2008 to 14.1 million in 2012, and its trend is projected to continue,
with the number of cancer cases close to 25 million over the next two decades. Furthermore,
approximately 39.6 percent of men and women will be diagnosed with cancer at some point during
their lifetimes (based on 2010-2012 data) [World Health Organization, 2015]. These data justify
that ﬁghting cancer has become one of the principal objectives in developed countries.
There has been a great improvement in cancer treatments during the last decades. Thanks to
constant investigation, important progress has been achieved in early diagnosis and treatment
[Mackie et al., 2003, Mageras and Yorke, 2004, Herman, 2005, Jaﬀray, 2005], increasing recover
expectancy in cancer patients.
Fighting cancer is a multidisciplinary task of high complexity due to the increment of combined
treatments. There are three main techniques which are used alone or in combination for treating
cancer: surgery, chemotherapy and radiotherapy. This last technique, radiotherapy, has an
essential role in cancer treatment, specially for localized tumors. Around 50% cases of cancer
will receive radiotherapy at least once during the course of their illness [Delaney et al., 2005], for
either tumor control or palliative treatment.
Radiotherapy arose soon after the discovery of X-rays by Röntgen in 1895 when ionizing radiation
was established as a powerful therapeutic agent, and has been evolving since then together with
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the advances in physics and oncology. This technique consists in the application of ionizing
radiation on the tumor in such a way that the interaction of these particles within the medium
may kill or prevent the malignant cellular proliferation.
Ideally, a radiotherapy treatment would only irradiate tumor cells, leaving healthy tissue
unaﬀected. However, these two objectives cannot be fully achieved simultaneously, and a
compromise between beneﬁcial and detrimental eﬀects of radiation must be achieved. Therefore,
in order to deliver the correct quantity of radiation dose, the oncologist must consider not only the
eﬀects of treatment on the tumor but also the consequences on normal tissues. For that, the ﬁnal
objective of radiotherapy is to deliver a lethal dose to the tumor while limiting radiation damage
to healthy tissue. The development of new techniques to limit the radiotherapy eﬀects in healthy
areas is a constant challenge, where medicine, biology, physics and engineering meet.
Since the ﬁrst radiotherapy treatments until now, treatment techniques have become more and
more sophisticated [Jaﬀray, 2005, Mackie et al., 2003, Halperin et al., 2008, Lamanna et al.,
2012, Hogstrom and Almond, 2006, Sadeghi et al., 2010]. In order to obtain the best results,
diﬀerent types of radiation and diﬀerent ways to deliver them are used. For example, certain
types of radiation can penetrate more deeply into the body than others. In addition, some types
of radiation can be very ﬁnely controlled to treat only a small area without damaging nearby
tissues and organs. Other types of radiation are better for treating larger areas. In general, the
various radiotherapy techniques can be classiﬁed in the following two categories:
External beam radiotherapy or teletherapy: The radiation source is located at a certain
distance of the patient. Teletherapy is typically carried out in the radiation oncology unit of a
hospital using photons or electrons from a linear accelerator (LINAC). The LINAC is a device
that uses high-frequency electromagnetic waves to accelerate charged particles such as electrons
to high energies (typically 5-25 MeV) through a linear tube [Sadeghi et al., 2010, Khan, 2009].
The high-energy electron beam itself can be used for treating superﬁcial tumors, or it can be
made to strike a target to produce X-rays for treating deep-seated tumors.
Internal radiotherapy or brachytherapy: Brachytherapy is a method of treatment in
which sealed radioactive sources are used to deliver radiation at a short distance by interstitial,
intracavitary, or superﬁcial application. With this mode of therapy, a high radiation dose can be
delivered locally to the tumor with a rapid dose fall-oﬀ in the surrounding normal tissue [Sadeghi
et al., 2010]. This involves placing implants in the form of seeds, wires or pellets directly into
the tumor. Such implants may be temporary or permanent depending on the implant and the
tumor itself. The typically used radioactive sources are Iridium-192, Cesium-137, Iodine-125 and
Palladium-103.
A special type of treatment is the intra-operative radiotherapy (IORT), considered half
way between external and internal radiotherapy. IORT treatment consists in directly irradiating
the tumor bed with a high, localized dose during surgery. The tumor is removed surgically and
the radiation beam is directly delivered to the the tumor cavity, in order to kill residual cancer
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cells to prevent recurrence. A high-dose radiation is given to the patient in only one fraction.
Since the radiation is given directly to the tumor bed, the surrounding healthy tissues and organs
can be protected and excluded. It can be either considered teletherapy, as the radiation source
is located outside the patient, and brachytherapy, as the applicators are introduced inside the
patient or in direct contact.
This thesis presents an extensive study about this last technique, IORT, so its main characteristics
and applications will be described in detail in the following sections.
1.2 Interaction of radiation with matter
Ionizing radiations are characterized by their ability to excite and ionize atoms of matter with
which they interact. Since the energy needed to cause a valence electron to escape an atom
is of the order of 4-25 eV, radiations must carry kinetic or quantum energies in excess of this
magnitude to be called ionizing" [Attix, 2008].
Ionizing radiation may be classiﬁed into two main groups: Directly ionizing radiation and
indirectly ionizing radiation [Attix, 2008, Knoll, 2010, Martin, 2006]. The ﬁrst group includes the
charged particle radiations that continuously interact with the electrons present in the medium
through the coulomb force, gradually losing their energy. On the other side, indirectly ionizing
radiations are uncharged, so they undergo a probabilistic and catastrophic interaction that
radically alters the properties of the incident radiation. In a single encounter, these particles
can loose an important percentage of their energy, or all of it. In this case, the energy transfer
to the medium is a two-step process: The photons (or neutrons) transfer energy to the charged
particles which are responsible of the bulk of the ionization eﬀects.
1.2.1 Interaction of photons with matter
When a clinical photon beam goes through a medium, diﬀerent interactions with matter take
place. All these processes (except for the Rayleigh scattering) lead to the partial or complete
transfer of the photon energy to electron energy. They result in sudden and abrupt changes in the
photon history, in which the photon either disappears or its scattered through a signiﬁcant angle
and secondary charged particles are emitted. These resulting particles can produce ionizations,
excitations or electromagnetic radiations in the medium.
We limit our considerations to the clinical energy range (keV-MeV), where the dominant
interaction processes are the photoelectric eﬀect, coherent (Rayleigh) scattering, incoherent
(Compton) scattering and electron-positron pair production (Figure 1.1).
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Figure 1.1: Basic interactions of photons with matter [Salvat et al., 2006].
Photoelectric eﬀect: A low-energy photon gives up all of its energy to a bounded orbital
electron and ejects it from the atom. The electron is ejected with an energy equal to the energy
of the incoming photon, hν, minus the binding energy of the electron in its particular orbit.
Since a vacancy is created in the electron shell, a characteristic X-ray, typically from ﬁlling the
K-shell, will also be emitted. The photoelectric eﬀect is most pronounced in high-Z materials
and for low-energy photons (less than 0.5 MeV).
Compton scattering: The interaction process of Compton scattering takes place between an
incoming photon and an electron in the absorbing material. The incident photon transfers a
fraction of its energy to an electron which is ejected from the atom. As a result, the photon is
deﬂected through an angle θ with respect to its original position. The Compton scattering is the
predominant interaction mechanism for low-Z materials and for energies employed in external
beam radiotherapy (around several MeV).
Rayleigh scattering: Also called coherent because the photon is scattered by the combined
action of the whole atom. The photon loses essentially none of its energy; the atom moves just
enough to conserve momentum. The photon is usually redirected through only a small angle.
Rayleigh scattering contributes nothing to dose, since no energy is given to any charged particle,
nor is any ionization or excitation produced.
Pair production: When a high-energy (>1.022 MeV) photon interacts with the strong
electromagnetic ﬁeld surrounding a nucleus, the photon may disappear and be replaced by an
electron-positron pair. All the excess energy carried in by the photon above the 1.022 MeV
required to create the pair goes into kinetic energy shared by the electron and the positron. Pair
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production is predominantly conﬁned to high-energy gamma rays.
The relative importance of Compton eﬀect, photoelectric eﬀect, and pair production depends on
both the photon quantum energy (E, = hν) and the atomic number Z of the absorbing medium.
Figure 1.2 shows the relative importance of the three major types of photon interaction. The
line at the left represents the energy at which Compton scattering and photoelectric eﬀect are
equally probable as a function of the absorber atomic number. The line at the right represents
the energy at which pair production and Compton scattering are equally probable.
Figure 1.2: The three major types of photon interaction [Evans and Noyau, 1955].
1.2.2 Interaction of electrons with matter
An incident electron interacts with one or more electrons or with the nucleus of practically every
atom it passes. Most of these interactions transfer only a fraction of the incident particle's kinetic
energy in each interaction, gradually losing its kinetic energy as they go through the medium (a
1-MeV charged particle would typically undergo ∼105 interactions before losing all of its kinetic
energy), so this mechanism is often called the continuous slowing-down approximation (CSDA).
When electrons interact with other electrons, they produce excitations and ionizations. When
interacting with the atomic nuclei coulomb ﬁelds, they generate radiative collisions. In these
processes electrons undergo abrupt changes in their trajectories.
The possible interactions of electrons and positrons with the medium are, as shown in ﬁgure 1.3:
elastic scattering, inelastic collisions and bremsstrahlung emission; positrons can also undergo
annihilation, either in ﬂight or at rest [Attix, 2008, Knoll, 2010, Martin, 2006, Cherry et al.,
2012].
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Figure 1.3: Basic interactions of electrons with matter [Salvat et al., 2006].
1.2.2.1 Collisions with atomic electrons
Soft collisions
When an electron passes at a certain distance of an atom, the particle's Coulomb force ﬁeld
aﬀects the atom as a whole, exciting it to a higher energy level, or ionizing it by ejecting a
valence-shell electron. In this process, the net eﬀect is the transfer of a very small amount of
energy (a few eV) to an atom of the absorbing medium.
For low and intermediate electron energies (non relativistic energies), this scattering is the main
energy transfer process, causing either excitation or ionization of the atoms.
Hard collisions
When the electron passes near the atom, it becomes more likely that the incident particle will
interact with a single atomic electron, which is then ejected from the atom with considerable
kinetic energy.
Ionization involving an inner shell electron eventually leads to the emission of characteristic
X-rays or Auger electrons. The ejected electrons might have enough energy to create further
ionization. That electron is called a delta ray. The delta rays dissipate their energy along
a separate path, so some of the energy transferred to the medium may be transported some
distance away from the primary particle track.
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The probability of hard collisions depends of the nature of the incident particle, and although
these kind of collisions are less in number than the soft ones, the energy fraction of the primary
particle lost in both processes is comparable.
1.2.2.2 Interactions with the external nuclear ﬁeld
These interactions occur when the incident particle actually penetrates the orbital electron
cloud and interacts with its nucleus. In most of the cases (97%−98%) the electron is scattered
elastically, losing just a negligible amount of energy due to the nucleus recoil. Hence this is not a
mechanism for the transfer of energy to the absorbing medium (the electron does not emit X-rays
or excite the nucleus), but it is the reason why the path of the electrons is very tortuous.
In the other 2-3 % of the cases in which the electron passes near the nucleus, an inelastic radiative
interaction occurs in which an X-ray photon is emitted. The electron is not only deﬂected in
this process, but gives a signiﬁcant fraction (up to 100%) of its kinetic energy to the photon,
slowing down in the process. Such X-rays are called bremsstrahlung (German word for braking
radiation). The energy of the bremsstrahlung photons can range anywhere from nearly 0 (events
in which the particle is only slightly deﬂected) up to a maximum equal to the energy of the
incident particle (events in which the particle is virtually stopped in the collision).
Bremsstrahlung is an important resource for dissipating energy in high Z media, but it is relatively
insigniﬁcant for tissue-like (low Z) materials for electrons below 10 MeV.
1.2.2.3 Positron annihilation
When a positron is combined with an electron in an annihilation reaction, their masses are
converted into energy. This energy appears in the form of two 0.511 MeV annihilation photons
that travel in opposite directions. However, if the annihilation takes place before the positron
stops, the resulting photons may be emitted in directions slightly oﬀ the ideal.
1.3 Intraoperative radiation therapy (IORT)
Once described how the diﬀerent types of radiation interact with matter, let's focus on describing
the main characteristics of intraoperative radiotherapy (IORT), because this treatment technique
will be the main subject of this thesis.
Intraoperative radiation therapy is a special radiation modality that allows the administration
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of a high localized dose (in the range of 10 to 25 Gy) in a single fraction during surgery, alone or
as a boost technique [Calvo et al., 1993, Lamanna et al., 2012, Beddar et al., 2006, Abe, 1984,
Rich, 1986, Gunderson et al., 2011, Debenham et al., 2013, Palta et al., 1995]. This modality
permits direct visualization of the region to be irradiated after the removal of the lesion and it
allows healthy tissue to be protected, by displacement or by shielding [Oshima et al., 2009, Russo
et al., 2012, Martignano et al., 2007].
Although IORT was ﬁrst introduced as a treatment technique at the beginning of the XX century
[Beck, 1909], it was not until the earlies 1970s and 1980s that modern IORT with electron beams
was developed [Abe et al., 1971, Abe and Takahashi, 1981]. Nowadays, IORT is widely used
and its beneﬁts in certain types of cancer (breast, gastrointestinal, prostate, pancreatic, brain,
vertebral, etc) have been widely achieved [Calvo et al., 1993, Orecchia et al., 2003, Orecchia and
Veronesi, 2005, Vaidya et al., 2001, Rich, 1986, Kraus-Tiefenbacher et al., 2005, Beatty et al.,
1996, Bodner et al., 2003, Wenz et al., 2010, Schneider et al., 2011].
IORT can combine the beneﬁts of the surgery with the beneﬁts of the radiotherapy in the
following aspects:
• Reduction of the possibility of a residual tumor regeneration, eliminating the microscopic
tumor focal points.
• Allowance of a better deﬁnition of the treatment area, minimizing the damage to the
healthy tissue.
• Maximization of the radiobiological eﬀect with a high, localized dose.
• Fewer side eﬀects, including rashes and skin irritation, that are commonly experienced
during traditional radiation therapy.
• Shortening of the external radiation therapy treatment time when combined with IORT.
IORT requires a complex organizing system speciﬁcally designed for this treatment, that includes
the collaboration of a multidisciplinary team made up by surgeons, oncologists, radiotherapists,
radiophysicists, anaesthetists, nursing staﬀ and assistants, among others.
There are two diﬀerent types of IORT treatment, depending of the radiation used: Intraop-
erative electron radiation therapy (IOERT) and Low energy X-rays intraoperative
radiation therapy (XIORT).
1.3.1 Intraoperative electron radiation therapy (IOERT)
IOERT is the most common intraoperative radiation modality. Megavoltage electrons, when
comparing to megavoltage photons, release the maximum dose at a similar depth as the photons.
However, while the dose of electrons is released in a few cm from the entry point, the dose of
photons is released at greater depths, as shown in ﬁgure 1.4 [Lamanna et al., 2012]. This fact
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makes electrons the most suitable particles to give the required dose of radiation directly to the
tissues displayed during surgery, thus protecting the underlying healthy tissues.
Figure 1.4: Percent Depth Dose (PDD) as a function of depth in water. The photon behavior is
compared to the electron delivered dose. [Lamanna et al., 2012]
There are two application possibilities for IOERT, regarding the used radiation equipment: Using
the linear accelerator treatment room, where the patient is carried from the operating room, or
using mobile accelerators [Beddar et al., 2006] and treat the patient directly in the operating
room. Both possibilities will be described in due course.
1.3.2 Low energy X-rays intraoperative radiation therapy (XIORT)
Intraoperative radiotherapy using electrons has been the favorite approach over orthovoltage
beams because of better dose homogeneity, decreased treatment time and less bone absorption
attributed to the photoelectric eﬀect [Park et al., 2010]. However, XIORT (also called electronic
brachytherapy because it uses X-rays produced by linear accelerators instead of using radioactive
materials) has advantages in some clinical settings and is more cost-eﬀective in most cases. The
potential major advantages of XIORT are disposability of the source after use and a lesser
requirement for protective shielding during the procedure [Eaton et al., 2011].
Intraoperative radiotherapy with low-energy X-rays (30-50 keV) is an innovative technique that
can be either used as a single treatment or as a boost radiation. Inmediately after tumor
resection the tumor bed can be treated with a low-distance X-rays by a single high dose [Kraus-
Tiefenbacher et al., 2005]. At such low energies, the dose fall-oﬀ from the eﬀective beam source
is extremely rapid. The highest dose is at the applicator surface and it decreases with increasing
tissue distance from the applicator. This allows a high irradiation to the surgical cavity (up to
a depth of 1-2 cm) preserving the healthy tissue underneath.
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XIORT is increasingly used since clinical results for breast cancer irradiation showed a similar
local control [Veronesi et al., 2013], less toxicity, especially chronic skin toxicity [Sperk et al.,
2012], and a overall survival beneﬁt [Vaidya et al., 2014] for patients treated with XIORT in
comparison to patients treated with external beam radiotherapy.
There are currently two commercial devices dedicated to low energy X-rays IORT (XIORT)
treatments: the Axxent R© Electronic Brachytherapy System (Xoft Inc., Fremont, California) and
the INTRABEAM R© device (Carl Zeiss Surgical Gmbh, Oberkochen, Germany). In this thesis
we will study the INTRABEAM R© device, so further description of this device can be found in
the next sections.
1.4 Dose delivery in IORT
1.4.1 Linear accelerators for IOERT
There are two IOERT types of linear accelerators (LINAC), as previously mentioned:
Conventional linear accelerators and dedicated mobile accelerators. The main characteristics
of both systems will be found below.
1.4.1.1 Stationary linear accelerators
The available clinical linear accelerators can produce either photon or electron beams. In general,
the generated radiation with this kind of devices is a high energy radiation with an energy
spectrum from a few keV to several MeV, depending on the model.
A linear accelerator is a device that uses high radio-frequency (10-100 MHz) electromagnetic
waves to accelerate charged particles (i.e. electrons) to high energies in a linear path, inside a
tube-like structure called the accelerator waveguide [Khan, 1994, Karzmark and Morton, 1981].
The most basic conﬁguration of a linear accelerator consists in using electron acceleration between
two electrodes by means of the electric gradient within them. The electron beam is accelerated
until it reaches kinetic energies between 4 and 25 MeV.
The LINAC has two working modes depending on the particles used for the treatment (ﬁgure
1.5):
In the X-ray therapy mode the electron beam hits a high-Z target, like tungsten. As a result,
the electron energy is converted into a spectrum of X-ray energies with maximum energy equal
to the incident electron energy.
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In the electron mode therapy, the target is replaced by a scattering foil that spreads the
beam.
Figure 1.5: Components of the treatment head of A: X-ray therapy mode and B: Electron therapy
mode [Khan, 1994].
The treatment head contains the collimation, stabilization and monitoring systems. The
treatment unit and the acceleration structure are held inside the gantry, which can rotate 360◦
around its axis. As the gantry rotates, the collimator axis (coincident with the central axis of
the beam) moves in a vertical plane. The point of intersection between the collimator axis and
the rotation axis of the gantry is known as the isocenter.
The ﬁnal dose distribution strongly depends on the beam modiﬁer systems:
Scattering foils: The electron beam, as it exits the window of the accelerator tube, is a
narrow pencil beam of about 3 mm diameter. In the electron mode of LINAC operation, this
beam is made to strike an electron scattering foil to spread the beam as well as get a uniform
electron ﬂuence across the treatment ﬁeld. The scattering foil consists of a thin metallic foil,
usually lead. The thickness of the foil is such that most of the electrons are scattered instead
of suﬀering bremsstrahlung. However, a small fraction of the total energy is still converted into
bremsstrahlung and appears as X-ray contamination of the electron beam.
Flattening ﬁlter: The beam intensity is peaked in the forward direction. To make the beam
intensity uniform across the ﬁeld, a ﬂattening ﬁlter is inserted. This ﬁlter is made of a metallic
material (usually lead) and it is thicker in the center than in the sides.
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Collimators: The emerging beam needs to be shaped to ﬁt the treatment area. This is done
by metallic jaws that change the beam area and size and focus the radiation.
IOERT applicators: All IOERT treatments need a speciﬁc collimator system [Nevelsky et al.,
2010, Björk et al., 2000, Pimpinella et al., 2007]. Besides primary and secondary collimators,
there are other systems called applicators that also collimate the beam.
Figure 1.6: Main components of an ELEKTA PRECISE device [Nevelsky et al., 2010]
An IOERT applicator has three main functions: Collimation of the electron beam, deﬁnition of
the treatment volume and detraction of the healthy tissue [Björk et al., 2000].
The main characteristics of applicators (used in both stationary and mobile linear accelerators)
are [Pimpinella et al., 2007, Björk et al., 2000]:
• Applicators have, in general, cylindrical shape, although some of them may be rectangular.
• Applicators can be beveled or non-beveled.
• They are usually made of PMMA or brass.
• Applicator thickness varies between 3 mm and 8 mm.
• They present diﬀerent lengths (from 30 cm to more than 1 m) and diameters (5-10 cm or
more).
When a conventional accelerator is used for IOERT treatments, speciﬁc designed applicators
must be employed [Nevelsky et al., 2010]. A telescopic device is attached to the accelerator head
to change the source-to-applicator-end distance in the range up to 100110 cm (ﬁgure 1.6).
The use of conventional accelerators for IOERT has several disadvantages. In this case, the
anesthetized patient must be moved from the operating room (OR) to a sanitized treatment
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Figure 1.7: IOERT procedure with a stationary linear accelerator. The treatment room changes
temporarily into an operating room with all the needed equipment for monitoring the anesthetized patient
[Calvo et al., 2013]
room, accompanied by OR personnel, as shown in ﬁgure 1.7. This is technically diﬃcult
and relatively ineﬃcient, with the LINAC often unavailable for conventional treatment for a
considerable time due to room preparation and waiting for the patient. [Beddar et al., 2006].
Most of the technical problems can be overcome with specialized operating rooms with integrated
accelerators. However, the dedicated IORT facility in an OR is quite expensive and the OR needs
to be properly shielded. To solve these problems mobile accelerators have been designed.
1.4.1.2 Mobile linear accelerators
The development of mobile linear accelerators has encourage the use of IOERT over the last
decade. These kind of machines can be directly used in the OR, without the need of any other
special shielding requirements.
Furthermore, the speciﬁc design of these mobile units can lead to advantages over conventional
units adapted to IORT. For example, electron beams can have ﬂatter beam proﬁles than
conventional LINACs, and the range of motion of the treatment head allows more ﬂexibility
in setting up the patient. On the other hand, limitations on these units are imposed by
practical concerns of storage, transport, treatment setup, and radiation protection [Beddar et al.,
2006].
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Actually there are several types of mobile LINACs:
Mobetron R©
The Mobetron R© (IntraOp Medical, Inc.) is a lightweight linear accelerator mounted on a C-arm
gantry. The gantry is attached to a stand that contains the accelerator cooling system and a
transportation system [Lamanna et al., 2012].
The gantry may be rotated ±45◦ in the transverse plane, and ±30◦ in the radial plane. Also,
the gantry may be moved in the horizontal plane, ±5 cm. These movements are unique features
not found in conventional accelerators used for IOERT.
Figure 1.8: Mobetron R© linear accelerator (extracted from www.md51.com).
Applicator sizes range from 3 to 10 cm diameter for ﬂat applicators, and 3 to 6 cm diameter for
30◦ beveled applicators, and produces electron beams of nominal energies 4, 6, 9, and 12 MeV.
The system is designed to deliver a large, uniform dose from 10 Gy to 25 Gy in a single fraction
at a dose rate of 10 Gy/min.
The Mobetron R© uses a soft-docking system [Beddar et al., 2006, Björk et al., 2000] in which
the treatment applicator is connected to a special rigid clamp system attached to the surgical
bed and the gantry is optically guided to the docking position above the applicator (Figure
1.9).
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As the unit is designed to operate only in the electron mode, beam currents are low, producing
less inherent radiation leakage. The accelerator design allows the system to be used in rooms
with no additional shielding.
Figure 1.9: The soft-docking system used by the Mobetron R©. (a) The electron applicator, in contact
with the tumor bed, is rigidly clamped to the surgical bed [Beddar et al., 2006].(b) The gantry being
moved for soft docking to the applicator [Beddar et al., 2006]. (c) Schematic diagram of the soft-docking
system [Björk et al., 2000].
Novac7 R©
Novac7 R© (Hitesys SpA (LT) Italy 1997), is a dedicated accelerator with four nominal electron
energy levels: 3, 5, 7 and 9 MeV [Lamanna et al., 2012, Mihailescu et al., 2006, Pimpinella et al.,
2007, Righi et al., 2013].
The most important characteristic of this accelerator is the very high dose-per-pulse, ranging
from 2.5 to 12 cGy/pulse, values up to 100 times greater than the doses per pulse produced by
a conventional accelerator.
Novac7 R© has both a mobile and a ﬁxed unit. The mobile unit is a stand structure on a motorized
base, which supports the accelerator and modulator. The stand structure has the form of an
articulated arm with four rotational joints, allowing movements similar to those of human arms.
The base permits the entire structure to move without modifying the head orientation.
The beam collimation is performed through PMMA applicators consisting of two separated
sections: the upper is fastened to the accelerator's head, and the lower is in contact with the
patient (Hard-docking system, see ﬁgure 1.11). The applicator's set consists of cylindrical tubes
with a wall thickness of 5 mm, diameter ranging from 4 to 10 cm, and face angles of 0◦45◦. The
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Figure 1.10: On the left, the mobile accelerator Novac7 R© in the operating room [Russo et al., 2012].
On the right, scheme of the accelerator head [Pimpinella et al., 2007].
length of the applicators varies according to the diameter: 80 cm for diameters up to 8 cm and
100 cm for those up to 10 cm.
Figure 1.11: Hard-docking system employed in Novac7 R©. (a) The collimation system ﬁxed to the
accelerator and the electron applicator before docking. (b) The hard-docking mechanism. (c) The unit
ready for treatment with the applicator in contact with the tumor [Beddar et al., 2006].
The Novac7 R© does not employ scattering ﬁlters which in conventional machines are the main
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source of stray radiation. The accelerator head has just a primary collimator and the exit
window (see ﬁgure 1.10). For this reason Novac7 R© has a low photon contribution: The total
bremmstrahlung photon dose for conventional accelerators is at least 2-3% of the dose at the
PDD (Percentage Depth Dose) maximum, mainly due to head scatter. For Novac7 R© with a 9
MeV nominal energy this value is 0.2% of the dose value at the PDD maximum.
Liac R©
Liac R© (SORDINA SpA Italy) is a dedicated IOERT linear accelerator, which produces electrons
with energies of 4, 6, 8 and 10 MeV with a dose rate between 5 and 20 Gy/min and a pulse
frequency between 5 and 20 Hz.
Figure 1.12: Liac R© (from soiort.com).
The Liac R© head has three degrees of freedom: it can be moved up and down for a maximum
distance of 100 cm, it has a roll angle of ±60◦ and a pitch angle between +30◦ and -15◦.
The output beam has a 3 mm diameter and is collimated by a 60 cm long applicator with diﬀerent
diameters and beveled angles. The dose homogeneity is generally guaranteed by a 100 µm brass
foil scattering ﬁlter inserted in front of the titanium window. This technique keeps the level of
stray radiation below the required limits.
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1.4.2 Mobile devices for XIORT
There are two main systems used for IORT with low energy X-rays. The ﬁrst is the Axxent R©
Electronic Brachytherapy System (Xoft Inc., Fremont, CA), a system of devices used for low-
energy radiation at a high dose rate. The second, the Zeiss Intrabeam R© (Carl Zeiss Surgical,
Oberkochen, Germany), is a mobile photon radiosurgery system that procures a miniature
electron beam-driven X-ray source [Park et al., 2010].
In this thesis the Intrabeam R© system will be studied, so a detailed description of the device is
given below.
1.4.2.1 Intrabeam R©
The Intrabeam R© system (Carl Zeiss Surgical, Oberkochen, Germany) is composed of a miniature,
light-height (1.6 kg) X-ray source (XRS), settled in a stand with six degrees of freedom [Park
et al., 2010, Kraus-Tiefenbacher et al., 2004, 2005]. Due to low-energy X-rays no special shielding
is needed, and the treatment can be carried out in standard operating rooms [Eaton et al.,
2011].
  
(a)
(b)
(c)
Figure 1.13: (a)The Intrabeam R© system (Carl Zeiss Meditec AG, Jena) (b) The scheme of the miniature
X-ray source. (c) The Intrabeam R© source. Courtesy of Zeiss [Zeiss, 2012].
18
1.4. Dose delivery in IORT
The electrons are generated and accelerated to a potential of 50 kV in the main unit and travel
via the electron beam drift tube with 10 cm in length and 3.2 mm in diameter. At its end the
accelerated electrons strike a gold target resulting in a nearly isotropic bremsstrahlung X-ray
distribution around the tip [Yanch and Harte, 1996, Beatty et al., 1996, Dinsmore et al., 1996].
The scheme of the miniature X-ray source is shown in ﬁgure 1.13 (b).
The X-ray system produces low energy photons (up to 50 keV) with a steep dose falloﬀ in
soft tissue. This dose falloﬀ in the tissue guarantees minimum exposure of the surrounding
tissue.
Diﬀerent cancer types can be treated with Intrabeam R©, using diﬀerent applicators, which can be
attached to the XRS. These applicators are optimized in shape, size and physical dose distribution
according to the cancer type, shape and location within the body. There are several applicators
available, such as spherical, needle, cylindrical, ﬂat and surface applicators (see ﬁgure 1.14).
  
(a) (b) (c)
(d) (e)
Figure 1.14: The Intrabeam R© applicators. (a) Spherical applicator. (b) Needle applicator. (c)
Cylindrical applicator. (d) Surface applicator. (e) Flat applicator [Zeiss, 2012].
a) Spherical applicators
The most used applicator for Intrabeam R© is the Spherical, specially for irradiating the tumor
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bed in breast-conserving surgery [Kraus-Tiefenbacher et al., 2005, Vaidya et al., 2001, 2010].
The applicator ﬁlls the tumor cavity created by the tumor excision. The probe tip is centered
within the applicator and therefore the tumor cavity. A complete set of spherical applicators
with diameters from 1.5 to 5.0 cm, in 0.5 cm increments, enables exact adaptation to the size of
the tumor bed.
b) Needle applicator
The Needle Applicator can be used for the interstitial irradiation of tumors, e.g. in the treatment
of spinal metastases. Spinal metastases are often accompanied by severed pain and the danger
of a compression fracture. In Kypho-IORT with the needle applicator, vertebral metastases can
be irradiated intraoperatively. After the IORT treatment, the aﬀected vertebra is ﬁlled by the
insertion of bone cement in a procedure known as kyphoplasty [Wenz et al., 2010, Schneider
et al., 2011]. The Needle Applicator has a diameter of 4.4 mm.
c) Cylindrical applicator
The INTRABEAM Cylinder V Applicator is used for the irradiation of vaginal wall tumors and
consists of a cylindrical applicator and a probe guard which may be inserted in the applicator.
It enables manual stepping of the probe tip and the establishment of a homogeneous cylindrical
dose distribution at a deﬁned length [Schneider et al., 2009a]. The applicators are available in
the diameters of 2, 2.5, 3 and 3.5 cm.
d) Surface applicators
The Surface Applicator is used to treat tumors on the surface of the body, for example, for
the irradiation of non-melanoma skin cancers. It is particularly useful for patients with high
surgical risk or for cosmetic purposes. The applicator generates an optimized ﬂat radiation ﬁeld
(by means of a ﬂattening ﬁlter) at the applicator surface [Schneider et al., 2014]. The surface
applicators are available in the diameters of 1, 2, 3 and 4 cm.
e) Flat applicators
The Flat Applicator is used in the treatment of tumors on surgically exposed surfaces, such
as gastrointestinal tract tumors [Schneider et al., 2014]. The Flat Applicator has an optimized
ﬂat radiation ﬁeld (by means of a ﬂattening ﬁlter) at 5 mm from the applicator surface. The
applicators are available in the diameters of 1, 2, 3, 4, 5 and 6 cm.
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1.5 Dosimetry in an IORT treatment
IORT treatments, as other modern radiotherapy techniques, have improved radiation delivery.
But these techniques have also increased the complexity of the treatment planning and quality
assurance needs to be done.
Dosimetry for IOERT treatments:
The most commonly used dosimeters for calibration of photon and electron beams are exposure-
calibrated ionization chambers [Khan et al., 1991, Almond et al., 1999]. However, IORT
dosimetry requires particular procedures for beam dosimetry and characterization, specially when
using dedicated LINACs, which are sometimes diﬀerent from those used in conventional external
beam radiotherapy.
The main diﬀerence is related to the high dose per pulse of IOERT dedicated LINACs that does
not allow the direct use of the ionization chamber as recommended in the IAEA 398 protocol
for the absolute dose determination because of ion recombination eﬀects [Marrale et al., 2015].
The direct use of ionization chambers could, in principle, lead to inaccurate measurements of
output factors (OF) when applied to electron beams with these features of dose rate and energy
and angular distribution. However, Björk et al. [Björk et al., 2004] have shown that ionization-
chamber-based international dosimetry protocols could be applied in direct manner for output
factor measurement in IORT beam, with an uncertainty less than 0.3%.
Furthermore, the high dose gradients used in IORT require high spatial resolution detectors.
Other conventional measuring systems such as semiconductors do not provide enough spatial
resolution. Thermoluminescent detectors are hard to setup and time consuming to read. Silver-
halide radiographic ﬁlm has large diﬀerences in sensitivity to photon energies in the 10-200 keV
region, its properties of energy absorption and transfer do not match those of biological tissues,
are sensitive to room light and require wet chemical processing [Niroomand-Rad et al., 1998,
Fuss et al., 2007].
In contrast, radiochromic dosimeters provide high spatial resolution, have low spectral sensitivity
variation and does not require post-processing, which make them one of the most reliable
dosimetry methods.
Dosimetry for XIORT treatments:
Kilovoltage X-ray beam dosimetry provides a number of challenges which are not present for
megavoltage X-ray beams [Hill et al., 2014, Ebert et al., 2002, Ebert and Carruthers, 2003].
Due to the low beam energy, the dose falls rapidly (∼1/r3 in water, r being the distance to the
center of the source [Armoogum et al., 2007]). Such a rapid falloﬀ of the dose may complicate
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dosimetry as dose can vary considerably across the volume of the detector when dose distributions
are being measured. For example, the recommended ionization chamber is a parallel-plate
chamber which has 1 mm width in the direction of the dose falloﬀ (Type 23342, PTW, Freiburg,
Germany), corresponding to a change in dose greater that 50% at 5 mm distance from the source
at 50 kV [Ebert et al., 2002].
In addition, the energy spectrum is hardened quickly inside the water which can aﬀect dosimetric
parameters such as energy absorption coeﬃcients and tissue equivalence materials.
Another issue is that the response of the dosimeter is sensitive to the materials used in its
construction. For low energy X-ray beams, the photoelectric eﬀect is a dominant interaction
process and the photoelectric cross section has a strong dependence on the atomic number of the
material.
The last challenge is that ionization chambers do not act as BraggGray cavities in the kilovoltage
X-ray energy range and so cavity theory cannot be used for reference dosimetry.
In contrast, some of the required dosimetric characteristics are found in radiochromic ﬁlms
[Avanzo et al., 2012, Ebert et al., 2009, Fletcher and Mills, 2008]:
• Intrabeam R© dose reaches a maximum of about 20 Gy around the applicator surface and falls
below 1 Gy at 3 cm depth in tissue. Gafchromic EBT3 (International Specialty Products,
Wayne, NJ, USA) are recommended to be used in the range from 1 cGy to more than 40
Gy.
• Radiochromic ﬁlms have a high spatial resolution, necessary for measuring the rapid
Intrabeam R© dose falloﬀ.
• As described before, one of the concerns of kilovoltage X-rays is the energy response of the
dosimeter. Gafchromic EBT3 are energy-independent.
• Regarding the dosimeter materials, these ﬁlms are near tissue-equivalent.
In this thesis, experimental measurements have been performed with the Intrabeam R© device.
Two diﬀerent dosimetric methods have been used: Ionization chambers and radiochromic
ﬁlm.
1.5.1 Ionization chambers
A ionization chamber is a gas ﬁlled detector. As radiation passes through a gas it can ionize the
gas molecules. The charge pairs can be made to move in opposite directions by the application
of an external electric ﬁeld. The result is an electric pulse that can be measured by an associated
measuring device. Based on the applied bias voltage, a detector can be operated in a number of
modes, which diﬀer from one to another by the amount of charges produced and their movement
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inside the detector volume. In the ion chamber voltage region, all the charges that are being
produced get collected.
Ionization chambers are widely used for absolute dose measurements in radiation therapy. By
applying a certain detector speciﬁc calibration factor (e.g. Gy/C), the detector signal is related
to a radiation dose value.
1.5.2 Radiochromic ﬁlms
The radiochromic ﬁlm consists of a radiation-sensitive dye embedded in an organic emulsion or an
inert polymer. When an energetic photon or electron transfers its energy to the active layer, the
active monomer components present in the ﬁlm react to form a colored polymer [Niroomand-Rad
et al., 1998, Schneider et al., 2009b, Fuss et al., 2007].
These ﬁlms have very high spatial resolution and low energy dependence. Furthermore, they are
insensitive to visible light, and the direct coloration does not require chemical, optical or thermal
processing or ampliﬁcation.
In this work Gafchromic EBT3 (International Specialty Products, Wayne, NJ, USA) have been
used to perform absolute dosimetry. The ﬁlm structure is made of an active layer (28 µm thick),
between two polyester substrates (125 µm thick) [Gafchromic-EBT3]. The active layer contains
the active component, a marker dye, stabilizers and other components giving the ﬁlm its near
energy-independent response.
1.5.2.1 Data analysis. The three channel technique
After irradiation, radiochromic ﬁlms need to be scanned and converted to dose. The optical
density has to be determined and, by using the dose-optical density response curve, the scanned
image can be converted into dose (dose mapping). A multichannel ﬂatbed scanner is the best
option, as it oﬀers the selection of the red color channel for greater sensitivity at lower doses and
the blue and green color channel for higher doses.
Since the radiochromic ﬁlm provides a diﬀerent response to each of the channels, scanned ﬁlms
can be separated and analyzed in two parts: one part which is dose-dependent, and another
dose-independent part which contains information about the diﬀerences in the ﬁlm or the scanner
(thickness inhomogeneities, noise, dust particles, scanner artifacts, etc) [Micke et al., 2011]. By
separating the independent-dose part from the image, the remaining information is more reliable
and therefore more useful for dosimetry.
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After performing the calibration measurements [Devic et al., 2005, 2009, Lewis et al., 2012],
ﬁlms are scanned and data is obtained from the diﬀerent channels at a resolution of 16 bits per
channel. The images are deﬁned by their optical density within a range between black (0: no
observed signal) and white (I0=65535; maximum signal). The optical density (OD) represents
the capacity of the system to detect and reproduce the color range of the scanned images. The
scanned optical density is deﬁned as:
dX = − log10X (1.1)
where X [0,1] is the normalized color channel,
X =
I
I0
(1.2)
This X depends on scanner coordinates (i,j); X = Xij reﬂects the optical density of the ﬁlm at
the coordinates (xi,yj).
The dose mapping is a nonlinear process and its conversion parameters are determined in the
calibration, where a suﬃcient number of ﬁlms exposed to a known dose are scanned to generate
a calibration table {Di,dx(Di)}. The calibration functions dX (one for each color channel) are
determined by correlating the calibration table, taking the form:
dX(D) = − log
(
a+ bD
c+D
)
(1.3)
In the triple-channel ﬁlm dosimetry method [Micke et al., 2011], the scanned optical density
value can be separated into a dose-dependent part dDX and a dose-independent ∆d.
dX = dDX(D)∆d (1.4)
And the dose value can be calculated for each color channel as
Dx = d
−1
X (dX∆d) (1.5)
Since the dose cannot depend on the color channel X, a sequence of multiple channels can
be selected and the diﬀerences in the dose results between the diﬀerent color channels can be
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Figure 1.15: Multichannel calibration curves [Micke et al., 2011]
minimized (ﬁgure 1.15).
Ω(∆d) =
∑
i 6=j
(DXi −DXj )2 → min
∆d
(1.6)
This minimization is equivalent to ﬁnding the nearest color to the color path { dR(D),dG(D),dB(D)}.
The distance of a point from his color path represents the disturbance value ∆d, and the value
of the path parameter is the best dose value.
Figure 1.16: Dose map and disturbance map, and horizontal proﬁles [Micke et al., 2011]
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Figure 1.16 shows the resulting dose and disturbance maps after performing a triple ﬁlm
dosimetry analysis to a radiochromic ﬁlm. The horizontal proﬁle in the dose map shows the
improved ﬂatness across the ﬁlm. The corresponding proﬁle along the disturbance map consists
of a low frequency pattern dominated by thickness variations in the active layer.
1.6 Dosimetric characteristics of electron beams
When a clinical electron beam needs to be characterized, we are mainly interested in knowing how
the dose is distributed inside the patient. In this section the main parameters that characterize
the electron beam will be described.
1.6.1 Energy and angular distributions
One of the main characteristics of an electron beam is its energy distribution or energy spectrum.
When a monoenergetic electron beam travels inside a scattering medium, its electrons are aﬀected
by the Coulomb interaction and its energy distribution is modiﬁed because of the elastic collisions
with the atoms in the irradiated medium, broadening the spectrum. So, despite the initial
monoenergetic electron beam when exiting the window, energy degradation of the beam produced
by going through the diﬀerent components located inside the accelerator head generates a broad
energy spectrum at the end of the device, as shown in ﬁgure 1.17. In IOERT accelerators,
because of the applicator need for further collimation, the energy broadening is bigger than in
conventional radiotherapy. The path of electrons through IOERT applicators generates a greater
amount of scattered electrons that can contribute to the ﬁnal dose up to 40 %, while scattered
electrons from conventional radiotherapy contribute up to 10% of the ﬁnal dose [Björk et al.,
2002]. This increase of scattered electrons results in a broadening of the energy spectrum when
compared to conventional radiotherapy beams.
Moreover, the electron beam undergoes multiple collisions when traveling through the medium,
what results in a whole beam scattering, and the scattering trajectories are characterized by the
angular distribution of the beam. As a consequence, angular distributions in IOERT accelerators
are broader than in conventional accelerators, as happens for energy spectrum.
The spectrum estimation is of great importance to make an accurate dose calculation, as it
determines the initial energies and angles of the incident particles.
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Figure 1.17: Energy distribution of an electron beam in a) the exit window, b) at the end of the
applicator, c) at a certain depth inside the medium [Herranz, 2013]
1.6.2 Depth dose proﬁles
The graphic representation of dose deposition with depth is called depth dose proﬁle (DDP),
and it is related to the attenuation of the radiation inside a medium. This dose variation with
depth along the central axis is one of the fundamental parameters for characterizing a radiation
beam.
The depth dose curve of a beam depends on various factors such as beam energy, distance
between the source and the irradiated surface, etc. To build these curves, the measured dose at
diﬀerent depths is usually normalized to the maximum dose measured. That is why these curves
are usually known as Percentage Depth Dose (PDD).
Figure 1.18 shows PDD curves for diﬀerent clinical energies. High energy electrons deposit little
energy between the surface and the point of maximum dose. From this point a great reduction
of intensity takes place, until it reaches almost zero at a depth that depends on the initial beam
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Figure 1.18: Percentage depth dose curves (PDD) for typical IOERT electron beams [Nevelsky et al.,
2010].
energy. The rest of the dose contribution after this descending linear portion of the curve is
caused by bremsstrahlung X-rays.
Diﬀerent parameters can be deﬁned looking at the PDD (see ﬁgure 1.19 (a)) [Delgado et al.,
2013]:
• Rmax: Depth where absorbed dose in the central axis reaches the maximum.
• R90: Depth where dose reaches 90% of the maximum. The region between z=0 and R90 is
called therapeutic range.
• R50: Depth where dose reaches 50% of the maximum.
• Rp: Depth of the point where the tangent to the descending linear portion of the curve
(at the point of inﬂection) intersects the extrapolated background. Also called Practical
Range.
• Bremsstrahlung tail: X-ray contamination area. Dose measured in the central axis at
d10 + 10 cm (d10 is the depth the dose reaches 10%) of the maximum.
1.6.3 Transverse dose proﬁles
Depth dose curves have not enough information to describe completely the deposited dose, and
3D dose distributions are necessary. To achieve this, dose measurements oﬀ-axis, also called
transverse dose proﬁles, are performed. These curves take into account the beam spatial variation,
and are used to know how dose is distributed perpendicularly to the beam. By combining depth
dose proﬁles with oﬀ-axis data, 3D dose distribution can be reconstructed.
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Information about symmetry and beam homogeneity can be obtained from lateral proﬁles. They
have two distinguished regions: Central area and penumbra (as shown in ﬁgure 1.19 (b)).
The central area represents the radiation ﬁeld central part, up to 10 to 15 mm from the
geometrical edge of the ﬁeld. In this area, the lateral proﬁle depends mainly on the ﬂattening
ﬁlter and the geometry of the accelerator head.
The penumbra region of the lateral proﬁle is characterized by a quick dose variation, which
strongly depends on the collimation system, the radiation source focal size and the scattering
properties of the charged particles.
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Figure 1.19: a) Depth dose curve illustrating the diﬀerent parameters. (b) Typical shape of a transverse
dose proﬁle [Herranz, 2013].
1.6.4 Isodose contours
The combination of the two previously described curves provides a bidimensional modeling of
the dose (Figure 1.20). Each curve represents an isodose level that includes spatial points that
receive a dose equal or bigger than the one indicated by the curve. This kind of representation
allows dose modeling inside a patient when he is irradiated.
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Figure 1.20: Isodose contours of a 18 MeV electron beam [Nevelsky et al., 2010]
1.7 Dosimetric characteristics of low energy X-rays
As previously done with electrons, in this section we are going to describe the main parameters
that characterize the Intrabeam R© photon beam.
1.7.1 Energy and angular distributions
The Intrabeam R© source is a miniature X-ray source where electrons are accelerated up to 50 kV
and hit a gold target. As a result, X-rays are emitted in all directions with a maximum energy
of 50 keV. Therefore, the energy spectrum of the Intrabeam R© source will be a classical X-ray
spectrum with characteristic X-rays and a bremsstrahlung background.
The energy spectrum of the Intrabeam R© X-ray source (XRS) can be seen in ﬁgure 1.21 (Left).
The location of the prominent peaks correspond with the characteristic X-rays for gold and other
materials of the source [Dinsmore et al., 1996, Beatty et al., 1996].
When an applicator is placed around the needle, the beam hardens as it passes through the
diﬀerent materials. As a result, there is a reduction of the characteristic X-rays and an increase
of the bremsstrahlung tail. The energy spectrum of a spherical applicator is shown in ﬁgure 1.21
(Right).
Angular distribution of the Intrabeam R© needle has been studied in previous works [Dinsmore
et al., 1996]. It has been found (ﬁgure 1.22) that intensity is nearly isotropic, with an approxi-
mately 10 % decrease perpendicular to the probe axis (due to photon self-absorption in the gold)
and a 7% dip in the forward direction (origin unknown).
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Figure 1.21: Left: Energy spectrum of the XRS. Right: Energy spectrum of the 1.75 cm radius spherical
applicator [Schneider et al., 2010].
Figure 1.22: Polar representation of the angular photon ﬂux in the plane of the probe axis [Dinsmore
et al., 1996].
1.7.2 Depth dose proﬁles
Depth dose curves for low energy X-rays diﬀer from the electron curves. The dose rate is
the highest at the surface of the applicator and falls rapidly as the distance to the applicator
increases.
These curves vary signiﬁcantly with the applicator. For spherical applicators (ﬁgure 1.23 (a)),
the applicator with the smallest diameter gets the highest dose at the surface. As the diameter
of the applicator increases, the falling gradient of the dose slows down [Xiao et al., 2015]. For ﬂat
and surface applicators similar behavior is observed (ﬁgure 1.23 (b)): dose rate increases when
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diameter decreases. Similarly, the falling dose gradient is slower when the applicator is bigger
[Schneider et al., 2014, Goubert and Parent, 2015]. When comparing ﬂat and surface applicators,
ﬂat applicators are about 1.5 times higher in dose rate value than the surface applicator of the
same size [Lam et al., 2014].
(a) (b)
Figure 1.23: (a) Depth dose curve rate for each spherical applicator [Xiao et al., 2015]. (b) Depth dose
curve rate for each ﬂat and surface applicator [Goubert and Parent, 2015].
1.7.3 Transverse dose proﬁles
Oﬀ-axis measurements for Intrabeam R© are signiﬁcant when ﬂat or surface applicators are
used.
Figure 1.24: Transverse dose proﬁles at diﬀerent depths for 3 cm (a) ﬂat and (b) surface applicators,
normalized to the dose along the central axis [Goubert and Parent, 2015].
In the case of surface applicators, transverse proﬁles give a uniform dose distribution at the
applicator surface, and when depth increases, dose on the periphery becomes lower than dose
at the center of the proﬁle. In the case of ﬂat applicators, dose uniformity is not reached until
depth is 5 mm. Before this depth, dose on the periphery of the proﬁle is higher than dose in the
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center. For larger depths, dose on the periphery becomes lower than dose at the center [Goubert
and Parent, 2015].
1.7.4 Isodose contours
Isodose contours are very useful to test the needle anisotropy. In previous studies, isodose
contours of the needle have been proven to be similar to the angular distributions [Dinsmore
et al., 1996]. According to vendor speciﬁcations, Intrabeam R© construction yields an isotropic
dose distribution with a maximal variation of 15% in all directions [Clausen et al., 2012].
(a) (b)
Figure 1.25: (a) Isodose contours of the Intrabeam R© bare X-ray source. (b) Isodose contours of the
Intrabeam R© needle applicator (from Carl Zeiss Meditec AG)
1.8 Radiance R©, a treatment planning system for IORT
A treatment planning system is an essential tool for oncologists, as it allows to perform an
estimation of the dose distribution inside the patient before irradiation.
Although treatment planning is mandatory for external beam radiotherapy, the diﬃculties in an
IORT treatment have not make it possible until recently. There are several reasons for this: most
organs at risk are displaced or protected during surgery, the electron beam presents a very high
dose gradient, and the treatment volume is directly visualized by the surgeon in the operating
room.
radiance R© is the ﬁrst treatment planning system specially designed for intraoperative
radiation therapy [Valdivieso-Casique et al., 2015, Pascau et al., 2012, GMV, 2015]. It is
a planning system for IORT with electron beams and IORT with the Intrabeam R©. It has
been developed by the GMV company, and it is a result of a large collaboration between
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private companies (Técnicas Radiofísicas), medical institutions (Hospital Universitario Gregorio
Marañón, Consorcio Hospitalario Provincial de Castellón, Clínica La Luz, Hospital Ramón y
Cajal) and universities (Universidad Politécnica de Madrid, Universidad Complutense de Madrid,
Universidad Rey Juan Carlos, Universidad de Valencia, Universidad de Granada).
radiance R© can be used in three diﬀerent phases of the treatment:
• Pre-planning: Allows to try diﬀerent positions of the applicator using CT images, and to
select the optimum parameters for each treatment (applicator diameter, bevel angle and
electron beam energy).
• Intra-planning: During surgery, previous planning studies can be checked and updates
can be done if the situation requires it, checking the eﬀects of these changes on the dose
distribution inside the patient.
• Post-planning: After surgery, control CT studies combined with the simulation tool enable
evaluation of the treatment.
Three dose calculation algorithms are implemented in radiance R©:
• A pencil beam (PB) algorithm [Hogstrom, 1985, López-Tarjuelo et al., 2010] for electrons.
PB is very fast (running times up to 4 seconds). But this algorithm presents some
limitations when heterogeneities are present (such as bad backscattering modeling).
However, these deﬁciencies are covered by the Monte Carlo model.
• AMonte Carlo (MC) algorithm for electrons which has been optimized for computational
eﬃciency.
• An Hybrid Monte Carlo algorithm capable of fast and accurate dose calculations with
low energy photons for the Intrabeam R© device.
Both Monte Carlo and Hybrid Monte Carlo implementations in the planning system have
been possible thanks to the results presented in this thesis, that have been incorporated in
radiance R©.
Two examples of treatment planning with radiance R© are shown in the ﬁgure 1.26.
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(a)
(b)
Figure 1.26: Dose distribution in radiance R© in a (a) IOERT treatment, and (b) in a XIORT treatment
with a needle applicator [Valdivieso-Casique et al., 2015]
35
1. Fundamentals of radiotherapy
1.9 Gamma evaluation
To evaluate a radiotherapy planning system, comparisons of measured and calculated dose
distributions are required, and quantitative evaluations need to be performed.
As a ﬁrst approximation to deﬁne a quantitative evaluation method, dose diﬀerence was used as
acceptance criterion. A distribution of dose diﬀerences can be represented to identify the regions
where the calculated dose and the measurement diﬀer. This criterion can be used in low gradient
areas but is inadequate in high gradient regions, where a small spacial shift results in a large
dose diﬀerence.
The sensitivity of the dose diﬀerence method to high dose gradients led to the development of a
new tool called Distance-to-agreement (DTA) [Van Dyk et al., 1993]. The DTA is the evaluation
of the distance between a measured data point and the nearest point in the calculated distribution
that exhibits the same dose. However, in small dose gradient regions, small dose diﬀerences can
lead to high DTA values.
Because of the complementary sensitivity of these methods, both evaluation images were merged
to create a more complete evaluation criterion, the gamma evaluation [Low et al., 1998, Low
and Dempsey, 2003, Depuydt et al., 2002].
Figure 1.27: Schematic representation of the gamma evaluation method between the reference dose
(rr,Dr) and the calculated dose (rc,Dc). The criteria is deﬁned by an ellipsoid of acceptance determined
by the dose diﬀerence tolerance ∆DM and the DTA tolerance ∆dM [Depuydt et al., 2002].
The gamma method, presented by Low et al. [Low et al., 1998], compares two dose distributions:
The reference dose (Dr(r)) and the calculated dose that needs to be evaluated (Dc(r)). The
acceptance criteria are denoted by ∆DM for the dose diﬀerence and ∆dM for the DTA. For a
reference point at position rr with a dose Dr, the surface representing these acceptance criteria
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is an ellipsoid deﬁned as:
1 =
√
∆r2
∆d2M
+
∆D2
∆D2M
(1.7)
Where ∆r is the distance between the reference and the calculated point and ∆D is the dose
diﬀerence at the position rc relative to the reference dose Dr in rr.
∆r =| rr − rc | (1.8)
∆D = Dc(rc)−Dr(rr) (1.9)
The calculated dose will ﬁt the gamma evaluation if at least one point (rc, Dc) of its dose
distribution is contained inside the ellipsoid of acceptance showed in ﬁgure 1.27, ie. one point
for which
Γr(rc, Dc) ≡
√
∆r2
∆d2M
+
∆D2
∆D2M
≤ 1 (1.10)
The pass-fail criterion becomes:
• γ(rr) ≤ 1, calculation passes.
• γ(rr) > 1, calculation fails.
For example, if a 3%-3 mm criterion is considered, points passing this criterion will be the
ones located at 3 mm or less from a point in which dose diﬀerence with the reference is 3% or
less.
Gamma evaluation limits depend on the type of radiotherapy and the location of the tumor. For
a stereotactic brain treatment, with high precision systems and with organs at risk very close,
it would be suitable a 1%-1 mm criterion. However, for IORT these precision requirements are
not so restrictive, because the surgeon limits the treatment area and protects the organs at risk.
Therefore, in IOERT it is reasonable to consider suitable a dosimetric study when 95% of the
points pass the 3%-3 mm limit [Alber et al., 2008]. Nevertheless, this approximation can not be
considered in a dose evaluation for the Intrabeam R©, because of the rapid decrease of the dose.
In this case, this limit can vary from 2%-1 mm [Nwankwo et al., 2013], to 2%-2 mm [Clausen
et al., 2012] or even 10%-1 mm [Chiavassa et al., 2014]. In this thesis we have considered diﬀerent
limits, depending on the voxel size used.
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Chapter 2
Monte Carlo methods in
radiotherapy
2.1 Introduction
Determination of a dose distribution inside a patient or a phantom is of crucial importance to
be able to determine the eﬀectiveness of a radiotherapy treatment and to evaluate the eﬀects
of radiation in matter. Any dose measuring method will be only an estimation, because dose
deposition will depend on the irradiated medium, and by introducing any dosimetry system the
medium will be modiﬁed. This estimation of the dose can be measured with diﬀerent dosimetry
techniques (ionization chambers, radiochromic ﬁlms, etc.), or calculated with numerical methods
that implement diﬀerent models of the interaction of radiation with matter.
The use of calculation algorithms in dosimetry allows the estimation of absorbed dose
distributions inside irradiated volumes. These algorithms are based in radiation transport models
that describe the mechanisms responsible for the transport and the interaction of radiation with
matter. There are two main trends of dose calculation algorithms based in diﬀerent mathematical
models of energy deposition: one is a deterministic strategy based in Boltzmann equation and
the other is based in Monte Carlo (MC) simulations.
In the deterministic approach, the model is built from a coupled set of equations (known as
Boltzmann equation) that describe how a variety of diﬀerent types of particles travel through
a material. This technique works adequately in homogeneous media but has some problems
with heterogeneities [Wang et al., 1996, Ding et al., 2005], which are specially important in
radiotherapy dosimetry.
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In the last years, Monte Carlo methods are becoming widely used. Monte Carlo simulation of
radiation transport uses the probability distributions governing the individual interactions of
electrons and photons in materials to simulate the random trajectories or histories of individual
particles. These methods are more precise than the deterministic models, specially in complex
media, but very time consuming.
In this chapter we will explain the basic concepts of MC methods and their application in
radiotherapy. We will also describe the main MC codes used in radiation transport, specially the
ones that have been used in this thesis.
2.2 Monte Carlo technique. Basic concepts
The name "Monte Carlo" references a group of mathematical procedures or numerical methods
used to model complex systems by using the previously known probabilities of occurrence of
the diﬀerent events involved in the problem [Sobol, 1994, Kalos and Whitlock, 2008]. In these
processes random variables are used, and by calculating their expected value we can reach the
approximated solution of the problem. Therefore, a Monte Carlo simulation is a quantitative
technique that uses statistics to mimic, by means of mathematic models, the behavior of a real
system.
All processes involved in particle transport are stochastic, which means that we can not foresee
what kind of interaction is going to happen next and where it is going to take place. We only can
assign a probability to each possibility. However, the probability distributions associated at every
event are well known, and, together with the use of a random number generator, they will be used
to sample parameter values for calculating a possible solution to the problem for a single history
or event. By simulating many histories, reliable average values can be obtained. Since the result
is an average, it is associated with a standard deviation that expresses the uncertainty due to
the fact that the simulated number of events is less than inﬁnite [Reynaert et al., 2006].
In a Monte Carlo dose calculation, the track of each individual ionizing particle through the
volume of interest is simulated. Along its way, the particle may interact with the matter through
which it is passing. Using a random number generator and probability distributions for the
diﬀerent types of interaction, the program samples the distance to the next interaction for every
particle at a given position and with a certain direction. The particle is propagated to the
interaction location and next, the program chooses the type of interaction that will take place.
After interaction, the same procedure is repeated with the remaining particle and secondary
particles (if generated) [Reynaert et al., 2006]. Therefore, each history or trajectory of the
particles can be seen as a sequence of free paths that end with an interaction event where the
particle changes its direction, loses energy and can generate secondary particles.
All Monte Carlo codes have some components in common, regardless of its application ﬁeld.
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• Probability distribution functions: They contain all the information regarding the
physical processes. All the physics or mathematical models must be described by these
functions.
• Random number generator: A tool to generate aleatory numbers uniformly distributed
between 0 and 1.
• Sampling method: A way to sample the variables of the probability distribution
functions.
• Scoring methods: All results must be stored for each variable of interest.
• Error estimation: It is convenient to determine the error associated to the number of
histories.
Furthermore, optimization tools can be found is most of the codes, such as:
• Variance reduction techniques: Methods introduced to increase the eﬃciency of MC
calculations.
• Parallelization techniques: Algorithms that increase the eﬃciency by using the additive
property of MC calculations. They require the use of advanced computer architectures.
2.2.1 Modeling of particle transport
The physics models are usually hard-coded in the Monte Carlo software. In radiation transport,
photons are transported in a similar manner as in a real medium. For example, to determine the
scattering angle and energy of a secondary electron in a Compton scattering event, we make use
of the Klein-Nishina cross section for Compton scattering [Rogers, 2002]. However, this is not
possible in the case of electrons because when an electron slows down in a material, it can undergo
hundreds or thousands of scattering events in which it is deﬂected slightly but loses virtually
no energy. Therefore, the simulation of each individual interaction is very time consuming and
impractical for radiotherapy applications [Reynaert et al., 2006]. To accelerate the simulations,
so-called condensed history techniques have been introduced. In section 2.2.5.2 further details
of condensed histories can be found.
The physics modeling can be also modiﬁed via a number of transport parameters, such as cut-oﬀ
energies or particles step length, that set thresholds when tracking a history. Depending on the
values given to these parameters, the simulation can be accelerated, but they have to be handled
with care because accuracy can be lost. These transport parameters are explained in section
2.2.5.1.
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2.2.2 Random number generator
A sequence of random numbers is one where next number in the sequence can not be predicted.
The random numbers used in MC are not really random, as they are generated with a computer
algorithm, but pseudo-random, and they are the base of a Monte Carlo code. This pseudo-
random nature of Monte Carlo simulations is what imitates the true stochastic or random nature
of particle interactions. The pseudo-random number generators use an initial seed or number as
a starting point for the sequence generation. The sequence will be suﬃciently unpredictable and
it will not be repeated in cycles. However, two sequences will be equal if the same initial seed is
used.
These numbers must accomplish some characteristics:
• Good distribution. Generated random numbers must be uniformly distributed between
[0,1].
• The sequence generated must be suﬃciently large to ensure non repeatability.
• Reproducibility. If the simulation is repeated under the same circumstances, the result
must be the same.
2.2.3 Probability distribution functions and sampling method
There are diﬀerent kinds of sampling techniques. We will consider two of them.
2.2.3.1 Invertible cumulative distribution functions (direct method)
The direct method is the form used to calculate a particle's distance to an interaction in all
Monte Carlo codes.
A probability distribution function, p(x) is a measure of the likelihood of observing x. For
example, x could be the position at which a photon interacts via the Compton interaction.
In general, p(x) has some special properties that distinguishes it from other functions [Bielajew,
2001]:
• p(x)≥0 since negative probabilities have no meaning.
• p(x) must be normalized to 1 ∫ xmax
xmin
p(x)dx = 1 (2.1)
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• xmin and xmax can be any real number as long as xmin is less than xmax.
Associated with each one-dimensional probability distribution function we ﬁnd its cumulative
probability distribution function [Bielajew, 2001].
c(x) =
∫ x
xmin
dx′p(x′) (2.2)
This cumulative function has the following properties:
• p(x) and c(x) are related by a derivative
p(x) =
dc(x)
dx
(2.3)
• c(x) is zero at the beginning of the range and one at the end of the range: c(x) is contained
within the range [0,1].
• c(x) is a monotonically increasing function of x as a result of p(x) always being positive.
Cumulative probability distribution functions can be related to uniform random numbers to
provide a way for sampling these distributions. We can map the cumulative probability
distribution function onto the range of random variables, r, where 0≤r≤1 and r is distributed
uniformly. That is, r=c(x).
Having mapped the random numbers onto the cumulative probability distribution function,
we may invert the equation (all cumulative probability distribution functions are invertible)
to give:
x = c−1(r) (2.4)
Then, by choosing r 's randomly over a uniform distribution and substituting them in the above
equation, we generate x 's according to the proper probability distribution function.
In the case of a particle interaction, the probability distribution function will be:
p(z)dz = µe−µzdz (2.5)
Where µ is the interaction coeﬃcient needed to sample the distance to the next collision for a
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given type of particle with a given energy in a given material [Reynaert et al., 2006]. Data tables
with interaction probabilities of each type of interaction for each element are usually provided
together with a Monte Carlo program.
The cumulative probability distribution will be:
r = c(z) = 1− e−µz (2.6)
Inverting it:
z = − 1
µ
log(1− r) (2.7)
If r is uniformly distributed over [0,1] then so is 1-r.
The invertible cumulative probability distribution function method is always possible, but it is
often impractical to calculate it because it may be exceedingly complicated mathematically or
may contain a structure that is diﬃcult to control. Another approach is to use the rejection
method.
2.2.3.2 Rejection method
The procedure is the following:
• Scale the probability distribution function by its maximum value obtaining a new
distribution function, f(x)= p(x)/p(xmax).
• Choose a random number, r1, uniform in the range [0,1] and use it to obtain an x which is
uniform in the probability distribution function's range [a,b] (by calculating x=a+(b-a)r1).
• Choose a second random number r2. If r2 < p(x)/p(xmax) then accept x, else, reject it and
go back to the second point.
This method only works if the probability distribution function is not inﬁnite anywhere and if it
is not extremely diﬃcult to determine the location of the maximum value. It is also restricted
to ﬁnite values of a and b.
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2.2.4 Error estimation
MC algorithms are statistical methods and, therefore, the results should be accompanied by the
corresponding error. In general, the associated error of a result is inversely proportional to
√
N ,
where N is the number of simulated histories. Thus, if the uncertainty wants to the reduced by
two, number of simulated histories must be increased by a factor four.
If we consider xi as one of the calculated and stored parameters of the simulation for a history
i, where 1≤i≤N, the mean value can be calculated as:
x¯ =
1
N
N∑
i=1
xi (2.8)
The variance associated to de xi distribution will be:
S2x =
1
N − 1
N∑
i=1
(xi − x¯)2 (2.9)
2.2.5 Monte Carlo optimization
The use in the clinic of the dose calculation systems requires a compromise between two main
goals: Accuracy and precision in the results and a reasonable calculation time. The last condition
is specially important in IORT, where the calculations must be done right after the surgery.
In MC methods the precision of the results can be improved by increasing the number of histories.
However, by improving the precision there is an increasing in the simulation time. To solve this,
some methods have been designed to reduce simulation time with diﬀerent techniques.
In this section we will describe the most common optimization techniques. Some of them imply
a certain loss in the results quality because the use simpliﬁcations in the physics model, in the
input data or incorporate some strategies inside the MC algorithm to reduce the amount of
needed histories regardless the consequences in the dose results.
Other techniques reduce computation time without losing quality in the data. Normally, they
keep the physics of the model unaltered and change the calculation algorithm. These strategies
are the most used and can be found in the conﬁguration input of most codes.
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2.2.5.1 Cut-oﬀ energies and step length
The mean free path of the particles (ie. the distance traveled between interactions) depends on
their energy. Furthermore, the particle transfers energy to the medium in each interaction, until
its energy is so low that the particle is absorbed. Some programs introduce these two facts in
their code to accelerate simulation time.
The cut-oﬀ energy value is a threshold in energy. When the energy of a history goes below the
cut-oﬀ energy value, the program stops following that particle. The particle is considered to be
absorbed at that point. There are diﬀerent cut-oﬀ values for the energy depending on the type
of particle and the type of interaction.
The step length parameter deﬁnes the distance between interactions. The bigger the value is,
the quicker the simulation.
The user may modify both of the mentioned parameters. They had to be handled carefully, as
such parameters may signiﬁcantly inﬂuence a simulation and accuracy might be lost.
Some of the available programs that use these techniques are: PENELOPE [Salvat et al.,
2006], EGS4 [Kawrakow and Rogers, 2000, Kawrakow et al., 2014] and VMC [Kawrakow et al.,
1996].
2.2.5.2 Condensed histories
Another optimization technique of the MC simulations is the use of condensed histories [Berger
et al., 1963, Kawrakow and Bielajew, 1998]. It consists of replacing the calculation of a certain
number of interactions (several thousands) by a single interaction whose eﬀect will be the sum
of all replaced particle eﬀects.
A typical fast electron slowing down inside a medium undergoes of the order of 105-106 collisions
with surrounding matter, causing in most interactions only minor changes in the particle's energy
and direction of ﬂight. This large number of interactions makes very diﬃcult to track every
electron individually, and the computation time of doing this is very high. To circumvent this
diﬃculty, Berger [Berger et al., 1963] developed the condensed history technique. In this method,
large numbers of transport and collision processes are condensed to a single electron step. The
cumulative eﬀect of the individual interactions is taken into account by the appropriate change
of the particles energy and direction of motion at the end of the step.
This approximation has a limitation. In multiple dispersion theories, it is assumed that particles
move in heterogeneous media and the distance they travel is bigger than their main free path. As
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a result, condensed history approximation can lead to artifacts in areas next to interfaces and,
in general, in any object with a comparable size to the mean free path of the particles. Another
limitation of the condensed simulation is that this approximation cannot take into account the
catastrophic eﬀects (ie. individual interactions that signiﬁcantly modify the energy or direction
of the particles). To solve these limitations a mixed model can be implemented. In this model,
condensed histories simulations are used to reproduce the soft interactions where the energy or
direction of the particles do not exceed an user-deﬁned threshold, and the rest of the simulations
are calculated in detail (known as hard interactions) [Berger et al., 1963].
2.2.5.3 Variance reduction techniques
The variance reduction techniques may be used to make calculations more eﬃcient. In some
cases, these techniques require that no further approximations must be made to the transport
physics. In other cases, the gains in computing speed come at the cost of computing results that
may be less accurate since approximations are introduced [Bielajew, 2001].
Lets introduce the most used variance reduction techniques.
The interaction forcing technique takes advantage of the fact that, usually, a high variance
comes from a low interaction rate. This is specially signiﬁcant for photons, where eﬃciency may
be lost because photons leave the geometry of the simulation without interacting and time is
spent tracking photons through a geometry that do not contribute to the score. This technique
forces photons to interact within the geometry of interest. These photons will then be weighted
by the probability that the photon would have had of interacting before leaving the geometry of
the simulation.
The particle splitting technique is used in situations where interest is focused on a particular
volume inside the geometry. To increase interaction statistics within that area, a splitting
technique can be used. It divides the particles with weight ω into a N smaller ones each with a
new weight, ω' = ω/N.
Another technique is used when particle weights become very small. If this happens and the
photon is headed away from the region of interest it can be used the russian roulette technique.
It selects a random number. If this random number lies above a threshold α, the photon is
discarded without scoring any quantity of interest. If the random number turns out to be below
α the photon survives but with a new weight, ω' = ω/α.
All these techniques distort the simulation results because they modify the probability
distribution functions of the involved interactions. In order to minimize the alteration,
parameters involved in these techniques must be chosen carefully.
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Now, we will describe a technique that accelerate the simulation without modifying the quality
of the results.
2.2.5.4 Pre-calculation of the source. Phase Space ﬁles
When a MC simulation of a treatment planning needs to be done, we need to simulate the detailed
geometry of the accelerator. But if in each treatment planning the simulation is performed by
starting the electrons at the beginning of the accelerator head, we will need a very long simulation
to achieve a dose distribution with low variance.
This is because the particles, before entering the medium, go though a serial of materials, such
as collimators, ﬂattening ﬁlters, etc., as seen in Chapter 1. Most particles will interact in the
accelerator head, being absorbed or generating secondary particles, and following their tracks
will slow down considerably the simulation, even though these interactions are not directly
contributing to the dose. But these elements, responsible of beam modiﬁcation, are usually
ﬁxed to the accelerator head and used in all treatments. By taking advantage of this property,
some codes have developed a strategy that consist of saving the information of the particles in a
ﬁle at a certain point, usually at the end of the collimation system. With this, a full simulation
of each accelerator head can be done once, and the information of the particles coming out
the accelerator is recorded. Next time a simulation of that accelerator is required, instead of
generating again the detailed geometry of all the components of the accelerator, all the beam
information coming out of the accelerator can be read from the stored ﬁle.
This ﬁle is known as Phase Space ﬁle. It contains all the information needed to characterize the
beam. This information includes type of particle, energy, position and direction of the particles,
among other properties particular of each code.
2.3 Main Monte Carlo codes in radiotherapy
ETRAN (Electron TRANsport): First MC code designed for electrons and photons transport
through simple geometries [Seltzer, 1991]. Its energy range is 1 keV-100 GeV.
EGS (Electron Gamma Shower): The actual version is called EGSnrc [Kawrakow and Rogers,
2000, Kawrakow et al., 2014]. It is a code that simulates photon, electron and positron transport
considering only electromagnetic interactions, with energies from 1 keV to 10 GeV. The geometry
can be built with a code called BEAMnrc [Rogers et al., 1995] that incorporates speciﬁc modules
designed for medical physics. It has been widely validated, as it is one of the most used MC
codes in medical physics. It is not an open code and may require that the user develops part of
the code in MORTRAN language to deﬁne complex geometries.
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FLUKA (FLUktuierendeKAskade): It is a code that reproduces the propagation in matter for
up to 60 diﬀerent particles, including electrons and photons (from 1 keV to 1000 TeV), hadrons
(up to 20 TeV), neutrons and heavy ions [Ferrari et al., 2005]. It allows to reproduce complex
geometries. Its main code is written in FORTRAN77.
GEANT4 (Geometry ANd Tracking): It is a code that simulates the transport of all kind of
particles inside an energy range between 250 eV and 10 TeV [Agostinelli et al., 2003]. It is very
powerful regarding the construction of complex geometries and can be used for a wide spectrum
of applications: from high energy physics to medical physics. Part of the code must be developed
by the user in C++ language. Its code is open source.
MCNP (Monte Carlo N-Particle): It is a code that simulates the transport of neutrons, photons
and electrons. Because its wide validation, it is considered the most reliable MC code for neutron
transport [Brown et al., 2002]. It is necessary a payment registration to use it.
MCNPX (Monte Carlo N-ParticleeXtended): It extends the application of the MCNP4C3 code
to almost all kind of particles in a wide energy range. The source code, written in FORTRAN90,
is only available by a previous agreement with the developers.
PENELOPE (PENetration and EnergyLOss of Positrons and Electrons): It is an open source
code to simulate electrons, photons and positrons transport, in an energy range between 50
eV and 1 GeV [Salvat et al., 2006]. Its main application ﬁeld is medical physics. Most of the
calculations done in this thesis are based in this code, so further description of PENELOPE can
be found in the next section.
2.4 PENELOPE
PENELOPE (PENetration and EnergyLOss of Positrons and Electrons) [Baro et al., 1995, Salvat
et al., 1996, 2006, Sempau et al., 1997, 2003] is a Monte Carlo code of general purpose that
simulates the transport of electrons, photons and positrons within an energy range from 50 eV
to 1 GeV. It is formed by a package of subroutines written in FORTRAN77. It is an open
source code developed by the Universitat Politèctica de Catalunya (UPC) and distributed by the
Nuclear Energy Agency (NEA).
The main features of PENELOPE are the accurate description of particle transport through
interfaces and the low-energy particles transport. It simulates with detail the transport of
photons and applies a mixed-scheme for electron and positron transport.
The mechanisms responsible for particle transport are controlled by some user deﬁned
parameters. Elastic interactions are controlled by the parameters C1 and C2:
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• C1 deﬁnes the average angular deﬂection produced by multiple elastic scattering through
the mean free path between consecutive elastic events.
• C2 sets an upper bound for the average fractional energy loss between consecutive elastic
events.
To ensure precision in the simulation, C1 and C2 must have small values. For both parameters,
0.05 is recommended and the maximum recommended value would be 0.2. Beyond this point,
the simulation will be quicker but precision will decrease.
User can also deﬁne two parameters related to the energy values that delimit the distinction
between hard and soft interactions:
• WCC : Cutoﬀ energy value (in eV) for hard inelastic collisions.
• WCR: Cutoﬀ energy value (in eV) for bremsstrahlung emissions.
Therefore, electron collisions whose energy loss is below WCC and inelastic radiative interactions
with energy loss below WCR are considered soft interactions and treated as condensed histories.
The step length parameter for these soft interactions can also be controlled externally with the
smax parameter.
WCC and WCR cutoﬀ energies will aﬀect the simulated energy distribution. If big values are
used, the simulation time is reduced but energy distribution will be distorted. In real practice,
energy distributions will not vary for diﬀerent WCC and WCR values as long as these numbers
are below the increment of energy used for energy distribution. Therefore, the desired energy
resolution will determine the maximum value of these cutoﬀ energy values.
PENELOPE code is formed by a set of FORTRAN 77 subroutines which are invoked from a
main program. The main codes included in PENELOPE are the following:
• penelope.f : Block of subprograms with the coupled electron-photon transport.
• material.f : Program which extracts atomic interaction data from the database and creates
the ﬁles with the physical information about each material.
• pengeom.f : Code that contains the geometry package. Any geometry is built from
homogeneous bodies limited by quadric surfaces.
• penvared.f : Program that allows users to employ variance reduction techniques.
PENELOPE also includes other programs:
• GVIEW: Program used for displaying two- and three-dimensional images of the geometry.
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• SHOWER: Program used to visualize particle tracks.
• EMFIELDS: Block of subroutines to simulate particle transport in static electromagnetic
ﬁelds.
• TABLES: Program to generate tables with the physical data of radiation transport.
2.5 PenEasy
PenEasy [Sempau et al., 2011, Badal Soler et al., 2008] is a modular, general-purpose main
program for PENELOPE that includes various source models and tallies. The goal of developing
this program was to provide a tool suitable for a wide spectrum of problems so that users would
not need to develop a speciﬁc code for each new application.
PenEasy is free and open software, and the source code is mostly written in FORTRAN77.
The code is structured in an initialization phase followed by three nested loops and the reporting
of results. The skeleton of the main program is shown in ﬁgure 2.1. Uppercase names
denote routines from PENELOPE, whereas lowercase subroutines are provided with the penEasy
package.
Figure 2.1: Basic structure of the FORTRAN version of the main program of penEasy. Calls to tallying
and other auxiliary subroutines have been removed for clarity [Badal Soler et al., 2008].
The main cycles are: history, particle and interaction. Each cycle of the loop named history
performs the simulation of one primary particle and all its descendants. Inside the cycle history
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there is the loop particle that simulates a single photon, electron or positron. Finally, inside this
loop we can ﬁnd the cycle of interact that reproduces a single interaction, or the crossing of an
interface if the distance to the intersection is shorter than the distance to the next interaction.
For calculating these interactions, inside this ﬁnal loop we ﬁnd an algorithm that essentially
consists of repeating the sequence of calls to subroutines JUMP, STEP and KNOCK: JUMP
computes the distance to the next interaction event, returned through the variable ds; STEP
determines if an interface is crossed before completing the step ds and displaces the particle; and
KNOCK simulates the eﬀect of the interaction and returns the energy lost by the particle. If an
interface is crossed (ncross not zero) the trajectory is truncated at the boundary, no interaction
takes place and a new interact cycle begins. The simulation of a particle ends when it leaves
the material system (mat is zero), or when its kinetic energy (e) falls below some user-deﬁned
absorption energy (eabs), which may depend on the material and particle type.
PenEasy allows the use of quadric geometry (by invoking subroutines from PENELOPE's
standard geometry package PENGEOM), voxelized geometry and a superposition of quadric
objects and voxelized regions (with the package penVOX).
2.5.1 Source models
PenEasy includes two types of source models [Sempau et al., 2011, Badal Soler et al., 2008].
Their conﬁguration parameters are set by the user through a global input ﬁle. Only one source
can be active in any given simulation.
The source called BIGS (Box Isotropic Gauss Spectrum) allows the deﬁnition of volumetric
sources limited by quadric surfaces. The type of particle can be either a photon, electron or
positron with an arbitrary energy spectrum of emission or, alternatively, with the spectrum
deﬁned by means of a Gaussian function.
The source called PSF (Phase-Space File) reads the initial state of the particles from an external
ﬁle. Usually, this ﬁle is created by penEasy in a previous simulation with the PSF tally. As
explained in section 2.2.5.4, the phase space ﬁle contains information to identify all particles,
either primary or secondary, belonging to the same history (i.e., descendants of the same primary
particle).
2.5.2 Tallies
PenEasy includes subroutines to score the most common quantities of interest. The tallies
available are listed below.
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• Section Tally Spatial Dose Distrib: Calculates absorbed dose per history scored in
parallelepiped bins.
• Section Tally Cylindrical Dose Distrib: Calculates absorbed dose per history in cylindrical
shells.
• Section Tally Spherical Dose Distrib: Calculates absorbed dose per history in spherical
shells.
• Section Tally Voxel Dose: Calculates absorbed dose when voxelized geometries are used.
• Section Tally Energy Deposition Pulse Spectrum: Determines the total deposited energy
in the detection material per simulated history.
• Section Tally Fluence Track Length: Calculates the ﬂuence spectrum per simulated history
in the detection material.
• Section Tally Phase Space File: Stores the phase space ﬁle in the detection material.
• Section Tally Particle Current Spectrum: Determines energy spectra and total number of
particles of each type entering a certain material.
• Section Tally Particle Track Structure: Allows the 3D representation of the particle tracks.
2.6 DPM
DPM (Dose Planning Method) [Sempau et al., 2000] is a MC code that share some of the
PENELOPE characteristics and allows the simulation of the dose deposited by electronphoton
showers under radiotherapy conditions in a fraction time of a regular MC calculation, such as
penEasy. It can be used as an alternative to the analytical algorithms for treatment planning,
as it gives an accurate dose in a very short time.
DPM employs the condensed history model for electron transport, and uses a mixed scheme for
the treatment of energy losses, treating large energy transfer collisions with a simpliﬁed model and
using the continuous slowing down approximation (CSDA) to model small-loss collisions.
The gain in performance time derives from a series of enhancements done to the algorithm
[Sempau et al., 2000]:
• Employment and reﬁnement of a new step size independent multiple-scattering theory.
• Use of new transport mechanics. DPM has adopted the `random hinge' scheme employed
in PENELOPE.
• Use of large electron transport steps, in which many voxels may be traversed before
sampling a multiple scattering angle.
• DPM exploits the small dynamic range (in energy and material) of radiotherapy class
problems. Energies are limited to those between 100 keV and 20 MeV, and cross sections
and distribution functions are determined by scaling them appropriately to computed data
in water.
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DPM is formed by four main programs:
• material.f : Extracts from PENELOPE library the physical data of the materials.
• predpm.f : Program that allows the pre-calculation of cross sections and other calculations
that DPM will use.
• genvoxel.f : Geometry program. The user can create a voxelized geometry or read a CT
image.
• dpm.f : Program that performs the MC simulation, considering the previously calculated
data from predpm.f
2.6.1 Source model
DPM generates the primary particles in the subroutine 'source'. In the original code, this routine
generates unidirectional and monoenergetic electrons or photons that impact in a phantom. The
source is centered in x=y=0 and its size can be deﬁned in the conﬁguration ﬁles.
However, DPM allows the user to write his own 'source' subroutine. In any case, the ﬁnal result
of this subroutine is to assign the particles the following variables:
• Kinetic energy of the particle in eV.
• Unit direction vectors {vx,xy,vz}
• Position coordinates of the particle in cm.
• Particle type.
In this work the 'source' subroutine has been modiﬁed to read the initial particle state from a
phase space ﬁle.
2.6.2 Tallies
Subroutine 'report' scores the deposited dose inside the region of interest deﬁned in the
conﬁguration ﬁles. This dose is written in an ASCII ﬁle, but the subroutine has been modiﬁed
to include also a binary ﬁle.
54
Chapter 3
Detailed simulations of IORT
systems
3.1 Introduction
Monte Carlo (MC) simulations are considered to be the most accurate methods for radiotherapy
dose calculations in homogeneous and heterogeneous geometries [Rogers et al., 1995, Rogers,
2006, Ma and Jiang, 1999, Siebers et al., 2000, McDermott et al., 2003], since all the relevant
eﬀects, such as material inhomogeneities, back-scatter and beam hardening can be modeled with
reasonable accuracy. While MC methods are computationally demanding, the development of a
few accelerated MC codes, such as DPM [Sempau et al., 2000], makes them more practical in
clinical settings.
MC dosimetry requires a realistic and reliable description of the electron and/or photon beams
employed in the radiotherapy procedure [Chetty et al., 2007]. A phase space (PHSP) ﬁle
containing the information of energy, angular and spatial distributions of the particles coming
from the electron or photon beam, has to be fed into the MC algorithm. A common approach to
build these PHSP ﬁles consists of carrying out realistic simulations of the accelerator head and
other elements involved in the radiotherapy procedure such as applicators and collimators [Ma
and Jiang, 1999, Capote et al., 2006, Faddegon et al., 1998].
Detailed MC modeling of IOERT accelerators and Intrabeam R© devices has been widely reported
[Ma and Jiang, 1999, Hogstrom and Almond, 2006, Janssen et al., 2008, Bush et al., 2008,
Clausen et al., 2012, Nwankwo et al., 2013, Verhaegen et al., 1999, Yanch and Harte, 1996] and
good results have been obtained with this method.
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In this chapter we have simulated the most relevant dedicated accelerators employed in IOERT
treatments (ie. NOVAC R©, LIAC R© and MOBETRON R©) with their corresponding applicators,
and Intrabeam R© needle, spherical, surface and ﬂat applicators. In most cases, the diﬀerent
components of the devices have been extracted from literature, in other cases, such as for ﬂat
and surface Intrabeam R© applicators, the geometry details have been provided by the vendor.
These simulations will represent a reference accelerator or applicator, and will be used to create
a database that will be employed to generate a PHSP ﬁle tuned to each user machine in a dose
treatment planning procedure explained in the following chapter.
From these simulations we will be interested especially in reproducing the shape of the
experimental transverse dose proﬁles from the diﬀerent machines. Our optimization procedure
will only tune the depth dose proﬁle (DDP) to the experimental data, so having the
characterization of the oﬀ-axis proﬁles will be essential for an accurate dose distribution at
the end of the procedure.
3.2 Intrabeam R© applicators
3.2.1 MC characterization of Intrabeam R© X-ray source
The Intrabeam R© X-ray source (XRS) has been described in several works [Dinsmore et al., 1996,
Beatty et al., 1996, Yanch and Harte, 1996, Clausen et al., 2012].
In the Intrabeam R© system X-rays are generated by a 50 keV electron beam that travels through
an evacuated tube (9 cm length and 3.2 mm diameter) and hits a 0.5 µm thick gold target at
the end of the tube [Yanch and Harte, 1996]. The most distal 1.6 cm of the tube consists of
beryllium. To make the XRS biocompatible, the target tube is coated on their outer surface
with a nickel ﬁlm and a titanium nitrite (TiN) layer [Dinsmore et al., 1996]. This construction
yields an isotropic dose distribution with a maximal variation of 15% in all directions [Yanch
and Harte, 1996].
In this thesis we have performed a detailed simulation of the XRS of the Intrabeam R© with
penEasy [Sempau et al., 2011, Badal Soler et al., 2008]. The objective was to test the accuracy
of the penEasy code for kilo-voltage energies and to ﬁx the shape of the energy spectrum. An
experimental spectrum of the XRS [Schneider et al., 2010] was used to compare and adjust the
simulation to the experiment.
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Figure 3.1: Cross section through the beryllium window of the INTRABEAM X-ray source (XRS) with
the gold target [Beatty et al., 1996].
The geometry of the XRS was generated to ﬁt the experimental measurements of the spectrum.
It is shown in ﬁgure 3.2. It was deﬁned as:
1. A 1.6 cm length beryllium needle with 1.1 mm inner radius and thickness of 0.5 mm.
2. A 0.5 µm layer of gold at the end of the probe.
3. A 5 µm layer of nickel surrounding the beryllium needle.
4. A 10 µm layer of TiN surrounding the nickel.
5. PHSP plane surrounding all the structure.
Regarding the electron source impinging on the gold target, it was characterized with a Gaussian
energy distribution with a mean energy of 50 keV and a full width at half maximum (FWHM) of
5 keV. The source was located 1.6 cm above the gold target. Concerning the spatial distribution
of the source, it was deﬁned as a circular foil of 0.1 mm diameter with a Gaussian distribution
centered at zero and a FWHM of 0.01 mm. The electron beam does not impact in all the target
surface, but in a annular area between 0.6 and 0.8 mm radii [Clausen et al., 2012].
The dose was scored at the exit of the probe surface with 4·1010 initial particles in order to
accumulate more than 200 millions particles in the scoring plane and to fulﬁll good statistics and
reduce statistical uncertainty of the simulation to around 2%. The voxel size employed in the
simulation was 0.25 mm. This calculation was split up into 200 simulations running in parallel
for around 12 hours in a high capacity cluster.
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Figure 3.2: Geometry of the simulated Intrabeam R© X-ray source visualized with the gview2d package
from PENELOPE and a inset with a zoom of the target. The numeration corresponds to: 1. Vacuum
inside the needle. 2. Beryllium. 3. Gold target. 4. Layer of nickel. 5. Layer of TiN. 6. PHSP plane
deﬁnition. 7. Water phantom.
A comparison of the simulated and experimental energy spectra is shown in ﬁgure 3.3, and the
classiﬁcation of the characteristic X-rays peaks is detailed in table 3.1. Both energy spectra are
very similar, although some diﬀerences can be seen in the characteristic X-rays peaks, mostly at
low energies, where the lowest energy peak (4.41 keV), corresponding to the Ti characteristic X-
rays is only seen in the simulation, and the second peak (7.54 keV), matching the Ni transitions,
presents a higher intensity in the simulation than in the experiment. However, the most intense
peaks, corresponding to the Au lines (9.54, 11.53 and 13.240 keV), present almost the same
intensity as the experiment. In the case of the 4.41 keV line, the characteristic X-rays present
such a small energy that is probably too low to be measured experimentally. In the case of the
second peak at 7.54 keV, the diﬀerence can be either explained by the limited eﬃciency of the
detector at measuring X-rays of such small energy or by a slight diﬀerence in the thickness of
the Ni layer. Nevertheless, the diﬀerences that appear in these X-rays will not be reﬂected in the
dose, as such low energetic X-rays are absorbed within the ﬁrst micrometers in the tissue.
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Figure 3.3: (a) Energy spectra obtained experimentally [Schneider et al., 2009b] and with the detailed
simulation for the XRS. (b) An expanded view of the line-radiation region of (a).
Energy (keV) Transition
4.41 L2-K and L3-K in Ti
7.54 L2-K and L3-K in Ni
8.12 <M>-K in Ni
9.54 <M>-L3 in Au
11.53 <M>-L2 in Au
13.24 <N>-L2 in Au
Table 3.1: Classiﬁcation of the characteristic X-rays present in the XRS energy spectrum.
Figure 3.4 shows the resulting 2D dose distribution for the XRS and the isodose lines at 40%,
20%, 10% and 5% of the maximum dose. Slight anisotropy in the backward direction of the
dose can be been. This result agrees with previous studies [Dinsmore et al., 1996, Beatty et al.,
1996], where was observed that there was an increase along the probe in the backward direction,
consistent with the escaping photons through beryllium.
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Figure 3.4: 2D dose distribution for the simulated XRS with isodose lines at 40%, 20%, 10% and 5%
of the maximum dose.
3.2.2 MC characterization of Intrabeam R© Spherical applicators
The spherical applicators are made of a polyether imide (PEI) material [Xiao et al., 2015], and
can be classiﬁed into two groups according to the inner structure: the interior wall of the probe
is embedded with a thin metal sheath for the applicators with diameter ≤ 3 cm whereas no metal
sheath is included in those with diameter > 3 cm, as shown in ﬁgure 3.5 [Eaton and Duck, 2010,
Xiao et al., 2015].
Figure 3.5: Computed tomography image showing the cross-section of 1.5 cm, 3.0 cm, 3.5 cm and 5.0
cm diameter applicator [Eaton and Duck, 2010].
In the case of spherical applicators, two diﬀerent sets of applicators were designed: one set for
diameters ≤ 3 cm, including the metal sheath, and another one for diameters > 3 cm, without
it. The PEI material was deﬁned with the material.f code from PENELOPE [Salvat et al.,
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1996] and used to generate all spherical applicators.
Instead of generating the complete geometry including the probe surrounded by the spherical
applicators, the PHSP ﬁle obtained from the simulation of the previous section was employed to
substitute the simulation of the XRS.
A solid sphere and a cylinder of PEI were deﬁned with penEasy surrounding an air cylinder and
semi-sphere designed for the location of the needle. For the smaller applicators, an aluminum
layer was set between the needle and the applicator. An example of both geometries can be seen
in ﬁgure 3.6. In order to obtain dose distributions with enough statistics, each applicator was
simulated during 24 hours in parallel in 200 diﬀerent cores in a high capacity cluster.
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Figure 3.6: Geometries employed in the simulation for the two diﬀerent set of applicators. Left: 1.5 cm
diameter spherical applicator. Right: 3.5 cm diameter spherical applicator. The numeration corresponds
to: 1. Air inside the applicator were the XRS is located. 2. Applicator walls made of PEI. 3. Water. 4.
Aluminum layer for the ≤ 3 cm diameter applicators.
For the 1.75 cm radius spherical applicator, we could compare the energy spectrum and the
depth dose proﬁle obtained from the simulation with experimental data, and a good agreement
was reached, as shown in Figure 3.7. For the other spherical applicators the obtained energy
spectra are similar to the energy spectrum of the 1.75 cm radius spherical applicator, and have a
reasonable shape with a bremsstrahlung background and characteristic rays located at the same
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energies.
Figure 3.7: Left: Energy spectra obtained experimentally [Schneider et al., 2010] and with the detailed
simulation for the 1.75 cm radius applicator. Right: Depth dose curves obtained experimentally [Schneider
et al., 2010] and with the detailed simulation for the 1.75 radius applicator.
Two examples of the 2D dose distributions obtained with the detailed simulations for a 1.5 cm
diameter applicator and a 4.0 cm diameter applicator against measurements are shown in ﬁgures
3.8 and 3.9, respectively.
The experimental 2D dose distributions of the detailed spherical applicators present a small
anisotropy in the backward direction. This anisotropy was reproduced in the detailed simulations
by displacing the PHSP ﬁle that replaces the XRS around 2 mm from the geometrical center
of the applicator. This would correspond to leaving a 2 mm extra space in the hole inside the
applicator to guarantee the protection of the XRS against the applicator walls when inserting
it.
Figure 3.8: 2D dose distribution obtained with penEasy (Left) and with a radiochromic ﬁlm (Right)
for a 1.5 cm diameter applicator with isodose lines at 90%, 70%, 40%, 20% and 5%.
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Figure 3.9: 2D dose distribution obtained with penEasy (Left) and with a radiochromic ﬁlm (Right)
for a 4.0 cm diameter applicator with isodose lines at 90%, 70%, 40%, 20% and 10% of the maximum
dose.
3.2.2.1 Approximation for Intrabeam R© needle and spherical applicators
In the previous section we have simulated in detail the spherical applicators, reaching a good
agreement with the experimental measurements. However, these detailed simulations required a
very high resource usage to do the calculations, as each applicator needed to run over 24 hours
in parallel in a high capacity cluster in 200 diﬀerent cores to obtain a dose distribution with
enough statistics. If only one CPU had been used, the simulation of each applicator would have
run for about 7 months to achieve good enough statistics.
Consequently, for this work we have used a simpliﬁed version of the spherical and needle
applicators. We have considered a photon source emitting isotropically in a vacuum sphere
with the radius of the real applicator. This way the simulation time needed to obtain a good
dose distribution is reduced up to several hours.
This approach may introduce some changes in the energy deposition distribution in depth.
However, these diﬀerences will be absorbed afterwards during the ﬁtting procedure explained
in the following chapter.
Regarding the anisotropy of the experimental measurements, it will not be reproduced with this
approximation. Nevertheless, the area where the anisotropy is presented has not clinical interest,
as it is behind the applicator, and we will take it into consideration in future works.
3.2.3 Simulation of Intrabeam R© ﬂat and surface applicators
For ﬂat and surface applicators characterization, the vendor provided the information of the
geometry, and therefore, the details are protected and can not be described in this work. Both
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types of applicators have a lead casing with a ﬁlter made of PEI inside. The main diﬀerence
between ﬂat and surface applicators lies in the shape of the ﬁlter inside each applicator. A
schematic geometry of these applicators is show in ﬁgure 3.10.
Figure 3.10: Schematic geometry for the (a) Flat applicators and (b) Surface applicators. The
numbering represents 1. XRS, 2. Air inside the applicator, 3. Lead walls, 4. PEI ﬁlter.
The photon beam was generated as a punctual source of 1 mm width with a spatial FWHM
of 0.01 mm. The energy distribution employed in the simulations corresponded to the energy
spectrum obtained in the XRS characterization, with a FWHM of 1 keV. The position of the
source inside the ﬁlter was provided by the vendors and the angular aperture of the beam was
determined to cover the interior of the applicator.
(a) (b)
Figure 3.11: Experimental and simulated transverse dose proﬁles for (a) 1 cm surface applicator and
(b) 2 cm ﬂat applicator.
Some results can be seen in ﬁgure 3.11, where a comparison between measurements and simulated
dose are shown for a 1 cm surface applicator and a 2 cm ﬂat applicator. To perform these
simulations, 109 histories were used.
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3.3 Dedicated electron accelerators
In the case of the dedicated electron accelerators we did not have access to the vendor
speciﬁcations. Some of the characteristics of the accelerator head and applicators have been
extracted from the literature, and the unknown information has been obtained by comparing the
simulations to the experimental measurements in water.
3.3.1 LIAC R©
For the detailed simulation of the LIAC R© (SORDINA, Italy), the available information about
the geometry of the accelerator head and the beam characteristics was extracted from previous
investigations [Iaccarino et al., 2011].
The diﬀerent components of the geometry of the simulated accelerator are the following:
1. Titanium exit window of 55 µm.
2. Aluminum scattering foil with an 820 µm thickness.
3. PEEK
TM
cylindric primary collimator with two sections: The ﬁrst section has an inner
radius of 0.87 cm, outer radius of 2.13 cm and 2 cm length. The second section has an
inner radius of 2 cm, outer radius of 3 cm and 6.5 cm length.
4. Mylar window with 0.1 mm thickness.
5. PMMA applicator with a length of 60 cm.
6. PHSP plane deﬁnition.
7. Water phantom.
The simulated geometry can be seen in ﬁgure 3.12. Simulations of each LIAC R© applicator, from
4 to 10 cm diameter, were done. In all of them the accelerator head remained the same and the
only change in the geometry was the diameter of the applicator.
Simulations were performed using 108 primary particles. The source was deﬁned as a circular
foil of 4 mm diameter with an angle of semi-aperture of 3◦ located 5 mm above the titanium
exit window. Regarding the energy distribution, the source was characterized as a Gaussian
distribution with FWHM of 0.1 MeV.
We also made a detailed study to see the impact of the air gap on patients dose distributions
[García-Marcos et al., 2014]. Results showed that it may have an impact on dose distributions
at the 3-4% level of the maximum dose, especially on the edge of the shallowest transverse dose
proﬁles and we decided to include a 5 mm air gap, as it is the simulation that best describes the
measured proﬁles.
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Figure 3.12: Geometry of the simulated LIAC R©. The numeration, materials and dimensions correspond
to the numbers shown in the description.
To validate the simulation and assure an accurate description of the accelerator, we compared
the results of our simulation against transverse proﬁles measured in water at the Hospital
Universitario Gregorio Marañón for energies of 6, 8, 10 and 12 MeV and the the diﬀerent
applicators. A comparison of transverse dose proﬁles is shown in ﬁgure 3.13.
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Figure 3.13: Transverse dose proﬁles in water for a 12 MeV LIAC R©, 6 cm diameter applicator.
3.3.2 NOVAC R©
For the NOVAC R© simulation, information about the accelerator was obtained from previous
works [Russo et al., 2012, Righi et al., 2013, Mihailescu et al., 2006]. The geometry is very
similar to LIAC R©'s, except for the absence of the scattering foil.
The diﬀerent components of the geometry of the simulated accelerator are the following:
1. Titanium exit window of 60 µm.
2. A primary collimator made of brass and PVC.
3. PMMA applicator with thickness 0.5 cm and with diﬀerent lengths depending on the
applicator diameter. For the inner applicator diameters of 4, 6, 8 and 10 cm, the lengths
are 69, 67, 67 and 87 cm, respectively [Mihailescu et al., 2006].
4. PHSP plane deﬁnition.
5. Water phantom.
The geometry of the accelerator can be seen in ﬁgure 3.14. Simulations of each NOVAC R©
applicator, from 4 to 10 cm diameter, were done. In all of them the accelerator head remained
the same.
Simulations were performed using 108 primary particles. According to Russo et al. [Russo et al.,
2012], the source was deﬁned as a circular foil of 1 mm diameter with an angle of semi-aperture
of 3◦ located 5 mm above the titanium exit window. Regarding the energy distribution, the
source was characterized as a Gaussian distribution with FWHM of 0.1 MeV.
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Figure 3.14: Geometry of the simulated NOVAC R©. The numeration, materials and dimensions
correspond to the numbers shown in the description.
Transverse dose proﬁles in water were measured in Düsseldorf and in Cefalu to validate the
simulations. A comparison of the transverse dose distributions for a 10 MeV NOVAC R©
accelerator, 6 cm diameter applicator can be seen in ﬁgure 3.15.
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Figure 3.15: Transverse dose proﬁles in water for a 10 MeV NOVAC R©, 6 cm diameter applicator.
3.3.3 MOBETRON R©
MOBETRON R© geometry has been extracted from diﬀerent works [Janssen et al., 2008, Beddar,
2005, Beddar et al., 2006, Mills et al., 2001]. The main diﬀerence of this accelerator is the
soft-docking system used for placing the applicators, so they are not ﬁxed to the accelerator
head.
The diﬀerent elements of the accelerator's geometry are listed below:
1. Beryllium exit window of 1 mm.
2. Primary scattering foil made of tantalum with thickness 0.1 mm.
3. Secondary scattering foil made of aluminum with thickness 1 mm.
4. Primary collimator made of tungsten with two conical parts. These two parts are 5 cm
long and are separated by 2 cm of air.
5. Stainless steel applicator with a thickness of 0.5 cm and with a length of 30 cm. Due to
the soft-docking system, the applicator is detached from the accelerator head.
6. PHSP plane deﬁnition.
7. Water phantom.
The geometry of the simulated accelerator can be seen in ﬁgure 3.16.
The electron beam has been deﬁned as a 3 mm diameter point source with an angle of aperture
of 5◦, spatial FWHM of 1 mm and a Gaussian energy distribution with FWHM of 0.1 MeV
[Janssen et al., 2008]. The source-to-surface distance (SSD) is ﬁxed to 547 mm.
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Figure 3.16: Geometry of the simulated MOBETRON R©. The numeration, materials and dimensions
correspond to the numbers shown in the description.
Simulations have been performed with 108 particles for all the accelerator working energies (6,
9 and 12 MeV) and applicators (ranging from 3 cm to 10 cm). Because of the soft-docking
system, the behavior of the transverse dose proﬁles changes slightly with every applicator, so the
geometries had to be re-adjusted for each case. Comparisons against experimental transverse
proﬁles measured in Cuneo (Italy) have been done to assure the accuracy of the simulation. An
example of these comparisons is shown in ﬁgure 3.17.
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Figure 3.17: Transverse dose proﬁles in water for a 12 MeV MOBETRON R©, 10 cm diameter applicator.
3.4 Phase Space parameterization
Since PHSP can be very heavy ﬁles and diﬃcult to use, a simpliﬁcation method was developed
in order to reduce ﬁles sizes and to improve the ﬂexibility while manipulating data, beneﬁting
from the symmetry of the diﬀerent applicators.
The huge amount of information contained in those ﬁles was parameterized and stored in bins.
Each bin represents an elemental primary source and will have a ﬁxed value of all the degrees of
freedom relevant in our problem [Herranz et al., 2014]. The number of bins (up to two millions in
the biggest PHSP ﬁle) of these parameterized PHSP ﬁles makes them easy to handle in a modern
personal computer. Regarding the bin size, a trade-oﬀ between accuracy of the representation
and number of requested bins was made.
We have performed three diﬀerent kinds of PHSP ﬁles parameterization, depending on each
geometry and its possible symmetries. Lets see all of them in detail.
3.4.1 Parameterization of PHSP ﬁles in the IOERT accelerators
For the parameterization of PHSP ﬁles in electron accelerators, the approach explained by
Herranz et al. [Herranz et al., 2014] was followed.
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Without loss of generality, it has been assumed that the PHSP ﬁle exiting a cylindrical applicator
presents cylindrical symmetry. This assumption has been done considering that all the electron
applicators studied in this project present a cylindrical shape. This hypothesis also requires that
the bevel of the applicator must be equal to 0◦. For those cases where a bevel of a certain angle
is needed, which is a frequent situation in IOERT treatments, the PHSP plane is located at
the point where the applicator looses its cylindrical symmetry (see ﬁgure 3.18), and the bevel is
included as an additional piece that is simulated together with the phantom.
Right angle 
applicator
Patient
PHSP plane
Bevel
Figure 3.18: Schematic view of the PHSP plane at the exit of the right angle applicator showing the
small piece of beveled applicator included in the simulation to compute the dose for non-right applicators
[Herranz et al., 2014].
Exploiting the cylindrical symmetry mentioned, the PHSP is fully deﬁned by the distribution of
particles in energy (E), distance to the applicator axis ρ, and two angles for the emission direction:
θ, deﬁned as the angle of the particle trajectory with the z axis, and φ, the azimuthal angle that
forms the plane containing the trajectory and the z axis. We assume azimuthal symmetry around
the applicator axis. In ﬁgure 3.19 the deﬁnition of these angles is shown.
This 4-dimensional representation was used to build a discretized ﬁnite set of up to a maximum
of around 2.000.000 elementary sources or bins. Each bin represents a source with ﬁxed values
of energy, radial distance to the applicator axis and trajectory angles.
The following ranges and binning widths (BW) were considered for the deﬁnition of the
elementary sources:
• Type of particle (electron, photon).
• Energy, ranging from 0 to 14 MeV (BW = 0.25 MeV).
• Axial angle θ, ranging from 0◦ to 29◦ (BW = 0.64◦).
• Azimuthal angle φ, ranging from 0◦ to 180◦ (BW = 20◦).
• Radial position ρ ranging from 0 to 10 cm (BW = 0.2 cm).
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Figure 3.19: Angular variables employed to deﬁne the direction of a particle with the parameterization
of the PHSP ﬁle. The green arrow represents the trajectory of the particle, contained in the red plane
(striped plane). The angle with the z axis and the angle of the striped plane with the reference plane (xz
plane) fully deﬁne the direction of the particle [Herranz et al., 2014].
To calculate dose from these binned PHSP ﬁles, we need to generate again the particle trajectories
from these parameterized PHSP ﬁles. A uniformly distributed angle has to be produced which,
in combination with the distance ρ to the applicator axis, deﬁnes the actual point in the xy
plane where the particle originates. The value of the z position (along the applicator axis) of
the point of origin of all the particles is assumed to be constant and it corresponds to the end of
the non-beveled applicator. Particles generated by the PHSP code are represented in standard
format [Capote et al., 2006] by n-tuples which include particle type, energy, (x,y,z) position and
angles of emission (θ, φ) with respect to the axis of the applicator. The decoded PHSP ﬁles can
be fed into MC dose-computation packages.
With regards to bin sizes, a trade-oﬀ between accuracy of the representation and number of
requested bins was made. Starting from a reference PHSP ﬁle made up by 200 million electron
particles, it was binned in successively coarser bins. The dose produced by the coarser bins was
compared to the one of the unbinned PHSP ﬁle. With the bin sizes employed in this work, the
doses from binned and unbinned PHSP ﬁles agree well within the 2%-2 mm gamma criterion
[Low et al., 1998].
In ﬁgure 3.20, the distributions with respect to the individual variables for a standard PHSP
ﬁle of an IOERT accelerator are shown. The distributions in energy, ρ and θ for PHSP ﬁles
suitable to IOERT have been studied previously [Iaccarino et al., 2011, Björk et al., 2002],
as well as the distribution in φ [Herranz et al., 2014]. From symmetry considerations, the
distribution of φ veriﬁes f(φ)=f(360◦ - φ) and thus, it is symmetrical around φ=180◦. As a
general rule, φ distributions peaked at values smaller than 90◦ would correspond to diverging
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Figure 3.20: Histograms for a 6 MeV NOVAC R© PHSP ﬁle with an applicator diameter of 60 mm,
showing both electron and photon distributions. The ordinate axis shows the number of particles in each
bin. The radial distribution shows number of particles crossing the unit of surface against ρ, the distance
to the axis of the applicator.
beams while distributions peaked at values larger than 90◦ would represent convergent or focused
beam. Radiotherapy beams in IOERT would be mostly diverging ones, with some non-dominant
converging component coming from secondary particles generated in the walls of the applicators
[Herranz et al., 2014].
3.4.2 Parameterization of PHSP ﬁles in the Intrabeam R© spherical applica-
tors
Exploiting the cylindrical geometry of the needle and spherical applicators, the PHSP ﬁle was
fully deﬁned by the distribution of particles in Energy (E) and two angles α and β, the ﬁrst to
position the particle in the sphere surface, and the second to determine the direction of emission
of the particle with respect to the direction of the radius of the sphere at the point of emission.
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We assumed that the particles were emitted from the spherical applicator surface. In the case of
XIORT applicators, no electrons are considered, therefore there is no need to include the particle
type parameterization. The deﬁnition of the angles is presented in Figure 3.21.
X
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β
Figure 3.21: Schematic view of the parameterization of the PHSP ﬁles for spherical applicators in terms
of the angles α and β.
In our parameterization we allow a dependency in the ﬂuence of the particles on their forward
or backward position along the surface of the sphere. We assume azimuthal symmetry around
the axis of the applicator, and azimuthal symmetry of the emission direction of the particles
with respect to the direction of the radius of the sphere at the point of emission of the particle.
With this parameterization the PHSP ﬁle is fully described with a maximum of 2.000.000 bins
or elementary sources.
To compute the actual dose, the condensed information contained in this compact PHSP ﬁle
has to be debinned to produce histories combining the information in the PHSP ﬁle with
two azimuthal angles with random values uniformly picked in between 0◦ and 360◦. One of
them combined with α ﬁxes the location of the emission point for the particle in the surface
of the sphere. The second one, combined with β, determines the direction of emission of the
particle.
To determine the bin sizes, the reference PHSP ﬁle was binned in successively coarser bins in
the variables previously described. The dose produced by the PHSP ﬁle from coarser bins, once
debinned, was compared to the one of the unbinned PHSP ﬁle. With the bin sizes employed
in this work, the doses from binned and unbinned PHSP ﬁles agree well within the 1%-1 mm
gamma criteria (more than 99 % of the voxels passed the test). Finally, the following ranges and
binning widths (BW) were considered for the deﬁnition of the elementary sources:
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Figure 3.22: Histograms for a 20 mm diameter spherical applicator PHSP ﬁle in terms of the relevant
variables (Energy, α and β), showing photon contributions. The ordinate axis shows the number of
particles in each bin.
• Energy, ranging from 0 to 50 keV (BW = 1 keV).
• α angle to position the particle in the sphere surface, ranging from 0◦ to 180◦ (BW = 0.9◦).
• Emission angle β, ranging from 0◦ to 20◦ (BW = 0.1◦).
In ﬁgure 3.22 the histograms of a parameterized spherical PHSP ﬁle in terms of the relevant
variables can be seen.
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3.4.3 Parameterization of PHSP ﬁle in the Intrabeam R© ﬂat and surface
applicators
For the case of Intrabeam R© ﬂat and surface applicators, the cylindrical approach used for
electron's PHSP parameterization can be also used, because we can assume the same symmetries.
However, a modiﬁcation regarding the binning parameters deﬁnition has been introduced.
Instead of parameterizing the diﬀerent degrees of freedom according to the z axis (applicator
axis), the PHSP ﬁle is going to be binned according to the original particle trajectory. To do this
approach the distance between the source location and the PHSP plane (SSD) must be known
and introduced in the calculations.
Figure 3.23: Schematic view of the parameterization of the PHSP ﬁles for ﬂat and surface applicators
in terms of the distance to the applicator ρ and the angle θ.
With this new binning, the angle φ turns to be almost isotropically distributed and can be
eliminated from the parameterized ﬁle, and the angle θ, now representing the deviation angle of
the particle trajectory when traveling through the interior of the applicator, will be decreased
up to a few degrees. Eliminating φ from the binning entails a great decrease in the number
of bins needed to characterize the PHSP ﬁle and allows a more detailed binning in the radial
distance to the applicator axis, needed to reproduce accurately the shape of the lateral proﬁles
that these applicators present. With this parameterization the PHSP ﬁle is fully described with
a maximum of 630.000 bins or elementary sources.
Therefore, the PHSP ﬁle is fully deﬁned by the distribution of particles in Energy (E), the radial
distance to the applicator axis ρ and the angle θ, the deviation angle of the particle with respect
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to the primary angle of the trajectory.
(a)
(c)
(b)
Figure 3.24: Histograms for a 20 mm diameter surface applicator PHSP ﬁle in terms of the relevant
variables (Energy, ρ and θ), showing photon contributions. The ordinate axis shows the number of
particles in each bin.
To select the optimal binning steps, the previously described approach of comparing dose from
binned and unbinned PHSP ﬁles was done. With the bin sizes employed in this work, more
than 99% of the dose voxels calculated from binned and debinned PHSP ﬁles passed the 1%-1
mm gamma evaluations. The following ranges and binning widths (BW) were considered for the
deﬁnition of the elementary sources:
• Energy, ranging from 0 to 50 keV (BW = 1 keV).
• Deviation θ angle of the particle trajectory, ranging from 0◦ to 18◦ (BW = 0.1◦).
• Radial position ρ, ranging from 0 cm to 3.5 cm (BW = 0.05 cm).
As in the other cases, to compute dose the PHSP ﬁle needs to be "debinned". The debinning
process works the same was as for electrons, where a uniformly distributed angle is produced
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which deﬁnes the position of the particle (x,y,z), in combination with the distance ρ to the
applicator axis.
In ﬁgure 3.24 are represented the histograms in terms of the variables used for the
parameterization of the PHSP ﬁle.
3.5 Conclusion
In this chapter we have simulated in detail a large group of IOERT accelerators and Intrabeam R©
applicators that represent accurately the experimental dose distributions.
Furthermore, with the parameterization of the PHSP ﬁles we have turned these huge ﬁles
containing all the information of the particle beam into an easy-to-manipulate ﬁle without loss
of information. These binned PHSP ﬁles can be stored and used without storage issues. And
ﬁnally, with the debinning tool we can transform the simpliﬁed version of the PHSP ﬁle into the
unbinned ﬁle.
The results from this chapter will be essential for the objectives of this thesis, because the
simulation results will be used as a pre-computed database that will be needed in the PHSP
optimization procedure explained in the following chapter. The binning and debinning tools will
make possible to handle and work with a large set of PHSP ﬁles.
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Chapter 4
Phase space optimization process
4.1 Introduction
Accurate calculation of dose distribution in an inhomogeneous medium such as a human body is a
complicated task. To date, the Monte Carlo (MC) method is considered to be the most accurate
algorithm for dose calculation but it requires the greatest processing time. Apart from the MC
method, all other methods make diﬀerent degrees of approximation and simpliﬁcation which lead
to much faster calculations but also result in less accurate dose distributions when comparing to
the MC simulation [Chen et al., 2014]. The ideal planning system would be a calculation tool
that can provide accurate dose distributions in minutes by means of a MC algorithm.
As we explained in chapter 3, MC codes for dosimetry require a realistic and accurate description
of the electron and/or photon beam employed in the radiotherapy procedure [Chetty et al., 2007],
and this information is included in the phase space (PHSP) ﬁle. The most common approach to
generate these PHSP ﬁles is by simulating in a realistic way the accelerator. To do this, we require
a detailed knowledge of the device and other elements, such as applicators. However, sometimes
this information is protected by the manufacturers, and even if the geometry is available, dose
distributions may vary slightly in diﬀerent devices of the same model, so each speciﬁc accelerator
should be tuned.
In the case of intraoperative electron radiotherapy, the development of new tools for MC
simulation of clinical linear accelerators, such a PRIMO [Rodriguez et al., 2013], can simplify
the simulation task as they include the geometry of some accelerators, but they still require a
few hours of simulation for each applicator diameter, LINAC model and energy conﬁguration,
and the tuning of each speciﬁc accelerator is not contemplated.
A previous procedure [Herranz et al., 2014, Herranz, 2013, Ibáñez, 2012, Ibáñez et al., 2014, Pérez-
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Liva, 2012] developed in our group was done to characterize beams of medical linear accelerators
for intraoperative radiotherapy with electrons. This method relied on ﬁtting with an iterative
procedure the relevant variables of a PHSP ﬁle (such as energy spectrum, spatial and angular
distributions of the particles) until it reproduced experimental dose measurements in water and
in air. Despite this method could perform the machine-speciﬁc tuning within minutes, the user
was required to introduce several input data of water and air dose proﬁles in the algorithm and
the accuracy of the ﬁtting depended strongly on the quality of the measurements.
The aim of this part of the thesis was to develop a fast and accurate phase space tuning tool which
can be ﬁtted to the user's device with only an experimental depth dose proﬁle (DDP) in water
[Ibáñez et al., 2015, Vidal et al., 2015, Udías et al., 2017a], and which has been implemented
into a commercial treatment planning system for intraoperative electron radiotherapy (IOERT)
and low energy X-rays radiotherapy (XIORT). The proposed process uses a parameterized phase
space model of the source deﬁned at the surface of the treatment applicator and optimizes it to
the user's source characteristics, by means of an optimization procedure that relies on a simple
set of experimental measurements.
In chapter 3 we have characterized all mobile IOERT accelerators as well as the spherical, needle,
ﬂat and surface Intrabeam R© applicators. We now will use these geometries to calculate a set
of monoenergetic (also called monochromatic) PHSP ﬁles and DDPs in water and store them,
in order to create a database to feed the PHSP optimization tool. After that, the optimization
method proposed in this thesis can be separated in two consecutive phases:
• In phase one, the set of monochromatic DDPs will be weighted and combined until the
sum of all the contributions reproduces the experimental DDP. This will be done with a
genetic algorithm and as a result of the ﬁtting process we will obtain an optimized energy
spectrum created from the relative contribution of each DDP to the experimental dose.
• In phase two, we will use the energy spectrum from phase one to weight the monochromatic
PHSP ﬁles stored in the database and generate an optimized PHSP ﬁle that will reproduce
the experimental data.
These two phases have to be performed for each energy and applicator of every accelerator or
Intrabeam R© that is going to be tuned, but the whole process takes only a few minutes, and once
the PHSP ﬁle is obtained it can be stored and used any time is needed. A scheme of the process
is shown in ﬁgure 4.1.
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Figure 4.1: Scheme of the phase space optimization process.
4.2 Database generation
First of all we need to generate the database that is going to be used in the rest of the process,
and to do this we will use the detailed simulations from chapter 3.
This part of the process requires a long simulation time, as we need to calculate enough
monoenergetic simulations of each device to cover its energy range. However, in a high capacity
cluster, a whole accelerator including its applicators can be characterized in several days.
Lets see the characteristics of the monochromatic simulations for the IOERT and XIORT
devices.
4.2.1 Intrabeam R© applicators
As explained in chapter 3, for spherical and needle applicators we did not simulate the full
description of the system but a simpliﬁed geometry which consists of a quasi-punctual source of
photons interacting with a standard geometry per applicator size. However, for ﬂat and surface
applicators this approximation could not be done and the detailed geometry of the applicators
was considered.
The photon beam exiting the source was characterized with a Gaussian energy distribution with
1 keV full width-half maximum (FWHM). The source had a spatial distribution deﬁned as a
circular foil of 0.01 cm radius and a spatial FWHM of 0.001 cm in order to approximate a point
source. 50 MC simulations, from 1 keV to 50 keV, were performed with 108 initial particles
for each applicator and the resulting PHSP ﬁles were collected at the external surface of the
83
4. Phase space optimization process
applicator.
Since PHSP are huge ﬁles and therefore diﬃcult to use, each one was parameterized in terms of
the relevant variables to make them easy to manipulate, following the considerations described in
section 3.4 of the previous chapter. All parameterized PHSP ﬁles were ﬁnally stored in a binary
format to reduce even more their size.
Regarding the monochromatic depth dose proﬁles (DDPs), they were either calculated with
penEasy at the same time as the PHSP ﬁles, or afterwards using a hybrid MC code speciﬁcally
developed to accelerate dose calculations for the Intrabeam R© photon beams. The code
description is detailed in chapter 6.
4.2.2 IOERT accelerators
Geometries of the MOBETRON R©, LIAC R© and NOVAC R© described in chapter 3 were used to
generate the IOERT database.
The source was deﬁned as circular, with a diameter of several millimeters (3-4 mm depending
on the accelerator) and with a Gaussian distribution centered at zero with 0.1 mm FWHM. 140
simulations were performed for each applicator and each accelerator, from 1 MeV to 14 MeV
with 0.1 MeV FWHM. 108 histories were calculated, and the PHSP ﬁles were parameterized in
the type of particle, energy, axial angle and radial position each 107 histories to save computer
memory. This part of the simulation took several days computation time (from 48 hours to 5
days depending on the accelerator geometry on a 8 cores high capacity cluster).
Depth dose proﬁles in water were obtained from these parameterized PHSP ﬁles with DPM
[Sempau et al., 2000] and stored as well (1 hour computation time on a 8 cores high capacity
cluster).
4.3 Optimization of energy spectrum
In the ﬁrst phase of the phase space optimization process, the monochromatic DDPs are going
to be adjusted to the experimental dose by means of a genetic algorithm [Fernandez-Ramirez
et al., 2008].
A genetic algorithm is an optimization tool inspired by the process of natural selection. The
algorithm creates a randomly generated population of possible solutions with a set of properties
that can be mutated. The evolution of this population follows an iterative process, where each
iteration is called a generation. In each generation, the more ﬁt individuals are selected, and
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their properties are mutated to form another generation, which is used in the next iteration of
the algorithm. The optimization ends when either a maximum number of generations have been
produced or a certain ﬁtness level has been reached.
The genetic algorithm requires a ﬁtting function, and in this case this function will be a
generic energy spectrum. This way, the genetic algorithm will generate an optimized energy
spectrum which weights the relative contributions of the monochromatic DDPs that reproduces
the experimental dose data.
The ﬁtting procedure will be the same for XIORT and for IOERT, but the shape of the initial
energy spectrum will diﬀer. Both energy spectra are going to de deﬁned by simple mathematical
functions describing the expected shape of the beam at the beginning of the accelerator head or
at the exit of the Intrabeam R© X-ray source.
4.3.1 Energy spectrum for Intrabeam R© applicators
The energy spectrum of the Intrabeam R© X-ray source is deﬁned as a function that describes
the Bremsstrahlung behavior of the energy spectrum and the characteristic rays. Based on
Kramers theory of the photons emitted when they hit a target (without taking into account the
characteristic lines) [Kramers, 1923], equation 4.1 describes the bremsstrahlung background of
the energy spectrum Sbackground in function of energy E:
Sbackground(E) = (E − E1)a
(
E0
E
− 1
)b
(4.1)
Where E0 is the maximal energy of the photon beam and E1 the cut-oﬀ energy. a and b are the
ﬁltration parameter and the Kramers law adjustment parameter respectively.
The gold characteristic X-rays have been added to the background at energies of 9, 12 and 14
keV, as measured by Schneider et al. at the probe surface [Schneider et al., 2010].
Sspectrum(E) = Sbackground(E) + c · Ip (4.2)
Where c is the mix parameter, ﬁxing the amplitude of the characteristic lines relative to the
spectrum background intensity and Ip the intensity of the characteristic line with energy E
relative to the other two lines.
For each experimental DDP provided by the user, the parameters E1, E0, a, b and c are varied
and the energy spectrum optimization results in a speciﬁc energy spectrum shape (with diﬀerent
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bremsstrahlung backgrounds and characteristic lines intensities) reproducing each experimental
DDP.
4.3.2 Energy spectrum for IOERT accelerators
In the case of electrons, the initial electron beam entering the accelerator head is simulated as
a combination of a Gaussian distribution with Kramers functions. For each central energy E0
of the Gaussian distribution, a Kramers function is generated. The sum of all combinations will
generate the energy spectrum.
A set of Gaussian distributions from E0-3.5σ to E0+3.5σ will be generated, being E0 the central
energy of the Gaussian distribution and σ its standard deviation:
ω(E) =
1√
2piσ2
e−
(E−E0)2
2σ2 (4.3)
These Gaussian distributions will be used to weight the 140 Kramers functions associated to
each monochromatic energy (Ec):
fKramers =
(
E
(E − Ec) + ∆
)α
(4.4)
Being ∆ a blurring parameter inserted to avoid diﬀerences in the denominator between diﬀerent
energies because of the energy binning that it is being used.
The energy spectrum will be the sum of all normalized Kramers functions weighted by the
Gaussian distributions:
Sspectrum(E) = ω(E)
∑140
i=1 fKramers(E, i)
normalization
(4.5)
For each experimental DDP provided by the user, the parameters E0, σ, α and ∆ will be varied
and, as in the case of XIORT, the optimization will result in a speciﬁc energy spectrum shape
reproducing each experimental DDP.
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4.3.3 Treatment of the experimental data
To perform this ﬁtting, usually a previous treatment of the experimental DDP needs to be
performed. Specially in the case of electron doses, sometimes the experimental proﬁles do not
have a soft shape and present some irregularities. This may aﬀect the ﬁtting process as these
errors are introduced in the algorithm. To avoid it and to guaranteer an accurate adjustment,
a previous treatment is done to the DDP by approximating it to a general function with the
form:
f(x) = A
[
e−Bx − Ce−Dx] e−Ex4+Fx2G +H (4.6)
Figure 4.2 shows the treatment done to an experimental DDP from a NOVAC R© accelerator with
9 MeV.
Figure 4.2: Experimental DDP and adjusted DDP for a 9 MeV NOVAC R© with 4 cm diameter.
4.4 PHSP weighting algorithm
Once the energy spectrum is optimized, we need to generate the tuned phase space ﬁle. To do
this, the monochromatic PHSP ﬁles are weighted with the optimized energy spectrum from the
genetic algorithm and merged to obtain the ﬁnal PHSP ﬁle. This ﬁle also needs to include a scale
factor that is going to be applied to the ﬁnal dose so that it is scaled to the input experimental
DDP.
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The genetic algorithm supplies a scale factor needed to scale the adjusted DDP to the
experimental one, and applies a normalization of the spectrum that will have to be considered
in the ﬁnal scale of the weighting procedure. However, this factor will not be suﬃcient to scale
the problem, and we will need to introduce an extra scale factor derived from the number of
particles used to calculate the monochromatic DDPs.
The ﬁnal scale factor will be a contribution of both factors:
f = fgenetic · fweighting (4.7)
The weighting procedure will depend on the way the monochromatic DDPs are generated.
Dose distributions obtained with any MC algorithm are always deﬁned as dose per primary
history. When the primary beam travels through the diﬀerent elements of the accelerator head
or the applicators, some of the original particles are absorbed or scattered and do not reach the
PHSP recollection plane. The number of lost particles increases as the energy decreases, so the
monochromatic PHSP ﬁles will not have information of the same number of particles for all the
energies. However, if the monochromatic DDPs are calculated in the same simulation as the
PHSP ﬁles, these dose distributions will be all divided by the same number of histories, ie. the
initial primary histories of the simulations. But if these curves are obtained with other code,
such as DPM or the hybrid MC algorithm described in chapter 6, they are going to be calculated
from the monochromatic PHSP ﬁles, and every curve will be divided by a diﬀerent number of
primary histories.
Therefore, two diﬀerent approaches must be taken into consideration, depending on the procedure
used for generating the monochromatic DDPs.
4.4.1 Weighting approach for DDPs with the same number of histories
If the monochromatic DDPs have been generated at the same time as the PHSP ﬁles, and
therefore they are all divided by the same number of primary histories, the optimized spectrum
will be used to directly weight the monochromatic PHSP ﬁles. The dose distribution obtained
with the optimized PHSP ﬁle will be divided by the number of its primary histories, which in
this case will be sum of the number of histories of each monochromatic PHSP ﬁle multiplied by
the corresponding value of the energy spectrum:
[
Emax∑
i=1
PHSP (i) · spectrum(i)]→ dose∑Emax
i=1 [weightPHSP (i) · spectrum(i)]
(4.8)
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Where weightPHSP (i) is the number of histories of the monochromatic PHSP ﬁle with energy i.
As mentioned before, there is also a normalization factor coming from the genetic ﬁtting that
needs to be included, the spectrum normalization. With this information, the extra scale factor
needed to reproduce the experimental dose will then be:
fweighting =
∑Emax
i=1 [weightPHSP (i) · spectrum(i)]∑Emax
i=1 spectrum(i)
(4.9)
4.4.2 Weighting approach for DDPs with diﬀerent number of histories
If the monochromatic DDPs have been calculated from the monoenergetic PHSP ﬁles, each one
will be divided by a diﬀerent number of primary particles. Therefore, in this case, the merging
procedure needs to be corrected by the number of histories of each monochromatic PHSP ﬁle,
the weightPHSP (i). So the merging we have to consider is:
Emax∑
i=1
[
PHSP (i) · spectrum(i)
weightPHSP (i)
]
(4.10)
The dose per history we will obtain from the merged PHSP will then be:
Emax∑
i=1
[
PHSP (i) · spectrum(i)
weightPHSP (i)
]
→ dose∑Emax
i=1
[
weightPHSP (i)·spectrum(i))
weightPHSP (i)
] (4.11)
And if we ﬁnally incorporate the normalization factor of the energy spectrum from the genetic
ﬁtting:
fweighting =
Emax∑
i=1
[
weightPHSP (i) · spectrum(i))
weightPHSP (i)
]
1∑Emax
i=1 spectrum(i)
= 1 (4.12)
We can see that, in this case, the scale factor will only be given by the genetic algorithm.
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4.5 Results
In this section we will focus on some of the results obtained from the ﬁtting procedure. A
full validation of the procedure can be found in next chapter, where comparisons against
experimental measurements and detailed simulations in diﬀerent heterogeneous phantoms have
been performed.
Some examples of the ﬁtted DDP obtained with the genetic algorithm, as well as the optimized
energy spectra, can be seen for the diﬀerent approaches in ﬁgures 4.3 (spherical applicator), 4.4
(ﬂat applicator) and 4.5 (IOERT accelerator).
Figure 4.3: Left: Comparison of experimental DDP and optimized DDP for the 1.75 cm radius spherical
applicator. Right: Optimized energy spectrum.
Figure 4.4: Left: Comparison of experimental DDP and optimized DDP for the 2 cm ﬂat applicator.
Right: Optimized energy spectrum.
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Figure 4.5: Left: Comparison of experimental DDP and optimized DDP for the 9 MeV NOVAC R© with
a 4 cm applicator. Right: Optimized energy spectrum.
As it can be seen from the diﬀerent ﬁgures, the ﬁtting procedure works accurately, reproducing
the provided DDPs while maintaining the physical shape of the spectra. Although the
optimization process only ﬁts the DDPs, by having extracted the monochromatic data from
detailed simulations of the diﬀerent accelerators we guarantee that the transverse proﬁles are
also going to behave correctly.
Computation time of the whole ﬁtting process (genetic + weighting algorithms) varies on each
case. The genetic algorithm is the most time consuming procedure. The number of dose values
of the experimental proﬁle and the voxel size employed in the simulation of the monochromatic
DDPs are a contributing factor in the running time of the code. However, its computation time
goes from less than a minute up to 6-7 minutes. The weighting algorithm is faster. In this part
of the procedure, the computation time is highly dependent on the number of bins in which
each PHSP ﬁle has been discretized. The computation time of this part of the ﬁtting progress
goes from 3-5 seconds (for the ﬂat and surface applicators) to about 40 seconds for the spherical
applicators. Nevertheless, in all cases the overall time needed to generate an optimized PHSP
ﬁle that reproduces any given experimental DDP is below 10 minutes.
4.6 Conclusion
In this chapter we have developed a ﬁtting procedure that allows to obtain a PHSP ﬁle that
reproduces the DDP of any device within minutes.
For this optimization, the user does not need to perform speciﬁc measurements to feed the
algorithm, because the only required input is the DDP in water, which is a measurement that
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has been previously done for each energy and applicator of the accelerator as it is mandatory for
the commissioning of the device.
By combining PHSP ﬁles and DDPs from realistic simulations and by using a realistic shape of
the energy spectra we guarantee an accurate behavior of the dose distributions, not only of the
DDP but also of the transverse proﬁles.
In the next chapter we will validate this procedure by comparing dose distributions calculated
from optimized PHSP ﬁles to measurements in diﬀerent scenarios, proving that the phase space
tuning process can be a powerful dosimetric tool.
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Chapter 5
Validation of the phase space
optimization process with experimental
data
5.1 Introduction
In this chapter we present the validation and application of the phase space optimization process
described in the previous chapter using experimental measurements from clinical intraoperative
electron radiotherapy (IOERT) accelerators and Intrabeam R© applicators used in low energy
X-rays intraoperative radiotherapy (XIORT) [Ibáñez et al., 2015, 2016, Vidal et al., 2015].
For the validation of XIORT applicators, a set of measurements based on clinical situations has
been used, such as air gaps or bone inhomogeneities, and in the case of IOERT validation, the
set of measurements were based on the ECWG (Electron Collaborative Working Group, AAPP)
report [Shiu et al., 1992] and on the quality control protocol [Rodríguez et al., 2005] for treatment
planning systems from the SEFM (Sociedad Española de Física Médica) [Ibáñez, 2012, Herranz,
2013, Leoz Munté, 2015].
The set of measurements includes homogeneous and heterogeneous phantoms. Usually, the
required measurements for the characterization of any clinical machine include air and water dose
distributions. But when a patient is treated, the radiation beam travels through heterogeneous
media, depositing its energy in a diﬀerent way than in water or air. Therefore, dose distributions
in heterogeneous phantoms are also very valuable to verify any radiotherapy device.
Gafchromic EBT3 ﬁlms were used for performing all the dose measurements. This choice of
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radiochromic ﬁlms is due to the high spatial resolution they present, as well as their low energy
dependence, which make them suitable for measuring dose distribution for both electron and
low-energy X-rays radiotherapy [Avanzo et al., 2012, Ebert et al., 2009, Fletcher and Mills,
2008].
5.2 Validation for XIORT applicators
Before every session of measurements, the isotropy and dose rate of the source were checked.
For this purpose, accessories of the Intrabeam R© were used: the photodiode array (PDA), which
contains ﬁve diodes at orthogonal positions in the front and side of the probe tip, to measure
and adjust isotropy; the PAICH unit, which contains a light source to verify straightness of the
probe and a holder for a type 23342 chamber, to measure stability of the dose rate [Avanzo et al.,
2012].
Films were marked for orientation, numbered, and were handled and stored in order to minimize
exposure to light. An Epson Expression 10000XL (US Epson, Long Beach, CA) ﬂatbed scanner
was used for scanning the ﬁlms. A scanning protocol was adopted that follows the modiﬁcation
of Devic et al. protocol [Devic et al., 2005] described by Avanzo et al. where, instead of reading
all the ﬁlms before and after exposure, only one piece of unirradiated ﬁlm was scanned and used
for all ﬁlms [Avanzo et al., 2012].
The scanning was performed at least 24 hours after irradiation. For proper warming up of the
scanner, ﬁve preview scans were done before scanning the ﬁlms. The ﬁlms were scanned in
transmission mode, in 48 bit RGB format, at a scanning resolution of 72 dpi (0.0847 mm=pixel)
with the Epson Scan software, with all the ﬁlters and image corrections turned oﬀ. All ﬁlms were
scanned in portrait orientation, one at a time, with the ﬁlm placed in the central area of the
scanner. No inhomogeneity correction in scanner response was applied. Every ﬁlm was scanned
two times consecutively [Aranda Escolástico, 2013].
Images were saved in uncompressed tagged image ﬁle format (TIFF). Film images were analyzed
using an in-house image manipulation routine written with MATLAB 7.6.0.324 (MathWorks,
Natick, MA, USA) based in the three channel technique explained in chapter 1 [Lewis et al.,
2012].
5.2.1 Experimental measurements for Spherical applicators
Measurements for all spherical applicators were done at the Universitätsklinikum Mannheim,
Germany. The set of measurements includes depth dose proﬁles (DDPs) in a water equivalent
phantom and 2D dose distributions, dose measurements in an air-water step phantom and
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calibration.
5.2.1.1 Calibration
The calibration phantom is a Gammex R© solid water phantom with two blocks joined with screws
to form a single block. One of the blocks is a (14×14×0.25) cm3 layer and the other is thicker,
a (14×14×1) cm3 block with a hole to insert the ionization chamber. On top of the chamber
the ﬁlm is located, in order to acquire a simultaneous measure from both the chamber and the
ﬁlm.
Films were cut into pieces of 5×5 cm2 for calibration, and were marked to keep the original
orientation of the ﬁlm. A PTW Soft X-Ray Chamber (Volume: 0.02cm3, type: 23342,
Physikalisch-Technische Werkstaetten, Freiburg, Germany) with a sensitive window radius of
1.5 mm and 1 mm thick was used. A PTW UNIDOS (Type: 10001-010582, Physikalisch-
Technische Werkstaetten, Freiburg, Germany) electrometer was used to read the dose lectures,
and the necessary corrections were included (pressure, temperature, etc) for an absolute dose
reading.
For the calibration measurements, a 4 cm diameter spherical applicator was used. A stand was
designed to ﬁx the distance between the Intrabeam R© XRS and the calibration phantom at a
known depth. This stand is a special construction built at the hospital intended to be used for
dosimetry measurements of the INTRABEAM XRS with or without attaching an applicator.
Instead of varying the distance between the source and the phantom at a ﬁxed irradiation time,
we decided to vary the irradiation time at a ﬁxed depth. Therefore, the distance between the
applicator and the ionization chamber was set at 0.75 cm, and the dose rate was ﬁxed to 0.716
Gy/min. 7 measurements (plus the unirradiated) were taken to cover the energy range of the
Intrabeam R©. The values of this calibration are shown in table 5.1.
Exposure time (s) Absolute dose (Gy)
0 0.00
300 1.37
600 2.78
900 4.16
1800 8.49
2700 12.50
3600 16.63
4500 20.73
Table 5.1: Measured dose values during the calibration procedure obtained with the ionization chamber.
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Figure 5.1: Left: Gammex R© solid water phantom employed in calibration measurements with the
ionization chamber and a EBT3 ﬁlm. Right: Experimental setup for the calibration measurements.
5.2.1.2 Experimental setup and phantom description
2D dose distributions in water
A Gammex R© phantom, speciﬁcally created to measure 2D dose distributions along the applicator
axis, was employed. It consists of two blocks made of solid water with an applicator-shaped hole.
The ﬁlm is located between the two blocks and the applicator is placed in the phantom hole.
This way, dose surrounding the applicator can be measured.
There are diﬀerent types of solid water plates used in radiotherapy dosimetry, but not all materials
are water-equivalent at kilovoltage energies due to increased number of photoelectric interactions,
which depends on the atomic number [Eaton and Duck, 2010]. Several authors have investigated
the suitability of diﬀerent materials in the kV energy range [Hermann et al., 1985, Meigooni
et al., 1988, Hill et al., 2005, 2010]. In this study "Gammex" solid water was used because it
seems to be the best suitable material for Intrabeam R© X-rays working energy.
Prescribed dose was set to 20 Gy at the surface, corresponding to the dose rate employed in a
breast cancer treatment.
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Figure 5.2: Gammex solid water phantoms employed in 2D dose distribution measurements.
Depth dose curves in water
Although Gammex is believed to be the best water-equivalent material for kV X-rays, in the
clinic there were only a few Gammex phantoms for speciﬁc measurements. Therefore, in order
to perform diﬀerent measurements, we were forced to use a CIRS Plastic Water R© solid water
phantom (Norfolk, VA).
To absorb possible diﬀerences in dose due to the material type, DDPs were measured for all
applicators with this solid water material and were used as the input experimental DDP needed
for the ﬁtting process.
Ten ﬁlms were placed at diﬀerent depths to reproduce the fall of the dose with distance.
Measurements at 1, 2, 4, 6, 8, 10, 15, 20, 30 and 40 mm were taken. In ﬁgure 5.3 a view
of the setup with the location of the radiochromic ﬁlms is shown.
A comparison between the measured DDPs and the DDPs provided by Zeiss in water was done
to check the diﬀerences of using the plastic water as reference. Figure 5.4 shows the comparison
for all the spherical applicators of the measured DDPs described above (dots) and the DDPs
provided by Zeiss (solid lines). It can be seen that the behavior of the measured curves is very
similar to the ones the provided by Zeiss.
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Figure 5.3: Experimental setup (left) and schematic view of the position where the radiochromic ﬁlms
were placed (right).
Figure 5.4: DDPs for all the spherical applicators. Dotted curves correspond to our experimental
measurements, and the solid lines correspond to the DDPs provided by Zeiss.
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Air step heterogeneous phantom
The same Plastic Water blocks presented from the DDP measurements were used to build a 5
mm air step. Three radiochromic ﬁlms were placed at diﬀerent depths, 5, 10 and 15 mm. In
ﬁgure 5.5 the experimental setup and a schematic representation of the heterogeneity with the
location of the EBT3 ﬁlms can be seen.
Dose distributions were measured for all spherical applicators with a prescribed dose of 20 Gy
at the surface.
Figure 5.5: Experimental setup (left) of the Air-water step and schematic view of the position where
the radiochromic ﬁlms were placed (right).
5.2.2 Experimental measurements for Flat and surface applicators
Measurements for ﬂat and surface applicators were done at the IUCT Oncopole (Toulouse,
France). The set of measurements includes calibration, DDPs and 2D dose distributions in
water, dose measurements in an air-water equivalent step phantom and in a bone-water equivalent
phantom.
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5.2.2.1 Calibration
To perform the calibration measurements, the Intrabeam R© water tank was used. This tank has
a positioning unit where the XRS is mounted that permits to move the XRS inside the tank. It
also contains a waterproof holder made of solid water to accommodate the soft X-ray ionization
chamber (manufactured by PTW Freiburg, Germany, type 23342) [Zeiss, 2011]. The ﬁlms were
placed on top of the holder.
Films were irradiated with the 4 cm diameter ﬂat applicator at a ﬁxed depth of 6 mm, and
ﬁlms were irradiated with 0, 1, 2, 3, 4, 5, 6 and 7 Gy. To do this, Zeiss provides the user with
conversion tables to extract, from each needed dose value at the ﬁlm depth, the corresponding
dose prescription at a ﬁxed depth of 21.5 mm. Table 5.2 shows the values of the calibration
curve.
Exposure time (s) Absolute dose (Gy) at 21.5 mm Absolute dose (Gy) at 6 mm
0 0.00 0.00
22 0.15 1.00
43 0.30 2.00
65 0.45 3.00
87 0.60 4.00
108 0.75 5.00
130 0.90 6.00
152 1.05 7.00
Table 5.2: Measured dose values during the calibration procedure obtained with the ionization chamber.
5.2.2.2 Experimental setup and phantom description
Dose distributions with depth for all applicators were measured with Gafchromic EBT3 by
locating a single ﬁlm parallel to the beam between solid water plaques. Two heterogeneous
situations were studied as well: An air step and a bone phantom.
Air step heterogeneous phantom
Several PMMA blocks were used to build a 5 mm air step. Three radiochromic ﬁlms were placed
at 5, 10 and 15 mm depth. Figure 5.6 shows the schematic representation with the location of
the ﬁlms.
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5 mm 
10 mm 
0 mm 
Figure 5.6: Schematic view of the air step setup with the position where the radiochromic ﬁlms were
placed.
Bone heterogeneous phantom
The same PMMA blocks were used to build a bone-equivalent heterogeneous phantom. To do
this, a Teﬂon block with 4 mm thickness was inserted between the PMMA blocks at a depth of 5
mm. Figure 5.7 shows a picture of the experimental setup and its schematic representation with
the location of the ﬁlms.
5 mm 
9 mm 
14 mm 
Figure 5.7: Experimental setup (left) of the bone heterogeneity and schematic view of the position
where the radiochromic ﬁlms were placed (right).
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5.2.3 Dose comparison for spherical applicators
The measured DDPs were used to ﬁt the monochromatic DDPs and phase space (PHSP) ﬁles
by means of our optimization algorithm, and the resulting PHSP ﬁles were used to compute
dose with penEasy in water and in the air step phantom. Results were then compared with the
radiochromic ﬁlm measurements qualitatively and quantitatively (ie. gamma evaluation).
5.2.3.1 Dose distributions in water
We have compared 2D dose distributions for the 40 mm diameter spherical applicator and the 25
mm diameter applicator. The reference DDPs were extracted from the radiochromic ﬁlms and
used to ﬁt the monochromatic PHSP ﬁles and DDPs in order to generate the optimized PHSP
ﬁle.
For the calculation of both the 40 mm and 25 mm diameter spherical applicator, 109 histories
were simulated in (120×120×120) voxels phantoms, with 1 mm voxel size.
0
>1
Gamma 
2%-2 mm
(a) (b)
(c)
Figure 5.8: 2D dose distributions in water for a 40 mm diameter spherical applicator obtained from
(a) radiochromic ﬁlms, (b) penEasy calculation with the reconstructed PHSP ﬁle and (c), the gamma
evaluation distribution for a 2%-2 mm criterion with 5% threshold. 83.82% voxels passed the test.
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Figure 5.9: 2D dose distributions in water for a 25 mm diameter spherical applicator obtained from
(a) radiochromic ﬁlms, (b) penEasy calculation with the reconstructed PHSP ﬁle and (c), the gamma
evaluation distribution for a 2%-2 mm criterion with 5% threshold. 94.43% voxels passed the test.
We have compared the experimental and computed dose distributions in terms of gamma
evaluation. For this section, we chose a 2%-2 mm criterion and considered a threshold of 5%.
The 2 mm distance criterion was chosen because of the voxel size we used. In this work the
diﬀerent distance-to-agreement criteria used in the gamma evaluations have been chosen to be
at least twice the voxel size, to allow the code to look for gamma values in the nearest neighbors
of the evaluated voxel.
The experimental and simulated dose distributions for the 40 mm applicator can be seen in
ﬁgure 5.8, as well as the gamma distribution for the 2%-2 mm criterion (5% threshold). The
same distributions for the 25 mm applicator are showed in ﬁgure 5.9. The main diﬀerences
between experimental and simulated images are due to the anisotropy presented in the ﬁlms in
the backward direction. Our spherical approximation considers isotropy in the particle emission,
and therefore the real behavior of the dose can not be exactly reproduced. This dose diﬀerence
in the backward direction is reﬂected in the gamma evaluation, specially for the 40 mm diameter
applicator, where a large concentration of voxels failing the criterion can be seen in the backward
area. As a result, only 83.82% of the voxels passed the test. In the case of the 25 mm diameter
applicator, the ﬁlm presented a less pronounced anisotropy in the dose distribution, and therefore
the number of voxels in the MC simulation of this applicator passing the evaluation increased
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up to 94.43%.
5.2.3.2 Dose distributions in heterogeneous phantoms
The phantoms were deﬁned by a volume of (100×100×126) voxels, with a voxel size of 1 mm.
The number of histories of each simulation varied from 109 histories to 3·109, depending on the
noise of the resulting dose distribution.
Due to the diﬃculty in assuring geometrical positioning of the experimental setup within 1 mm
or less, the simulation had to be slightly modiﬁed for every case, moving the interface air-water
from the center when necessary.
Figure 5.10 shows an example of the results we obtained. It includes the 2D dose distributions
at the depths where the ﬁlms were located from the radiochromic ﬁlms (a) and from penEasy
(b) for the 40 mm diameter spherical applicator.
(a)
(b)
z = 0.5 cm z = 1.0 cm z = 1.5 cm
Figure 5.10: 2D dose distributions in the air step at the diﬀerent measured depths for a 40 mm diameter
spherical applicator obtained from (a) radiochromic ﬁlms, (b) penEasy calculation with the reconstructed
PHSP ﬁle.
We also performed a gamma evaluations of the results. As the voxel size was set at 1 mm, we
chose a 2%-2 mm criterion with a 5% threshold. The results are presented in table 5.3.
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Gamma evaluation with 2% - 2 mm
Air step
Spherical φ 15 mm 96.77%
Spherical φ 20 mm 99.40%
Spherical φ 25 mm 99.30%
Spherical φ 30 mm 95.69%
Spherical φ 35 mm 99.49%
Spherical φ 40 mm 99.61%
Spherical φ 45 mm 99.11%
Spherical φ 50 mm 99.29%
Table 5.3: Results of gamma evaluation between MC simulations and measurements in the air step
phantom (5% threshold).
For all the cases, more than 95% voxels passed the 2% - 2 mm gamma index, which indicates
that there is a good agreement between simulations and measurements.
5.2.4 Dose comparison for ﬂat and surface applicators
5.2.4.1 Dose distributions in water
Dose in water was calculated from the optimized PHSP ﬁle and compared with measurements
from radiochromic ﬁlms for two cases: a 3 cm diameter ﬂat applicator and a 3 cm surface
applicator. Dose was calculated in volumes of (120×120×120) voxels with a voxel size of 1 mm.
The results of these comparisons are displayed in ﬁgures 5.11 and 5.12.
In terms of gamma evaluation, there is a good agreement with the measurements, with more
than 99% voxels passing the 2%-2 mm criterion (with a 5% threshold) for the 3 cm ﬂat applicator
and more than 95% voxels passing it in the case of the 3 cm surface applicator.
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Figure 5.11: Dose distribution comparison for a 30 mm diameter ﬂat applicator obtained with (a) a
radiochromic ﬁlm and (b) penEasy calculation from the reconstructed PHSP ﬁle.
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Figure 5.12: Dose distribution comparison for a 30 mm diameter surface applicator obtained with (a)
a radiochromic ﬁlm and (b) penEasy calculation from the reconstructed PHSP ﬁle.
5.2.4.2 Dose distributions in heterogeneous phantoms
The experimental DDPs measured at Toulouse were introduced into the ﬁtting algorithm to
generate the optimized PHSP ﬁles for each applicator, and they were used to calculate dose
distributions in the diﬀerent heterogeneous phantoms.
The phantoms were deﬁned by a (200×200×100) voxels volume, with 1 mm voxel size. As for
the spherical validation, the number of histories varied with the applicator, depending on the
noise of the dose distribution, from 5·108 to 109 histories.
Two examples of the results that we have obtained can be seen in the following ﬁgures. Figure
5.13 includes 2D views of the dose distribution in the bone phantom for a 3 cm ﬂat applicator
at the depths where the ﬁlms were placed obtained with (a) the radiochromic ﬁlms and (b)
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penEasy. The same comparison is showed in ﬁgure 5.14 with a 3 cm surface applicator in the air
step phantom.
(a)
(b)
z = 0.5 cm z = 0.9 cm z = 1.4 cm
Figure 5.13: 2D dose distributions in the bone phantom at the diﬀerent measured depths for a 30
mm diameter ﬂat applicator obtained from (a) radiochromic ﬁlms, (b) penEasy calculation from the
reconstructed PHSP ﬁle.
(a)
(b)
z = 0.5 cm z = 1.0 cm z = 1.5 cm
Figure 5.14: 2D dose distributions in the air step at the diﬀerent measured depths for a 30 mm diameter
surface applicator obtained from (a) radiochromic ﬁlms, (b) penEasy calculation from the reconstructed
PHSP ﬁle.
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Finally, dose distributions were also compared in terms of gamma evaluation with a 2%-2 mm
criterion (5% threshold). The results of the evaluation are presented in table 5.4. In the bone
phantom, more than 95% voxels passed the evaluation in all the applicators. In the case of
the air step, these percentages dropped a little, but even though a good percentage of voxels
passed. We can conclude that a reasonable agreement was reached between simulations and
measurements.
Gamma evaluation with 2% - 2 mm
Air step Bone
Flat φ 10 mm 93.91% 98.79%
Flat φ 20 mm 96.67% 99.17%
Flat φ 30 mm 96.85% 99.23%
Flat φ 40 mm 93.61% 97.80%
Flat φ 50 mm 93.37% 97.30%
Surface φ 10 mm 94.88% 96.94%
Surface φ 20 mm 96.66% 99.38%
Surface φ 30 mm 97.54% 99.28%
Table 5.4: Results of gamma evaluation between MC simulations and measurements in the air step
phantom and in the bone heterogeneity (5% threshold).
5.3 Validation for IOERT accelerators
5.3.1 Experimental measurements for IOERT accelerators
In the case of IOERT accelerators we had access to fewer experimental data.
Transverse dose proﬁles and DDPs in water were provided for all the dedicated accelerators,
but in the case of heterogeneities, only one set of data from a NOVAC R© was provided. These
measurements were performed at the Universitätsklinikum Düsseldorf, Germany.
5.3.1.1 Experimental setup and phantom description
As previously said, the set of measurements were based on quality control reports designed for
electron beams, such as ECWG report [Shiu et al., 1992] or SEFM report [Rodríguez et al.,
2005]. Four diﬀerent setups were considered:
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Solid water step
Several solid water blocks were used to create an air-water step. First, a 10 mm layer was placed
in order to create the step. Then there was a 2 mm layer, under which the ﬁrst ﬁlm was located,
and then other 5 mm layer with the second ﬁlm. Finally, an appropriate thickness of solid water
layers were placed to avoid retro-diﬀusion (60 mm). In ﬁgure 5.15 the schematic location of the
ﬁlms are represented.
12 mm
17 mm
Figure 5.15: Experimental setup (left) of a solid water step measurement and its schematic view with
the location of the ﬁlms (right).
Lung heterogeneity, costal wall type
The ﬁrst solid water layer was 10 mm thick with a ﬁlm underneath. Then, another 1 mm thick
solid water layer was placed with a ﬁlm in the interface with the cork. Following this ﬁlm, two
5 mm-cork layers with ﬁlms were placed and ﬁnally several cork layers were placed for retro-
diﬀusion (30 mm). The schematic view with the ﬁlm locations is showed in ﬁgure 5.16.
10 mm
11 mm
16 mm
21 mm
Figure 5.16: Experimental setup (left) of a lung heterogeneity measurement and its schematic view
with the location of the ﬁlms (right).
Heterogeneity mediastinum-lung type
The ﬁrst solid water layer was 10 mm thick with a ﬁlm underneath. Then, there was a 5 mm
cork and solid water layer with a ﬁlm, followed by a 10 mm layer with the corresponding ﬁlm
and ﬁnally we had a 1 mm solid water layer to see the rebuild-up in the cork part with two ﬁlms,
one before and the other after the layer. After that, some solid water layers were placed for
retro-diﬀusion (60 mm). Details about the location of the ﬁlms can be seen in ﬁgure 5.17.
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10 mm
15 mm
25 mm
30 mm
31 mm
Figure 5.17: Experimental setup (left) of a mediastinum-lung type measurement and its schematic view
with the location of the ﬁlms (right).
3D internal heterogeneity water/bone type
A Teﬂon block was used to simulate bone. Here only one ﬁlm was used, just under the Teﬂon.
First, a 10 mm thick solid water layer was placed followed by a (30×160×10) mm3 Teﬂon block
surrounded by solid water layers and the ﬁlm. Finally, some solid water layers were placed for
retro-diﬀusion (60 mm). The schematic view is shown in ﬁgure 5.18.
20 mm
Figure 5.18: Experimental setup (left) of a water/bone type measurement and its schematic view with
the location of the ﬁlms (right).
5.3.2 Dose comparison for IOERT accelerators
Radiophysicists from Universitätsklinikum Düsseldorf provided us with DDPs and transverse
proﬁles in water for all NOVAC R© energies and applicators, and regarding the heterogeneous
phantoms, they supplied the central transverse proﬁles extracted from the radiochromic ﬁlms for
a 4 cm diameter applicator and a 9 MeV working energy. Therefore, we will focus the IOERT
validation in these heterogeneities.
Furthermore, we extended the validation to include the LIAC R© and MOBETRON R© accelerators,
where dose distributions in heterogeneous phantoms were compared against simulations from
detailed accelerators.
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5.3.2.1 Dose distributions against measurements
The PHSP ﬁle was reconstructed from the experimental DDP for the 9 MeV, 4 cm diameter
NOVAC R©, following the procedure explained in the previous chapter. This PHSP ﬁle was then
used to calculate dose distributions in the diﬀerent heterogeneities with DPM [Sempau et al.,
2000]. The volumes were deﬁned by (161×161×200) voxels with 1 mm voxel size, and 200 million
histories were simulated.
The results of these simulations can be seen in the following ﬁgures, where the transverse
proﬁles from the reconstructed PHSP ﬁle are represented against the proﬁles extracted from the
radiochromic ﬁlms for the diﬀerent setups. Figure 5.19 shows the results in the solid water step
calculation, ﬁgure 5.20 corresponds to the costal wall phantom, ﬁgure 5.21 to the mediastinum-
lung heterogeneity and ﬁgure 5.22 to the water/bone phantom.
As it can be seen from the ﬁgures, in all the cases a reasonable agreement was reached. A
gamma evaluation with 2%-2 mm criterion (5% threshold) was also performed and the results
are presented in table 5.5. Despite the low number of dose values to compare, more than 95% of
voxels fulﬁlled the evaluation in most cases. It can be seen from the experimental proﬁles that
some of the measurements present positioning errors, so the accuracy of the comparison was
mostly limited by the diﬃculty of reproducing these misplacements in the simulations.
Figure 5.19: Transverse dose proﬁles at 1.2 (shifted up by 20%) and 1.7 cm depth in the solid water
step phantom obtained from the radiochromic ﬁlms and from the reconstructed PHSP ﬁle (NOVAC R©,
9MeV, 4 cm φ applicator).
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Figure 5.20: Transverse dose proﬁles at 1.0 (shifted up by 5%), 1.1, 1.6 and 2.1 cm depth in the lung
heterogeneity, costal wall type phantom obtained from the radiochromic ﬁlms and from the reconstructed
PHSP ﬁle (NOVAC R©, 9MeV, 4 cm φ applicator).
Figure 5.21: Transverse dose proﬁles at 1.0 (shifted up by 10%), 1.5, 2.5, 3.0 and 3.1 cm depth in the
mediastinum-lung type phantom obtained from the radiochromic ﬁlms and from the reconstructed PHSP
ﬁle (NOVAC R©, 9MeV, 4 cm φ applicator).
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Figure 5.22: Transverse dose proﬁles at 2.0 cm depth in the water/bone type phantom obtained from
the radiochromic ﬁlms and from the reconstructed PHSP ﬁle (NOVAC R©, 9MeV, 4 cm φ applicator).
Gamma evaluation with 2% - 2 mm
NOVAC R©, 9 MeV, 4 cm φ
Step 96.19%
Costal wall 93.21%
Mediastinum 95.91%
Water/bone 96.92%
Table 5.5: Results of gamma evaluation between MC simulations and measurements in the diﬀerent
phantoms (5% threshold).
5.3.2.2 Dose distributions against simulations
We decided to include in the validation the LIAC R© and MOBETRON R© accelerators, but as we
did not have access to experimental data of these accelerators in heterogeneous phantoms, we
compared against simulations.
We used the detailed simulations from chapter 3 of the 6 cm diameter applicator LIAC R© and the
MOBETRON R© with 9 cm diameter applicator and calculated dose distributions with a realistic
energy spectrum of 12 MeV (for the LIAC R©) and 9 MeV (for the NOVAC R©). We used the DDPs
from these simulations as the input dose that feeds the genetic algorithm and the monochromatic
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DDPs and PHSP ﬁles were optimized to generate the ﬁtted PHSP ﬁle that was used afterwards
in four diﬀerent heterogeneous phantoms.
The setups used for the validation are shown in ﬁgure 5.23. They are very similar to the ones
used in the validation with radiochromic ﬁlms, with the exception of using a phantom with a
lead protection disk instead of the costal wall type phantom.
Figure 5.23: Setups where the dose produced by the solution PHSP ﬁle and the full MC simulation
were compared.
Two sets of simulations were performed for each phantom: One with the optimized PHSP ﬁle and
the other directly with the PHSP ﬁle obtained from the detailed simulation of the accelerators.
Dose was calculated in volumes with (161×161×200) voxels (voxel size: 1 mm) and 200 million
histories were employed. Figure 5.24 shows two of the results of these comparisons. In ﬁgure 5.24
(Left) it is represented the dose comparison in the air-step phantom with the 12 MeV LIAC R©, and
5.24 (Right) compared the proﬁles for the 9 MeV MOBETRON R© in the bone phantom.
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Figure 5.24: (Left) Dose proﬁles at 1.5 (shifted up by 20%), 2.5 (shifted up by 10%) and 3.5 cm depth
in the air-water step phantom for the 12 MeV LIAC R©. (Right) Dose proﬁles at 1.95 (shifted up by 20%),
3.0 (shifted up by 10%) and 4.0 cm depth in the bone phantom for the 9 MeV MOBETRON R©
A gamma evaluation was performed, again with the 2%-2 mm criterion (5% threshold). Table
5.6 includes the results of this evaluation. Almost 100% the voxels accomplish the gamma index,
because in this case we have eliminated possible inaccuracies in the geometrical positioning of
the reference dose.
Gamma evaluation with 2% - 2 mm
LIAC R© (12 MeV, φ=6 cm) MOBETRON R© (9 MeV, φ=9 cm)
Step 99.95% 99.81%
Mediastinum 100.00% 100.00%
Bone 100.00% 99.99%
Disk 100.00% 100.00%
Table 5.6: Results of gamma evaluation in the diﬀerent phantoms (5% threshold).
5.4 Conclusion
In this chapter we have tested the proposed phase space optimization process against
experimental data for the diﬀerent Intrabeam R© applicators and the mobile IOERT accelerators.
To do this, we have compared dose distributions in water and in heterogeneous phantoms
measured at diﬀerent European hospitals.
For the validation of dose distributions in water with Intrabeam R© spherical applicators, we found
some discrepancies between simulations and measurements due to the anisotropy of the dose in
115
5. Validation of the phase space optimization process with experimental data
the backward direction. The isotropic approach we considered for our spherical dose deﬁnition
does not reproduce completely the experiment. However, the area presenting the anisotropy is
next to the cone of applicator, which is an area without clinical interest, and in any case it should
be corrected by introducing an angular-dependent function in the X-rays beam ﬂuence, which is
the next approach we want to introduce in future work.
Regarding the dose distributions in water with Intrabeam R© ﬂat and surface applicators, we
found a good agreement for the two cases studied, with more than 95% of the voxels fulﬁlling
the gamma criterion at the 2%-2 mm level.
In the dose comparisons inside heterogeneous phantoms, either with Intrabeam R© applicators
or IOERT accelerators, we reached a reasonable agreement at the 2%-2 mm level, specially
considering that a non-negligible contribution to the dose diﬀerences is attributed to uncertainties
in the measurements, such as asymmetries or displacements of the ﬁlms. When these
uncertainties disappear, the agreement increases substantially, something that has been seen
in the validation of IOERT accelerators against simulations, where almost a 100% of the voxels
passed the 2%-2 mm level in all the phantoms.
Therefore, in view of the results of this chapter, we can conclude that the proposed optimization
method works accurately reproducing dose distributions in clinical situations. In fact, it has
already been implemented for the tuning of the diﬀerent IOERT and Intrabeam R© devices in
radiance R© [Valdivieso-Casique et al., 2015, Pascau et al., 2012], the ﬁrst treatment planning
system for intraoperative radiotherapy.
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Chapter 6
Hybrid Monte Carlo for dose
calculation
6.1 Introduction
The use of intraoperative radiotherapy with low energy X-rays is increasing rapidly in the clinical
ﬁeld, as has been previously explained in this thesis.
However, this technique is currently limited by the inherent diﬃculties associated with the
planning process and until recently there was no commercial tool for 3D planning of the
Intrabeam R© system (Carl Zeiss Surgical Gmbh, Oberkochen, Germany) that allowed a fast
an accurate dose deposition inside the patient. The commercial planning tool that users got
with the device was based in isodose curves in water. Even if this procedure works correctly
in homogeneous tissues, inaccuracies appear when heterogeneous media are treated. In October
2016 the companies Carl Zeiss and GMV signed a commercial collaboration agreement, and ever
since every Intrabeam R© machine is being sold with the radiance R© treatment planning system
(TPS), thus incorporating the TPS codes described in this thesis, fully taking into account
patient's anatomy.
Detailed Monte Carlo simulations of miniature 50 keV accelerators have been performed in the
past. Simulations of a radiosurgery X-ray tube used to treat brain tumors were done [Yanch
and Harte, 1996] with ITS 3.0 code. A Geant4/GATE code suitable to Intrabeam R© treatment
issues [Bouzid et al., 2015] was also developed, and the Intrabeam R© source was modeled with
the EGSnrc code [Ebert and Carruthers, 2003].
A high level of accuracy is reached with full Monte Carlo simulations, however it is still a time-
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consuming technique and it is not suitable to real-time planning in operating room.
The use of phase space (PHSP) ﬁles, as we have discussed previously, reduces the overall
computation time because the radiotherapy device and applicators do not need to be simulated
for every treatment. Therefore, in order to speed up dose calculation, Clausen et al. developed
a Geant4-based source model using PHSP ﬁles and decreased computation time to 12 minutes
for a full gynecological treatment [Clausen et al., 2012]. However, the proposed technique was
tested only for water dose calculations and simulation time would increase when applied to more
complex geometries with heterogeneities. Moreover, PHSP ﬁles could have some disadvantages
like lack of ﬂexibility in manipulating the data, huge storage requirement and resources for
reading-in the stored data during simulation.
Alternatively, Nwankwo et al. approximated PHSP ﬁles by a virtual source model to generate
photons for a speciﬁc Intrabeam R© source deﬁned in Geant4 and a reasonable calculation
uncertainty was achieved within 2 hours of simulation [Nwankwo et al., 2013]. Nevertheless,
dose computation time is still too long for operating room irradiations or to be implemented in a
commercial treatment planning system, and the proposed methods are not prepared for tuning
easily every actual X-ray source.
In chapter 4 the procedure to generate an optimized PHSP ﬁle tuned to a given Intrabeam R©
device, using as input just experimental DDP in water has been described. The accuracy of this
method has been validated in chapter 5. In the case of IOERT, the DPM code [Sempau et al.,
2000] gives an accurate deposited dose in a short time. However, we found that DPM would not
be an eﬃcient and fast solution to describe photon interactions in the energy range from 1 to 50
keV.
We thus decided to develop from scratch a new algorithm, named hybrid Monte Carlo
(HMC), to calculate dose deposited by the Intrabeam R© device within minutes, fully taking
into account the diﬀerent tissues and structures in the region of patient, i.e. as derived from a
CT image.
HMC computes an accurate dose for both homogeneous and heterogeneous media [Vidal et al.,
2014b,a, Udías et al., 2017b], as it incorporates all the relevant physics processes at Intrabeam R©
working energies. The savings in calculation time are possible thanks to taking to the extreme
some variance reduction techniques. The HMC algorithm has been complemented with PHSP
ﬁles generated for the needle, spherical, ﬂat and surface applicators.
To face the problem of fast dose calculation, lets ﬁrst analyze the speciﬁcs of the radiotherapy
situation we are dealing with, and of the MC simulations in general.
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6.2 MC simulations
MC packages assume a stochastic approach to generate particles and to decide the fate of
these radiation particles. Probability distributions of the diﬀerent processes are taken from
computations, tables, etc. The particles are generated in random positions and emitted at
random directions (following the known distributions) from the primary source in the simulated
device. They are tracked by the code, and interaction and evolution of the particles are computed,
stochastically, based upon assumed probabilities for diﬀerent processes (Compton interactions,
Rayleigh interactions, photoelectric eﬀect, etc.) to happen.
The random nature of the variables deﬁning every particle we generate introduces a statistical
noise, due to the limited amount of particles (histories) we deal with in any actual simulation. In
ﬁgure 6.1 it is showed a representation of a pure random sampling in a XY plane. If the number
of points is very big, the sampling becomes homogeneous, but is the number of points is not big
enough, areas with high concentration of points are visible, as well as empty spaces in between,
introducing statistical noise.
Figure 6.1: Randomly generated coordinates populating a XY plane.
The statistical noise of MC simulations bears no interest in radiotherapy (it is, however, very
important to keep it close to the actual statistical level of the real images, when simulating
medical imaging devices), as the actual number of particles involved in any radiotherapy
treatment, even in regions of low dose (say 5% of the dose at the maximum) is well in excess
of 1012, for any realistic treatment. With this in mind, we have taken the idea of condensation
of histories to compute the dose not from the number of histories reaching a region, but rather
from the relative change of weights of these histories when traveling through this region. We will
describe the algorithm in detail in what follows.
119
6. Hybrid Monte Carlo for dose calculation
6.3 Code description
In the energy region, and with the geometry of the Intrabeam R© device, particle interactions
are not distributed very uniformly. Particularly for small applicators (the needle case being the
extreme), depth dose proﬁles show a very fast reduction of dose with the distance to the source,
in part due to the solid angle eﬀects, but also due to absorption of photons via photoelectric
eﬀect. Indeed, after traveling a couple of cm in water, in a typical MC calculation, most of the
histories we have produced at the source, and that are being tracked so expensively, will have
disappeared and will not contribute to statistical accuracy.
In a traditional MC, to keep a large number of histories in regions away from the source, we
would have to produce a very large number of histories at the source. The result would be an
oversampling closer to the source, that is, we will have the best precision where we do not need
it, and we would spend a lot of time in those regions that already have good precision, in order
to improve precision away from the source. The same happens when we include shieldings in
the simulation, if we want to obtain accurate readings of the dose after the protection, we must
send many histories to the shield, most of which will die without contributing to the result in
the region we are interested.
Of course, there are several ways to improve the eﬃciency of MC simulations under these
circumstances, such as factorizing the problem in diﬀerent regions, using particle splitting when
the particles reach the region of interest or stop tracking the particles when the ﬂuence is below
a certain threshold. In our tool, we generalized this idea, without the need to adapt it to
diﬀerent tissues or to enable a diﬀerent detail of simulation when ﬂuences fall below a certain
threshold.
Summarizing what we have just said, a regular Monte Carlo will calculate millions of histories,
even if they would barely interact or leave energy in the medium, increasing signiﬁcantly the
simulation time. Furthermore, small size, low energy photon sources present very high ﬂuence
gradients, which implies high statistics next to the applicator, but very low statistics when the
distance to the source increases. Therefore, obtaining an accurate dose distribution with small
statistical noise will require very long simulations. We want to improve this situation.
The algorithm we have developed, called Hybrid MC algorithm, or HMC algorithm,
will include all the relevant physics of a Monte Carlo algorithm minimizing the contribution
of statistical noise. The HMC algorithm takes into consideration photoelectric and Compton
interactions. Rayleigh interactions are not included because they are not a relevant mechanism
for energy deposition at the energies considered here.
Condensed histories and particle splitting approximations will be generalized in this algorithm.
We will use meta-histories (m-histories for short) to represent particles, each one of them
representing the fate of an arbitrary high number of photons N. Every m-history carries a
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weight when it is generated at the source, proportional to the number of photons that should
be generated with the given characteristics (energy, position, emission angle). The probability
of interaction of this m-history, either by photoelectric (PPE) or Compton eﬀect (PCE), will be
computed in a continuum way as 1-e−µdx, where dx is the spatial displacement in the direction
of the m-history since the last update and µ is the attenuation coeﬃcient for the photoelectric
or the Compton eﬀects, taken from the material tables of PENELOPE [Salvat et al., 1996], at
the spatial point where the updates of m-history position is being done. More information about
the material tables generation can be found in the appendix A.
In other words, instead of studying microscopically each interaction, which has a high
computational cost, we will condensate many possible interactions into a single one with an
accumulated probability which will be the sum of all individual interactions. We will score
the accumulated probability of interaction after moving a given step size. After each step,
the new weights for the m-history will be computed, taking into account the lost weight by
photoelectric and Compton interactions. Moreover, new m-histories, corresponding to secondary
photons coming from Compton interactions, can be generated with the corresponding weight,
and stacked in the pile for calculating them in the same way as primary photons.
Thus, condensed histories (m-histories) of the photons at the source are generated from the
information stored in the PHSP ﬁles, and transported throughout the volume in steps of ﬁxed
length dx, whose value is typically smaller than half the voxel size. At each step, a fraction of the
m-history will interact, being absorbed by photoelectric eﬀect or being scattered by Compton
eﬀect. Each condensed history updates its weight as it travels through matter, according to the
weight lost until the moment.
This way, the number of m-histories remains constant along the volume, being only its weight
reduced at each interaction, so that the number of m-histories does not decrease far from the
source due to photon absorption. Dose is computed not from the number of interactions or the
number of photons who are absorbed in a region, but rather from the accumulated reduction of
the weight of the m-histories as they travel through the region. Therefore, problems associated
with low statistics are reduced, as we have always the same number of primary virtual histories, no
matter how much attenuation the material oﬀers. Due to the fact that we follow in a detailed way
the trajectory of all m-histories and that we produce also secondary m-histories, our simulation
will be able to reproduce all the relevant phenomena related to interaction of radiation in media
such as backscatter, build-up or diﬀraction.
Consequently, the following aspects are included in the simulation:
• The m-histories approximation. Every primary m-history represents the fate of many
photons. The m-history can scatter or undergo photoelectric eﬀect, with a given probability,
and the weight of the m-history is shared among the diﬀerent secondary particles that this
m-history can produce. Weights are updated after each spatial time progression.
• Photoelectric forced interaction. After each simulation step, a fraction of the energy of
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the primary m-history is deposited in the voxel and the new weight w of the m-history is
w(1-PPE).
• Compton scattering is implemented by creating N secondary m-histories, each of them
with a fraction w/N of the initial weight w of the particle and weighted by the associated
probability of the primary m-history of experiencing a Compton interaction, from the
previous computed position.
• A ﬂuence normalization has been implemented to reduce dose artifacts due to poor statistics
or suboptimal sampling of the region of interest.
6.3.1 Photoelectric eﬀect
In a photoelectric interaction, the photon is absorbed and an electron is emitted. At each step of
the simulation, a fraction of each m-history will suﬀer a photoelectric interaction, decreasing the
weight of the m-history. The energy of the emitted electron is very low, as well as it is its range,
so we assume that it is absorbed in the same voxel where the interaction is being assigned.
Therefore, the deposited energy will be the product of the weight of the m-history, the energy of
these m-histories, and the probability of a photoelectric absorption after a distance dx has been
traveled in the material.
dW = N · E · (1− e−µphdx) (6.1)
The beam intensity (weight) after the m-history has traveled a distance dx will be decreased by
a factor e−µphdx:
N ′ = N · e−µphdx (6.2)
6.3.2 Compton eﬀect
In a Compton interaction, part of the energy of the incident photon is transferred to an emitted
electron. As it was the case for the photoelectric eﬀect, the energy of the released electron is
very low and thus we assume that it is immediately absorbed at the voxel where the interaction
took place. The weight associated to the scattered photons disappears from the weight of the
primary m-history, and secondary m-histories will be produced with their corresponding weight
and energy. These photons will have even less energy than the primary beam and thus they will
interact almost exclusively by photoelectric eﬀect, relatively near to the place where they were
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created. The primary m-history keeps traveling through the volume with the same direction,
but with an updated weight and the same initial energy.
Similarly to the photoelectric eﬀect, the deposited energy will be the product of the weight of the
primary m-history, the average energy lost in the Compton interaction (into the electron that is
locally absorbed) and the Compton interaction probability when a distance dx is traveled in the
material:
dW = N < Eave(Compton) > (1− e−µcdx) (6.3)
And the weight of the primary m-history after traveling a distance dx will be decreased by a
factor e−µcdx:
N ′ = N · e−µcdx (6.4)
Regarding secondary photons created during Compton interactions, they are also treated as m-
histories. The weight corresponding to each secondary m-history is split into NCompton diﬀerent
m-histories, each one of then with a fraction of the original weight w/NCompton. They would be
emitted in diﬀerent angles and with diﬀerent energies, according to the energy-angle relationship
for the Compton eﬀect on bound electrons. However, at these low energies, the angular
distribution is essentially isotropic and thus secondary photons are emitted along uniformly
distributed random directions.
The energy deposited by the secondary particles is calculated analogously to the one of the
primary particles, after photoelectric or Compton interactions. Now, as said before, these
secondary particles have lower energy. If for the primary particles, the most likely energy is
of the order of 30 keV, and the maximum photon energy is 50 keV, for the secondary particles,
the large majority of photons are below 30 keV and thus they decay mostly via photoelectric
absorption. For speed reasons, the code has been limited to ﬁrst and a half order Compton
interactions, meaning that Compton interactions of the secondary photons would not produce
traceable tertiary photons, but rather null-range tertiary photons that, as it is case for secondary
or tertiary electrons, are assumed to deposit all their energy in the same voxel than they were
generated.
We have compared the results of this ﬁrst and a half order Compton interaction with a second
and a half Compton interaction version of the code, and indeed we have veriﬁed that the changes
in the computed dose are very small, while the increase in simulation time can be noticeable.
Figure 6.2 shows the comparison of two depth dose proﬁles (DDPs) for a 1.5 cm diameter spherical
applicator. The ﬁrst dose distribution (solid line curve) was calculated with the ﬁrst and a half
Compton interaction, and for the second one (dotted line) two and a half Compton interactions
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were considered. It can be seen that including in the simulation a whole second Compton vertex
does not aﬀect signiﬁcantly the dose distributions, with diﬀerences between both curves well
below 1%. Thus, it is the ﬁrst and a half Compton interactions version of the code the one that
has been implemented in radiance R© and, unless otherwise indicated, the one we would use in
the remainder of this work.
(a) (b)
Figure 6.2: (a) Comparison of DDPs of a 1.5 cm diameter spherical applicator with a single full Compton
interaction (solid line) and with two full Compton interactions (dots). (b) Statistical diﬀerence between
the two proﬁles in (a).
6.3.3 Study of the zero range approximation for electrons
A MC study has been performed to evaluate the range of electrons with energies up to 50 keV in
diﬀerent media. For all the energies, more than 99% of electrons are absorbed before 0.25 mm.
Therefore, in the case of the electrons emitted by photoelectric or Compton interactions, it is
reasonable to consider that they are absorbed in the same voxel as they are generated, provided
voxel sizes are not much smaller than 0.25 mm.
6.3.4 Flow chart of the code
A simpliﬁed ﬂow chart of the HMC can be seen in ﬁgure 6.3. After each update of the
position along the trajectory of the m-history, given by dx, the probabilities of photoelectric
and Compton interactions are calculated for every condensed history. The absorbed energy due
to the photoelectric interaction and to the secondary electron from the Compton interaction
are stored within the interaction voxel. Compton secondary photons are generated randomly
and at each dx step, photoelectric and Compton probabilities are calculated, and the energy
due to photoelectric absorption and secondary Compton electrons is stored in a similar way as
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for the primary photon m-histories. Finally, deposited dose is calculated and ﬂuences (weights)
are updated from the weights of the previous step, minus the weight that has decayed due to
photoelectric and Compton interactions.
Figure 6.3: Flow chart of the HMC.
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6.4 Dose normalization
The use of m-histories, each one of them representing a high number of photons, and the fact
that these primary histories never die away, only their weight gets reduced, makes possible a
large reduction of the statistic noise, for the same number of primary particles, when comparing
to a pure MC calculation. Statistical noise comes now almost exclusively from the fact that the
number of secondary photons is ﬁnite and that the emission angles are random.
If the number of primary m-histories is not big enough, ray patterns may appear in the dose
image. This is due to, on the one hand, the stochastical procedure that is used to pick histories
inside the PHSP ﬁle. If only few histories are chosen, the initial angular distribution may not be
just homogeneous enough. And as typically seen in pure random sampling (see ﬁgure 6.1 with
the XY points where one can see clusters and empty spaces), it is likely that two m-histories
are produced very close to each other, thus producing a high-intensity ray-like artifact, while
there are angular ranges left without any m-history, producing a low-intensity ray-like artifact.
On the other hand, artifacts in dose computation may also appear due to the use of voxelized
geometries and the subsequent subsampling leading to aliasing artifacts, more apparent if a very
low number of m-histories is used. The trajectories of the m-histories have diﬀerent inclinations
within a ﬁnite number of angles in the PHSP ﬁle. The angle of the history with respect to the
orientation of the Cartesian grid has an impact in the path length of the history inside a given
voxel. This makes that diﬀerent voxels present an apparent higher number of interactions than
others, even if they are at the same distance to the source.
In standard MC codes these patters are not appreciated, because the step taken to update
particle position, their emission angles, and the resulting angles after interactions are purely
stochastic. Statistical noise is clearly present in standard MC, and thus no ray-like patterns are
visible.
Figure 6.4 shows a comparison of dose distributions for a 40 mm spherical applicator with
penEasy and HMC using diﬀerent number of (m-)histories. When using HMC, we can see that
the streak or radial artifact decreases with the number of histories. When using penEasy, no
patterns are appreciated, but the dose is very noisy, even when 5 million histories are used (Figure
6.4 (b)).
In order to solve this problem, a ﬂuence normalization for the primary histories has been
incorporated in the code. As m-histories never die inside the region considered, it is possible to
know the number of m-histories that have traveled through every voxel of the volume, and how
many interactions have taken place in each voxel. And this is independent on the materials the
region is made of. Diﬀerent materials, thus diﬀerent absorptions, would only aﬀect the weights,
but not the ﬂuence of the number of m-histories. Therefore, for a given source, the number of
m-histories in a region is identical if the region is made out of water or if it has heterogeneities.
This means that this number of m-histories, and moreover, the number of interactions of these
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(a) (b) 
(c) (d) 
Figure 6.4: Comparison of dose distributions calculated with penEasy and the HMC algorithm for
diﬀerent number of histories or m-histories. (a) penEasy simulation with 0.5 million histories, (b) penEasy
simulation with 5 million histories, (c) HMC simulation with 0.5 million m-histories, (d) HMC simulation
with 5 million m-histories.
m-histories at every voxel, is known beforehand with the information of the PHSP ﬁle, and it
is independent of the composition of the region where dose is being computed. Thus, we can
calculate a priori the number of m-histories and interactions that should correspond to each
voxel from the known source ﬂuence (say, for example, in a spherical source for which the ﬂux
of histories decreases following an inverse-square law). These two facts make possible to apply
a normalization to the dose that will remove the artifacts described before and will generate
an accurate, artifact-free dose using a much smaller number of primary m-histories. The only
requisite is that, of course, in every voxel where we want to compute the dose, interactions must
have been recorded.
The normalization will be done by comparing the number of interactions inside each voxel for
the HMC calculation, with the estimated value based on the known ﬂuence. As explained before,
this comparison is meaningful only if the primary m-histories in the HMC do not disappear, no
matter how small is their associated weight.
Thus, a normalization volume will be generated, norm(x,y,z), and the value for each voxel will
be incremented by an unit each time a m-history interacts inside the voxel, irrespectively of its
weight. This matrix volume contains the actual ﬂuence (how many rays travel through a given
voxel for a particular source, eﬀects of anisotropy and homogeneity) in the HMC calculation,
and it is inﬂuenced by eﬀects of sampling imperfections due to aliasing, statistical ﬂuctuations,
irregularities in the PHSP ﬁle sampling, subsampling or others, in exactly the same way as the
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deposited dose is. The diﬀerence is that the dose accumulates interactions weighted by the weight
of the m-histories and the interaction probabilities.
As it has been already said, in the HMC the ﬂuence of primary m-histories in dose calculation
will only depend on the ﬂuence at the source, not on medium heterogeneities. The dose eﬀect
due to heterogeneities will be reﬂected in the associated weights, that will be updated after each
interaction and that are adjusted dynamically as the particle travels in the medium.
In the normalized implementation of the algorithm, the dose accumulated in each voxel is divided
by the voxel normalization, removing to a high extent sampling error and aliasing eﬀects. But
taking this ratio also removes the dependence on the ﬂuence of m-histories from the accumulated
dose. To recover it, the normalized accumulated dose has to be multiplied by the ideal ﬂuence
for the given source and a homogeneous material.
To clarify more the method, we will apply it for the case of isotropically emitting sources,
representing ideal spherical applicators, and for ﬂat and surface applicators. As we have just
said, the normalized dose will be computed as:
normalized dose(x, y, z) =
dose(x, y, z)
norm(x, y, z)
fluence(x, y, z) (6.5)
Where ﬂuence(x,y,z) is the ﬂuence of an identical source as the one considered here, traveling
through an homogeneous, non attenuating medium, let's say in vacuum.
6.4.1 Calculation of the expected ﬂuence for spherical applicators
In spherical applicators there is a localized source in space emitting particles with ﬂuence f(θ,φ)
per surface unit. We assume that ﬂuence does not depend on the azimuthal angle φ, that is, we
are assuming that the spherical sources exhibit, at least, rotational symmetry. This assumption
can be removed if needed, but we will keep it here for the purpose of simplicity in the explanation
of the normalization procedure.
The number of primary m-histories passing through a diﬀerential area dS is f(θ)dS, being
dS=r2sin(θ)dθdφ. f(θ) can be obtained by making a histogram in θ of the PHSP ﬁle. If we
consider the source isotropic, there is no dependence on θ. This way, the expected ﬂuence can
be obtained with a simple analytical expression.
Let us consider a spherical shell covering all the angles. If N rays are generated, the number of
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rays per surface unit will be
N
4piR2
(6.6)
On the other hand, if every ray is sampled longitudinally every dl, in a spherical shell with
radius dR there will be dR/dl samples per each ray traversing it. Therefore, in total there will
be N(dR/dl) samples within the spherical shell with radius dR.
The volume of the spherical shell is:
dV = 4piR2dR (6.7)
Then, the density of sampling points within the spherical shell will be:
density =
Number samples shell
Shell volume
=
N dRdl
4piR2dR
=
N
4piR2dl
(6.8)
Therefore, the number of samples corresponding to a voxel with volume f3 will be the density
described in equation 6.8 multiplied by the voxel volume, or:
fluence =
N · f3
4piR2dl
(6.9)
The dose per m-history will be:
[
dose(x, y, z)
norm(x, y, z)
] [
1
N
] [
Nf3
4piR2dl
]
(6.10)
Finally, the normalized dose can be written as:
normalized dose(x, y, z) =
dose(x, y, z)
norm(x, y, z)
f3
4piR2dl
(6.11)
Image 6.5 shows the eﬀect of the normalization of the dose for a 3 cm diameter spherical applicator
and 5 million m-histories. When the normalization is applied, the dose distribution shows the
expected angular uniformity and no artifacts are visible.
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(a) (b) 
Figure 6.5: Eﬀect of normalization on a 3 cm diameter spherical applicator dose distribution calculated
with the HMC algorithm and 5 million m-histories. (a) Unnormalized dose, (b) normalized dose.
6.4.2 Calculation of the expected ﬂuence for ﬂat and surface applicators
In ﬂat and surface applicators, the source is located at a known position inside the applicator and
the beam goes through diﬀerent ﬁlters before reaching the surface of the applicator. Therefore,
in this case there are no simple analytical expressions to obtain the expected ﬂuence.
R
0
rz
r
0


Figure 6.6: Schematic representation of the parameters that characterize the ﬂuence in ﬂat and surface
applicators.
The number of particles reaching a voxel is going to be determined (see ﬁgure 6.6) by the emission
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angle α, that deﬁnes each particle's position with respect to the origin. Therefore, normalization
is going to depend on α and is going to decrease as 1/r2.
f(α)
r20
r2
(6.12)
With:
r0 =
R0
cos(α)
and r =
R0 + z
cos(α)
(6.13)
The angle α needs to be corrected to remove the dependency of the number of particles with ρ.
The normalization will have the following aspect:
f(α)
ρ
R20
(R0 + z)2
(6.14)
The angular ﬂuence factor is extracted from the PHSP ﬁle. Taking advantage of the symmetry
of the reference dose, two normalization histograms are computed: One stores the volume of
the number of interactions in Cartesian coordinates (norm(x,y,z)) that will be used to correct
the reference dose, and the other stores the 2D-surface containing the ﬂuence normalization in
cylindrical coordinates (norm(ρ,z)) that will be used to reintroduce the ﬂuence in the dose after
normalizing by the 3D-normalization volume.
The normalization in cylindrical coordinates contains the ideal ﬂuence of the photons emitted
from the source, after going through the ﬂat and surface ﬁlters, and therefore we expect if to be a
rather smooth function with the angle, so we can ﬁlter the (ρ,z) 2D-histogram to avoid possible
patterns that may still remain in it due to ﬁnite size of bins in ρ and z.
Finally we need to consider the number of interactions per unit of volume, which will be the
voxel volume (f 3) for the Cartesian normalization, and the volume of the ring between ρ and
ρ+dρ with a width dz for cylindrical normalization (pi[(ρ+dρ)2-ρ2]dz ).
With all this, the normalized dose will be obtained from the following expression:
normalized dose(x, y, z) =
dose(x, y, z)
norm(x,y,z)
f3
[ norm(ρ, z)
pi[(ρ+ dρ)2 − ρ2]dz
]
(6.15)
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Image 6.7 shows the eﬀect of the normalization of the dose for a 2 cm diameter surface applicator
and 5 million m-histories. As in spherical applicators, the dose distribution after normalization
is as smooth as expected, and the streak and aliasing artifacts disappear.
(a) (b) 
Figure 6.7: Eﬀect of normalization on a 2 cm diameter surface applicator dose distribution calculated
with the HMC algorithm an 5 million m-histories. (a) Unnormalized dose, (b) normalized dose.
6.5 Validation of the Hybrid Monte Carlo against MC simula-
tions
Several tests have been performed in order to validate the HMC for every applicator. For
each validation case, the same PHSP ﬁle has been used to calculate dose with penEasy and
with HMC. These reference phase space ﬁles have been obtained with penEasy [Sempau et al.,
2011, Badal Soler et al., 2008] from realistic simulations of the diﬀerent Intrabeam R© applicators,
and have been then used to compare dose distributions from both codes in homogeneous and
heterogeneous phantoms.
6.5.1 Hybrid Monte Carlo for spherical applicators
First of all, we calculated the PHSP ﬁles for all spherical and needle applicators, in order to use
them afterwards for the comparison between penEasy and HMC. These PHSP ﬁles were obtained
considering the spherical approximation explained in section 3.2.2.1, and the X-ray source was
characterized by the energy spectrum extracted from the detailed XRS simulation of section
3.2.1.
With these PHSP ﬁles we calculated our reference dose distributions with penEasy in the diﬀerent
validation phantoms. For all penEasy calculations, 500 million histories were used and phantoms
of (5×5×5) cm3 were generated (volumes of (200×200×200) voxels, with a voxel size of 0.5
mm).
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The PHSP ﬁles were also used to obtain dose distributions with the HMC. These calculations
were done simulating 5 million histories in (5×5×5) cm3 phantoms, also with a voxel size of 0.5
mm.
We also included a quantitative evaluation of the dose. For all validation cases, a gamma index
calculation was computed to compare 3D dose distributions with diﬀerent dose distance criteria:
1%-1 mm, 2%-1 mm and 5%-1 mm.
6.5.1.1 Homogeneous phantoms
Dose was computed in water, lung and bone phantoms, as shown in ﬁgure 6.8. The dose
distributions from full MC simulations were compared to the dose distributions obtained by the
HMC in the same conditions for all spherical applicators, including the needle applicator.
Water
Bone
Lung
Applicator
Figure 6.8: Schema of the homogeneous phantoms surrounding the spherical or the needle applicators.
Some results of DDPs and 2D dose maps can be seen below. Figure 6.9 shows the transverse
view of the dose and the DDPs in water for a 15 mm diameter spherical applicator using penEasy
and the HMC. The same information can be seen in ﬁgure 6.10 for a dose calculation in lung
with a 40 mm diameter applicator, and in ﬁgure 6.11 for a dose calculation in bone with a 30
mm diameter applicator.
We can see that, in all the cases presented, dose distributions with the HMC show a good
agreement with the reference penEasy distributions, reproducing appropriately the dose falloﬀ
in the diﬀerent materials.
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(a) (b)
(a)
(b)
(c)
Figure 6.9: 2D dose distributions in water for a 15 mm diameter spherical applicator using (a) penEasy
and (b) the HMC and their DDPs (c).
(a)
(b)
(c)
Figure 6.10: 2D dose distributions in lung for a 40 mm diameter spherical applicator using (a) penEasy
and (b) the HMC and their DDPs (c).
134
6.5. Validation of the Hybrid Monte Carlo against MC simulations
(a)
(b)
(c)
Figure 6.11: 2D dose distributions in bone for a 30 mm diameter spherical applicator using (a) penEasy
and (b) the HMC and their DDPs (c).
Gamma evaluations have been performed for all cases with 1%-1 mm, 2%-1 mm and 5%-1 mm
criteria. The results are presented in the following tables.
Gamma evaluation in water
1% - 1 mm 2% - 1 mm 5% - 1 mm
Needle 96.13% 98.50% 99.51%
Spherical φ 15 mm 95.81% 98.11% 99.40%
Spherical φ 20 mm 96.22% 98.84% 99.77%
Spherical φ 25 mm 96.47% 98.86% 99.75%
Spherical φ 30 mm 96.38% 99.25% 99.91%
Spherical φ 35 mm 95.69% 99.21% 99.97%
Spherical φ 40 mm 95.84% 99.04% 99.99%
Spherical φ 45 mm 97.02% 99.47% 99.98%
Spherical φ 50 mm 95.78% 99.23% 99.98%
Table 6.1: Results of gamma evaluation between MC simulations and HMC calculations in water (5%
threshold).
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Gamma evaluation in lung
1% - 1 mm 2% - 1 mm 5% - 1 mm
Needle 95.84% 98.59% 99.59%
Spherical φ 15 mm 98.05% 99.44% 99.90%
Spherical φ 20 mm 98.52% 99.73% 99.96%
Spherical φ 25 mm 98.52% 99.80% 99.97%
Spherical φ 30 mm 98.40% 99.80% 99.97%
Spherical φ 35 mm 97.95% 99.70% 99.99%
Spherical φ 40 mm 96.59% 99.24% 99.96%
Spherical φ 45 mm 97.91% 99.71% 99.98%
Spherical φ 50 mm 97.19% 99.52% 99.91%
Table 6.2: Results of gamma evaluation between MC simulations and HMC calculations in lung (10%
threshold).
Gamma evaluation in bone
1% - 1 mm 2% - 1 mm 5% - 1 mm
Needle 86.03% 91.59% 95.57%
Spherical φ 15 mm 87.31% 92.38% 96.99%
Spherical φ 20 mm 86.49% 92.58% 97.46%
Spherical φ 25 mm 85.51% 92.62% 97.81%
Spherical φ 30 mm 85.86% 92.38% 97.91%
Spherical φ 35 mm 86.58% 92.23% 98.35%
Spherical φ 40 mm 87.02% 92.46% 97.88%
Spherical φ 45 mm 87.63% 92.97% 98.38%
Spherical φ 50 mm 88.37% 93.67% 98.75%
Table 6.3: Results of gamma evaluation between MC simulations and HMC calculations in bone (5%
threshold).
The best results of the gamma evaluation correspond to the water and lung measurements. In
these phantoms, all applicators fulﬁll the most restrictive criterion (1%-1 mm) with more than
95% voxels with γ < 1. The worst evaluation is obtained with the bone phantom, where only
around 90% voxels pass the 2%-1 mm criterion for the spherical applicators. We have to go to
the 5%-1 mm criterion to obtain results above 95%.
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The bone phantom presents the highest dose gradients of all the materials studied in this section.
Actually, if we look at the DDPs in ﬁgure 6.11, we can see an 80% drop of the dose only in the
ﬁrst 3 mm. This can produce high dose diﬀerences in the gamma evaluation, even if the behavior
of the dose distributions seems to be very similar, because we can ﬁnd dose diﬀerences of about
10% in the distance between the beginning and the end of a 0.5 mm voxel. Furthermore, if the
falloﬀ of the dose is quicker than in other cases, it means that the dose threshold imposed in the
gamma evaluation is reached sooner in depth, and therefore the number of voxels contemplated
in the gamma evaluation is lower.
6.5.1.2 Heterogeneous phantoms
Dose was computed in heterogeneous phantoms representing possible clinical situations. In
the ﬁrst situation, the applicator was simulated surrounded by water, a layer of bone 1.5 mm
thick, and then water, representing a surface cancer. The second situation represented a spinal
metastasis with the applicator surrounded by lung, then a layer of bone 1.5 mm thick, and then
lung. And the last phantom represents a breast cancer treatment with the applicator surrounded
by water, then a layer of bone 1.5 mm thick, and then lung. The scheme of the three phantoms
is presented in ﬁgure 6.12.
Water
Bone
Lung
Applicator
Figure 6.12: Schema of the heterogeneous phantoms surrounding the spherical or the needle applicators.
As in the previous section, we show some of the obtained results of DDPs and 2D dose maps.
In ﬁgure 6.13 the comparison of the transverse dose view calculated with penEasy and with the
HMC for the needle applicator in the water/bone phantom is shown, as well as the DDPs. The
same comparisons are shown in ﬁgure 6.14 in the case of a 50 mm diameter spherical applicator
in a lung/bone phantom, and in ﬁgure 6.15 for a 20 mm diameter spherical applicator in a
water/bone/lung phantom.
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(a)
(b)
(c)
Figure 6.13: 2D dose distributions in a water/bone phantom for the needle applicator using (a) penEasy
and (b) the HMC and their DDPs (c).
(a)
(b)
(c)
Figure 6.14: 2D dose distributions in a lung/bone phantom for the 50 mm spherical applicator using
(a) penEasy and (b) the HMC algorithm and their DDPs (c).
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(a)
(b)
(c)
Figure 6.15: 2D dose distributions in a water/bone/lung phantom for the 20 mm spherical applicator
using (a) penEasy and (b) the HMC algorithm and their DDPs (c).
Looking at the examples, the HMC seems to behave accurately when heterogeneities are present.
The HMC DDPs for all cases agree with the reference ones obtained with penEasy.
Gamma evaluations have also been performed for all cases with 1%-1 mm, 2%-1 mm and 5%-1
mm criteria. The results are exposed in the following tables.
Gamma evaluation in the water/bone phantom
1% - 1 mm 2% - 1 mm 5% - 1 mm
Needle 95.15% 97.82% 99.29%
Spherical φ 15 mm 90.33% 96.22% 99.23%
Spherical φ 20 mm 89.40% 96.18% 99.45%
Spherical φ 25 mm 88.44% 95.75% 99.36%
Spherical φ 30 mm 83.31% 93.70% 99.45%
Spherical φ 35 mm 82.48% 93.29% 99.40%
Spherical φ 40 mm 81.32% 92.63% 99.26%
Spherical φ 45 mm 85.78% 95.75% 99.74%
Spherical φ 50 mm 86.02% 95.53% 99.60%
Table 6.4: Results of gamma evaluation between MC simulations and HMC calculations in the
water/bone phantom (5% threshold).
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Gamma evaluation in the lung/bone phantom
1% - 1 mm 2% - 1 mm 5% - 1 mm
Needle 97.72% 99.17% 99.59%
Spherical φ 15 mm 89.30% 96.34% 99.64%
Spherical φ 20 mm 85.76% 95.03% 99.26%
Spherical φ 25 mm 88.64% 96.33% 99.99%
Spherical φ 30 mm 89.30% 96.31% 99.52%
Spherical φ 35 mm 89.86% 96.66% 100.00%
Spherical φ 40 mm 89.80% 96.65% 99.63%
Spherical φ 45 mm 89.89% 96.68% 99.63%
Spherical φ 50 mm 89.92% 96.64% 99.66%
Table 6.5: Results of gamma evaluation between MC simulations and HMC calculations in the lung/bone
phantom (5% threshold).
Gamma evaluation in the water/bone/lung phantom
1% - 1 mm 2% - 1 mm 5% - 1 mm
Needle 95.08% 97.77% 99.26%
Spherical φ 15 mm 89.98% 96.25% 99.29%
Spherical φ 20 mm 89.76% 96.25% 99.45%
Spherical φ 25 mm 88.14% 95.75% 99.44%
Spherical φ 30 mm 86.64% 95.26% 99.56%
Spherical φ 35 mm 85.30% 94.84% 99.57%
Spherical φ 40 mm 83.37% 93.96% 99.43%
Spherical φ 45 mm 85.56% 95.43% 99.68%
Spherical φ 50 mm 85.65% 95.50% 99.69%
Table 6.6: Results of gamma evaluation between MC simulations and HMC calculations in the
water/bone/lung phantom (5% threshold).
The results from the gamma evaluation in heterogeneities show that, if we consider the most
strict limit of 1%-1 mm, the number of voxels passing the test is below 90% average for all
scenarios, which is not good enough. For the 2%-1 mm this number increases to values around
95%, although some applicators still remain a little underneath. And if we extend the limit to
5%-1 mm, all cases obtain values close to 100%.
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6.5.2 Hybrid Monte Carlo for ﬂat and surface applicators
The same validation procedure was applied to ﬂat and surface applicators. Diﬀerent setups were
considered, including homogeneous and heterogeneous phantoms representing diﬀerent clinical
situations.
6.5.2.1 Homogeneous phantoms
As in the spherical applicators validation, dose was computed in water, lung and bone. The dose
distributions from full MC simulation were compared to the dose distributions obtained by the
HMC in the same conditions for all ﬂat and surface applicators.
The same PHSP ﬁle was employed to compute dose with penEasy and with the HMC.
Phantoms of (200×200×200) voxels were used, with a voxel size of 0.5 mm. In the case of
the HMC simulations, 5 million meta-histories were calculated, while 500 million were used
when calculating with penEasy.
For all the cases studied, a good agreement was reached between penEasy and our HMC. Some
of the obtained results are shown below. In ﬁgure 6.16 it is represented the transverse view of the
2D dose distribution for a 3 cm ﬂat applicator in water for both penEasy and HMC algorithms,
as well as their transverse proﬁles at diﬀerent depths. The same comparison is shown in ﬁgure
6.17 for a 2 cm surface applicator in a lung phantom and in ﬁgure 6.18 for a 6 cm ﬂat applicator
in a bone phantom.
(a)
(b)
(c)
Figure 6.16: 2D dose distribution in a water phantom for the 30 mm ﬂat applicator using (a) penEasy
and (b) the HMC algorithm and (c) their transverse proﬁles at 0, 2 and 5 mm depth.
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(a)
(b)
(c)
Figure 6.17: 2D dose distribution in a lung phantom for the 20 mm surface applicator using (a) penEasy
and (b) the HMC algorithm and (c) their transverse proﬁles at 0, 2 and 5 mm depth.
(a)
(b)
(c)
Figure 6.18: 2D dose distribution in a bone phantom for the 60 mm ﬂat applicator using (a) penEasy
and (b) the HMC algorithm and (c) their transverse proﬁles at 0.5, 2 and 5 mm depth.
Figure 6.19 also shows a dose comparison between penEasy and HMC, where the DDPs obtained
in the diﬀerent media for a 1 cm ﬂat applicator are represented. Solid lines correspond to the
curves computed with the HMC, and the dash lines to the ones calculated with penEasy.
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Figure 6.19: Depth dose curves obtained with the HMC (solid lines) and penEasy (dashed lines) in the
3 diﬀerent phantoms.
Furthermore, quantitative evaluations were also performed in terms of gamma index. As in
spherical applicators, three criteria were calculated; 1%-1 mm, 2%-1 mm and 5%-1 mm (5%
threshold). The results are shown in the following tables.
Gamma evaluation in the water phantom
1% - 1 mm 2% - 1 mm 5% - 1 mm
Flat 10 mm 96.33% 98.84% 99.56%
Flat 20 mm 96.29% 98.34% 99.62%
Flat 30 mm 96.79% 98.77% 99.76%
Flat 40 mm 96.52% 98.84% 99.79%
Flat 50 mm 96.36% 99.13% 99.93%
Flat 60 mm 96.78% 99.10% 99.91%
Surface 10 mm 97.39% 98.21% 98.44%
Surface 20 mm 97.18% 98.38% 98.81%
Surface 30 mm 97.42% 98.93% 99.65%
Surface 40 mm 97.63% 99.27% 99.88%
Table 6.7: Results of gamma evaluation between MC simulations and HMC calculations in the water
phantom (5% threshold).
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Gamma evaluation in the lung phantom
1% - 1 mm 2% - 1 mm 5% - 1 mm
Flat 10 mm 97.62% 99.42% 99.95%
Flat 20 mm 96.89% 98.68% 99.72%
Flat 30 mm 96.75% 98.84% 99.74%
Flat 40 mm 95.03% 98.60% 99.72%
Flat 50 mm 92.83% 98.66% 99.77%
Flat 60 mm 90.82% 98.28% 99.53%
Surface 10 mm 98.45% 99.03% 99.19%
Surface 20 mm 98.09% 99.31% 99.86%
Surface 30 mm 98.33% 99.57% 99.97%
Surface 40 mm 98.32% 99.66% 99.98%
Table 6.8: Results of gamma evaluation between MC simulations and HMC calculations in the lung
phantom (5% threshold).
Gamma evaluation in the bone phantom
1% - 1 mm 2% - 1 mm 5% - 1 mm
Flat 10 mm 94.89% 96.44% 98.12%
Flat 20 mm 93.23% 96.01% 98.84%
Flat 30 mm 88.91% 94.50% 99.14%
Flat 40 mm 90.14% 94.69% 99.32%
Flat 50 mm 88.83% 94.38% 99.30%
Flat 60 mm 90.87% 95.95% 99.50%
Surface 10 mm 95.41% 96.37% 97.56%
Surface 20 mm 94.85% 96.29% 97.98%
Surface 30 mm 94.25% 95.74% 98.58%
Surface 40 mm 93.76% 96.65% 99.21%
Table 6.9: Results of gamma evaluation between MC simulations and HMC calculations in the bone
phantom (5% threshold).
In the water phantom, it can be seen that the 1%-1 mm criterion present good results, with all
applicators having more than 95% voxels passing the gamma. For the lung phantom the values
for this limit are a bit lower, presenting some cases below this percentage. However, for the
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2%-1 mm criterion the number of voxels with γ < 1 are above 98% for all applicators. Once
again, the worst results are obtained with the bone phantom where the dose gradients are higher.
Nevertheless, around 95% average voxels pass the 2%-1 mm criterion and more than 97% voxels
pass the test in the 5%-1 mm limit for all cases.
6.5.2.2 Heterogeneous phantoms
3 case studies were analyzed including heterogeneous situations:
• Bone layer: A 2 mm thick layer of bone located at 5 mm from the water surface.
• Air gap: An air disk with diameter φ/2, being φ the applicator diameter, located at the
surface of the water phantom and with a thickness of 2 mm.
• Lead protection disk: A lead disk with diameter φ, being φ the applicator diameter,
located at 5 mm from the water and with a thickness of 2 mm.
The scheme of these case studies is shown in ﬁgure 6.20.
Water 
Bone 
Lead 
Figure 6.20: Schemes of the heterogeneous phantoms used for the validation of the ﬂat and surface
applicators.
As in the homogeneous phantoms, the same PHSP ﬁle was employed to compute dose with
penEasy and with the HMC. Phantoms of (200×200×200) voxels were used, with a voxel size of
0.5 mm. 5 million meta-histories were calculated when using the HMC, while 500 million were
used when calculating with penEasy.
A good agreement was also reached between penEasy and our HMC. Some of the obtained results
are shown below. In ﬁgure 6.21 both algorithms were compared for a 4 cm ﬂat applicator in the
bone layer phantom. 2D transverse dose distributions are showed for both algorithms, as well as
the corresponding DDPs and transverse proﬁles. The same results are showed in ﬁgure 6.22 for
the air gap phantom with a 2 cm ﬂat applicator, and in ﬁgure 6.23 for the dose in the phantom
with a lead protection disk with the 3 cm surface applicator.
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(a) (b)
(c) (d)
Figure 6.21: 2D dose distribution in the bone layer phantom for the 40 mm ﬂat applicator using (a)
penEasy and (b) the HMC algorithm. (c) Depth dose proﬁles obtained with both codes and (d), their
transverse proﬁles at the water surface, at the bone surface and right after the bone layer.
(a) (b)
(c) (d)
Figure 6.22: 2D dose distribution in the air gap phantom for the 20 mm ﬂat applicator using (a)
penEasy and (b) the HMC algorithm. (c) Depth dose proﬁles obtained with both codes starting after
the air gap and (d), their transverse proﬁles at 2 mm, 4 mm and 6 mm depth.
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(a) (b)
(c) (d)
Figure 6.23: 2D dose distribution in the lead protection disk phantom for the 30 mm surface applicator
using (a) penEasy and (b) the HMC algorithm. (c) Depth dose proﬁles obtained with both codes and
(d), their transverse proﬁles at the water surface, at the lead interface and right after the disk.
In the case of the dose comparison for the air gap phantom (ﬁgure 6.22), the dose distributions
seem to diﬀer in the air material. This is due to the low interaction that the photons present in
air. In the penEasy dose distribution, despite the high number of initial histories, the statistics
in air are very low, while this does not happen in the HMC, as we have previously explained.
However, right after the air gap both distributions behave similarly, which proves that the HMC
reproduces accurately the physical interactions in the diﬀerent media. If the number of histories
employed in the penEasy simulation would have been much higher, the resulting dose distribution
would behave as the one of the HMC. Therefore, once again it seems that the HMC reproduces
the reference dose distributions in heterogeneous phantoms.
Gamma evaluations have been done as well. The next tables contain the percentage of voxels
with γ < 1 with diﬀerent criteria: 1% - 1 mm, 2% - 1 mm and 5% - 1 mm (5% threshold).
147
6. Hybrid Monte Carlo for dose calculation
Gamma evaluation in the bone layer phantom
1% - 1 mm 2% - 1 mm 5% - 1 mm
Flat 10 mm 90.18% 95.57% 98.97%
Flat 20 mm 90.18% 95.57% 98.97%
Flat 30 mm 90.60% 95.31% 98.64%
Flat 40 mm 91.45% 96.23% 99.21%
Flat 50 mm 91.19% 95.28% 98.25%
Flat 60 mm 92.65% 96.99% 99.41%
Surface 10 mm 89.77% 95.97% 98.35%
Surface 20 mm 90.36% 95.79% 98.25%
Surface 30 mm 90.41% 95.79% 98.43%
Surface 40 mm 90.73% 96.43% 99.32%
Table 6.10: Results of gamma evaluation between MC simulations and HMC calculations in the bone
layer phantom (5% threshold).
Gamma evaluation in the air gap phantom
1% - 1 mm 2% - 1 mm 5% - 1 mm
Flat 10 mm 93.37% 96.47% 98.84%
Flat 20 mm 95.06% 97.30% 99.02%
Flat 30 mm 95.52% 97.79% 99.19%
Flat 40 mm 94.90% 97.60% 99.08%
Flat 50 mm 94.31% 97.56% 99.08%
Flat 60 mm 94.72% 98.12% 99.21%
Surface 10 mm 93.52% 96.87% 98.85%
Surface 20 mm 94.87% 97.51% 98.96%
Surface 30 mm 95.43% 97.92% 99.36%
Surface 40 mm 96.01% 98.27% 99.39%
Table 6.11: Results of gamma evaluation between MC simulations and HMC calculations in the air gap
phantom (5% threshold).
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Gamma evaluation in the protection lead disk phantom
1% - 1 mm 2% - 1 mm 5% - 1 mm
Flat 10 mm 87.17% 93.82% 96.17%
Flat 20 mm 87.48% 92.44% 96.41%
Flat 30 mm 87.71% 92.55% 96.05%
Flat 40 mm 86.50% 92.08% 95.78%
Flat 50 mm 87.63% 93.13% 96.35%
Flat 60 mm 88.10% 93.12% 96.55%
Surface 10 mm 88.97% 93.24% 94.50%
Surface 20 mm 87.10% 91.08% 93.24%
Surface 30 mm 86.08% 90.48% 94.32%
Surface 40 mm 85.97% 91.36% 95.61%
Table 6.12: Results of gamma evaluation between MC simulations and HMC calculations in the
protection lead disk phantom (5% threshold).
We obtain a good gamma evaluation with a 2%-1 mm criterion for all applicators in the bone
layer and in the air gap phantoms, where more than 95% voxels pass the evaluation. In the
protection disk phantom the number of voxels with γ < 1 is lower, and even with the 5%-1 mm
limits we still have some applicators with less than 95% voxels passing. Again, this case presents
very high dose diﬀerences in the interface water-lead, and, besides, after 5 mm the dose falls
abruptly to 0, decreasing considerably the number of voxels involved in the evaluation.
6.5.3 Validation in clinical situations
Finally, to conclude the validation of the HMC, two simulations have been performed in a patient
CT. We will focus on two of the most common treatments with Intrabeam R© nowadays: A partial
breast irradiation and a Kypho-IORT.
6.5.3.1 Simulation of a partial breast irradiation treatment planning
The aim of partial breast irradiation is to reduce the risk of local recurrence in the tumor bed
after the surgery. In this case, the surgery is immediately followed by an irradiation of the
surrounding tissue, requiring approximately 2-3 hours for the entire process, reducing overall
treatment time and cost [Bouzid et al., 2015]. The main diﬃculty is to obtain reliable data of
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the dose distribution inside the patient, because, as it is been previously explained in this thesis,
at the Intrabeam R© working energies the dose gradients are so high that measuring them is a
very diﬃcult task. Furthermore, at 50 kV the assumption of considering the patient as water
may not be appropriate, particularly in regions where tissue densities and heterogeneities may be
present. In order to overcome these limitations, some MC dose calculations platforms have been
developed [Bouzid et al., 2015]. However, the time limitation in the clinic requires the look for
other alternatives, such as the HMC. To test the viability of our algorithm in a real CT planning,
a comparison against penEasy has been done.
We used a thorax CT from a female patient to calculate dose distributions in breast with
penEasy and the HMC. The region of interest of our CT had (340×340×400) voxels with a
voxel size of 0.5 mm. For the HMC calculations, 5·106 histories were enough to achieve good
statistics, taking less than 5 minutes simulation time, while 109 histories were needed in penEasy
(several days of computation time). The results of the simulation are shown in ﬁgure 6.24, where
dose distributions in the transverse, coronal and sagittal views are represented for (a) penEasy
calculation and (b) HMC calculation.
Transverse view Coronal view Sagittal view
(a)
(b)
Figure 6.24: Dose distribution on a CT representing a breast conserving treatment with (a) penEasy,
(b) HMC
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Dose distributions were evaluated by means of a gamma index. We used the 2%-1 mm criterion
and 5% threshold. 95.51% of the voxels passed these values, as can be seen in ﬁgure 6.25, where
the gamma distribution is represented. The black voxels correspond to the point which failed
the gamma evaluation.
0
> 1
Transverse view Coronal view Sagittal view
Gamma values
Figure 6.25: Gamma distribution on the partial breast irradiation treatment simulation with a 2%-1
mm criterion and 5% threshold. 95.51% of the voxels passed the evaluation.
6.5.3.2 Simulation of a Kypho-IORT treatment planning
The skeletal system is one of the most common places that develop metastases. Up to 85%
of the patients with breast, prostate and lung cancer suﬀer from bone metastases, of which
approximately 50% are in the spinal cord [Schneider et al., 2011]. Cancer treatments in the
spine are usually treated with a combination of radiotherapy (for tumor treatment) and surgery
(for pain relief). Kypho-IORT is a novel treatment that combines both treatments in a single
procedure, shortening overall treatment time up to 90 minutes [Wenz et al., 2010]. The needle
applicator is placed in the center of the metastases, irradiating the tissue with 8 Gy at 5 mm
distance during 90 seconds. Then, Intrabeam R© source is removed and the surgeon proceeds to
perform the kyphoplasty.
As in the breast study, it is very diﬃcult to obtain the dose deposited during the IORT treatment
inside the patient, and the water approximation is particularly not accurate in this case, as
very diﬀerent density tissues are involved (vertebral bone, tissue, lung). Therefore, our HMC
seems to be a good candidate for dose calculation. We have calculated the dose delivered with
the Intrabeam R© needle applicator in a patient CT and we have compared the results with
penEasy.
A patient CT scan of the spine was used to compute dose distributions with penEasy and the
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HMC. The image had (150×150×150) voxels with a voxel size of 0.5 mm. As in the breast
study, 5·106 histories were enough to achieve good statistics in the HMC dose calculation, taking
less than 5 minutes simulation time, while in penEasy we needed 109 histories. The results of
the simulation are shown in ﬁgure 6.26, where dose distributions in the transverse, coronal and
sagital views are represented for (a) penEasy calculation and (b) HMC calculation.
Transverse view Coronal view Sagital view
(a)
(b)
Figure 6.26: Dose distribution on a CT representing a Kypho-IORT treatment with (a) penEasy, (b)
HMC
A gamma evaluation was performed for the 2%-1mm criterion and 5% threshold. 95.11% of
the voxels passed these values, as can be seen in ﬁgure 6.27, where the gamma distribution is
represented. The black voxels correspond to the points which failed the gamma evaluation.
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Figure 6.27: Gamma distribution on the Kypho-IORT treatment simulation with a 2%-1 mm criterion
and 5% threshold. 95.11% of the voxels passed the evaluation.
6.6 Conclusion
In this chapter we present an in-house developed dose calculation algorithm suitable for XIORT
with the Intrabeam R© device, calledHybrid Monte Carlo (HMC). This algorithm includes all
the physics of a MC calculation and generates dose distributions suitable for dose planning within
minutes. It takes into consideration photoelectric and Compton interactions, and brings to the
extreme some variance reduction techniques to accelerate the calculations. As a result, instead of
the regular histories used in any standard MC, the HMC employs meta-histories. Each m-history
represents the fate of many photons and has a special property, diﬀerent from the common MC:
the m-histories never die, only their weights are decreased after each interaction.
This characteristic allows us to know how many times has each m-history interacted inside each
voxels, and which voxels has the ray crossed. By knowing this, we can perform a normalization of
the dose, eliminating the dependence on how many histories have deposited dose into each voxel
(which introduces artifacts if the number of m-histories is not high enough), and introducing an
ideal ﬂuence that only depends on the trajectory of the m-history.
By doing this, we are able to obtain very soft dose distributions (free of statistical noise) using
only few m-histories, shortening considerably the simulation time. The normalization does not
aﬀect to the physics of the radiation, as all the possible interactions are contemplated in the
weight of the m-history, not in its ﬂuence.
We have validated the HMC against penEasy in diﬀerent phantoms, including homogeneous and
heterogeneous media. We have also compared dose distributions in two clinical situations, a
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partial breast irradiation and a Kypho-IORT. In general, good results were obtained with the
gamma evaluation, for some situations even with the 1%-1 mm criterion. In a few cases we had
to go to a 5%-1 mm criterion to achieve a good agreement. However, the gamma limits for
the Intrabeam R© has not been stipulated, and values of previous studies can go from 2%-1 mm
[Nwankwo et al., 2013], 2%-2 mm [Clausen et al., 2012] to even 10%-1 mm [Chiavassa et al.,
2014].
Therefore, we can conclude that the HMC is a powerful tool that provides soft dose distributions
accurately and within minutes. It can be used as a dose calculation tool in the operating room
(OR), as its high speed allows an on-the-ﬂy dose calculation which includes the realistic eﬀects
of the beam in the diﬀerent tissues within the patient's body.
The HMC, in combination with the phase space optimization process described in chapter 4,
provides dose distributions that reproduce the experimental data of any given Intrabeam R©'s
applicator in minutes, and both codes have been integrated into radiance R©.
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The main contributions and conclusions of the thesis are summarized in this chapter.
Detailed simulation of IORT systems
We have simulated the most relevant dedicated accelerators employed in IOERT treatments (ie.
NOVAC R©, LIAC R© and MOBETRON R©) with their corresponding applicators, and Intrabeam R©
needle, spherical, surface and ﬂat applicators. In most cases, the diﬀerent components of
the devices have been extracted from literature, in other cases, such as for ﬂat and surface
Intrabeam R© applicators, the geometry details have been provided by the vendor. These
simulations will represent a reference accelerator or applicator, and will be used to create a
database that will be employed to generate a PHSP ﬁle tuned to each user machine in a dose
treatment planning procedure.
After characterizing each device, we used the geometries to calculate monoenergetic simulations
and store the PHSP ﬁles and DDPs. The PHSP ﬁles were parameterized in order to reduce the
size of the ﬁles. The monoenergetic simulations covered the energy range of the devices. For
the IOERT accelerators, 140 simulations, from 1 MeV to 14 MeV were done. In the case of
Intrabeam R© applicators we calculated 50 simulations, from 1 to 50 keV.
The conclusions of this part are:
• Regarding the X-ray source study, a slight anisotropy in the backward direction of the dose
can be seen, which is consistent with previous studies [Dinsmore et al., 1996, Beatty et al.,
1996], where an increase along the probe in the backward direction was observed from the
escaping photons through beryllium.
• For the spherical applicators characterization, the backwards anisotropy seen in the
experimental measurements was reproduced by displacing the PHSP ﬁle that replaces the
XRS around 2 mm from the geometrical center of the applicator, corresponding to leaving
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a 2 mm extra space in the hole inside the applicator to guarantee the protection of the
XRS against the applicator walls when inserting it.
• In the simpliﬁed approach for the spherical applicators, while the possible diﬀerences in the
energy deposition distribution with depth will be absorbed afterwards in the optimization
process, the anisotropy will not be reproduced.
• For the ﬂat and surface Intrabeam R© applicators, the detailed geometries provided by the
vendor led to accurate dose distributions for all diameters.
• Regarding the electron beam dedicated accelerators, we were able to reproduce the dose
distributions by extracting the information from the literature and tuning the geometries.
• While for the LIAC R© and the NOVAC R© the same geometries were used to simulate all the
applicators and energies, for the MOBETRON R© we had to re-adjust slightly the geometries
for each case, due to changes in the transverse proﬁles with every applicator. This is
possibly a consequence of its soft-docking system.
• The parameterization performed to the PHSP ﬁles reduce the number of lines of each ﬁle
up to a maximum of 2 million. Regarding the bin size, a trade-oﬀ between accuracy of the
representation and number of requested bins was made.
Phase space optimization process and validation
We have developed a fast and accurate accelerator's tuning tool which can be optimized to the
user's device with only an experimental DDP in water [Ibáñez et al., 2015, Vidal et al., 2015,
Udías et al., 2017a] for IOERT accelerators and Intrabeam R© applicators. This optimization
process will be possible thanks to the database of monochromatic PHSP ﬁles and DDPs in
water that has been obtained and stored from the detailed simulations that we have previously
done.
A complete validation has been carried out against experimental measurements.
We have seen that:
• The procedure works accurately, reproducing the provided DDPs while maintaining the
physical shape of the spectra.
• Computation time of the whole optimization is below 10 minutes for all cases.
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• The optimization process only ﬁts the DDPs, which is why it is essential that the rest of
the dose distribution behaves correctly.
• By combining PHSP ﬁles and DDPs from realistic simulations and by using a realistic
shape of the energy spectra we guarantee an accurate behavior of the dose distributions,
not only of the DDP but also of the transverse proﬁles.
• For the validation of dose distributions in water with spherical applicators, we found some
discrepancies between simulations and measurements due to the anisotropy of the dose in
the backward direction.
• The next step in the future work should be correcting these discrepancies due to the
anisotropy by introducing an angular-dependent function in the X-rays beam ﬂuence.
• Regarding the dose distributions in water with ﬂat and surface applicators, we found a
good agreement for the two cases studied, with more than 95% of the voxels fulﬁlling the
gamma criterion at the 2%-2 mm level.
• In the dose comparisons inside heterogeneous phantoms, either with Intrabeam R©
applicators or IOERT accelerators, we reached a reasonable agreement at the 2%-2 mm
level, specially considering that a non-negligible contribution to the dose diﬀerences is
attributed to uncertainties in the measurements, such as asymmetries or displacements of
the ﬁlms.
• When these uncertainties disappear, the agreement increases substantially, something that
has been seen in the validation of IOERT accelerators against simulations, where almost a
100% of the voxels passed the 2%-2 mm level in all the phantoms.
Hybrid Monte Carlo
We have developed a new dose computation algorithm for the Intrabeam R© applicators, named
hybrid Monte Carlo (HMC) [Vidal et al., 2014b,a, Udías et al., 2017b]. The HMC calculates
dose deposited by the Intrabeam R© device within minutes, fully taking into account the diﬀerent
tissues and structures in the region of patient, i.e. as derived from a CT image.
The HMC algorithm has been complemented with PHSP ﬁles generated for the needle, spherical,
ﬂat and surface applicators and has been validated in diﬀerent phantoms including clinical
situations.
We can conclude:
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• HMC computes an accurate dose for both homogeneous and heterogeneous media, as it
incorporates all the relevant physics processes at Intrabeam R© working energies.
• The savings in calculation time are possible thanks to taking to the extreme some variance
reduction techniques.
• By not letting the meta-histories die inside the volume, we can normalize the dose,
decreasing substantially the statistical noise of the distribution, and therefore, decreasing
the number of needed initial particles and consequently, the simulation time.
• The limitation of the number of Compton scatterings to one does not aﬀect the ﬁnal dose,
and the reduction of the simulation time is considerable.
• It can be considered that the electrons produced by the X-rays interactions inside the
media are absorbed in the same voxel as they are generated, provided voxel sizes not much
smaller than 0.25 mm.
• Regarding the validation of the HMC, good results were obtained, in general, with the
gamma evaluation, for some situations even with the 1%-1 mm criterion. In a few cases
we had to go to a 5%-1 mm criterion to achieve a good agreement. However, the gamma
criteria for the Intrabeam R© has not been stipulated, and values of previous studies can go
from 2%-1 mm [Nwankwo et al., 2013], 2%-2 mm [Clausen et al., 2012] to even 10%-1 mm
[Chiavassa et al., 2014].
• For all the validations performed, we see that the worst results in terms of gamma evaluation
appear when the dose gradients are higher, corresponding also to the cases were the number
of evaluated voxels is lower.
The ﬁnal conclusions of this thesis are:
• The proposed phase space optimization process works accurately reproducing dose
distributions in clinical situations for both electrons or X-rays beams. It has proven to
be fast, ﬂexible and accurately enough for IORT planning.
• The HMC provides soft dose distributions accurately and within minutes. It can be used
as a dose calculation tool in the operating room (OR), as its high speed allows an on-the-
ﬂy dose calculation which includes the realistic eﬀects of the beam in the diﬀerent tissues
within the patient's body.
• The HMC, in combination with the phase space optimization process, provides dose
distributions that reproduce the experimental data of any given Intrabeam R© in minutes,
and both codes have been integrated into radiance R© [Valdivieso-Casique et al., 2015,
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Pascau et al., 2012].
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Appendix A
Generation of the material list for the
Hybrid Monte Carlo
The Hybrid Monte Carlo extracts the photon's attenuation coeﬃcients for the diﬀerent materials
from PENELOPE. One of the programs included in the distribution package is tables, which
generates tables with the physical information (physical properties, interaction cross sections,
attenuation coeﬃcients, etc) from an input material data ﬁle. These material data ﬁles are
created by means of the material program which extracts atomic interaction data from the
PENELOPE database [Salvat et al., 2006].
Of all the physical information provided by the tables program for the diﬀerent materials, we will
be interested in the photon mass attenuation coeﬃcients. This table includes the photoelectric,
Compton, Rayleigh and pair production attenuation coeﬃcients for the selected material and for
diﬀerent energies. The attenuation table has to be interpolated to cover the energy range of the
Intrabeam R©, from 1 keV to 50 keV (50 values for each material).
We have implemented 20 materials in the HMC code, covering diﬀerent densities and materials
(biologic and non-biologic):
• Air [Reference density (g/cm3): 1.21·10−3]
• Water [Reference density (g/cm3): 1.00]
• Solid Water [Reference density (g/cm3): 1.02]
• Methacrylate [Reference density (g/cm3): 1.10]
• Aluminum [Reference density (g/cm3): 2.70]
• Brass [Reference density (g/cm3): 8.60]
• Lead [Reference density (g/cm3): 11.35]
• Copper [Reference density (g/cm3): 8.96]
• Cork [Reference density (g/cm3): 2.40·10−1]
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• Teﬂon [Reference density (g/cm3): 2.20]
• PVC [Reference density (g/cm3): 1.40]
• Dry Air [Reference density (g/cm3): 1.21·10−3]
• Lung [Reference density (g/cm3): 3.00·10−1]
• Adipose Tissue [Reference density (g/cm3): 9.20·10−1]
• Muscle Striated [Reference density (g/cm3): 1.04]
• Muscle [Reference density (g/cm3): 1.11]
• Sacrum [Reference density (g/cm3): 1.29]
• Rib [Reference density (g/cm3): 1.41]
• B100 [Reference density (g/cm3): 1.45]
• Cortical Bone [Reference density (g/cm3): 1.85]
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